AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR|CRUDE_CI_LOWER|CRUDE_CI_UPPER|CRUDE_RATE
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634568|Female|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|40634568|Female|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40463030|Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|40463030|Female|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|201297106|Female|All other|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|201297106|Female|All other|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40309832|Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|40309832|Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40214174|Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|40214174|Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|40158900|Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151170|Female|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|40151170|Female|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|39865121|Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|31|40382360|Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40634568|Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40463030|Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Anaplastic astrocytoma|2011-2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|185|201297106|Female|Anaplastic astrocytoma|2011-2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40309832|Female|Anaplastic astrocytoma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.2|0.1|Malignant|50|40214174|Female|Anaplastic astrocytoma|2013|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|40158900|Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|40151170|Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40634568|Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40463030|Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Anaplastic oligodendroglioma|2011-2015|~|~|~
0-19|~|~|~|Malignant|~|201297106|Female|Anaplastic oligodendroglioma|2011-2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40309832|Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40214174|Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40158900|Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40151170|Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|93|39865121|Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|92|39998876|Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|40165421|Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|40382360|Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|85|40576293|Female|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|40670476|Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|95|40634568|Female|Astrocytoma, NOS|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|40463030|Female|Astrocytoma, NOS|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Astrocytoma, NOS|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|432|201297106|Female|Astrocytoma, NOS|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|83|40309832|Female|Astrocytoma, NOS|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|40214174|Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40158900|Female|Astrocytoma, NOS|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40151170|Female|Astrocytoma, NOS|2015|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|29|39865121|Female|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|39998876|Female|Choroid plexus|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|40382360|Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|40670476|Female|Choroid plexus|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40634568|Female|Choroid plexus|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40634568|Female|Choroid plexus|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40463030|Female|Choroid plexus|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40463030|Female|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|129|201297106|Female|Choroid plexus|2011-2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|47|201297106|Female|Choroid plexus|2011-2015|0.0|0.0|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|40309832|Female|Choroid plexus|2012|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40309832|Female|Choroid plexus|2012|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40214174|Female|Choroid plexus|2013|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40214174|Female|Choroid plexus|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|40158900|Female|Choroid plexus|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40158900|Female|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|40151170|Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40151170|Female|Choroid plexus|2015|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|82|39865121|Female|Craniopharyngioma|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|77|39998876|Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|76|40165421|Female|Craniopharyngioma|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|40382360|Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|64|40576293|Female|Craniopharyngioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|40634568|Female|Craniopharyngioma|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40634568|Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|84|40463030|Female|Craniopharyngioma|2011|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40463030|Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|415|201297106|Female|Craniopharyngioma|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|201297106|Female|Craniopharyngioma|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|78|40309832|Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40309832|Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|85|40214174|Female|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40214174|Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|40158900|Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40158900|Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|79|40151170|Female|Craniopharyngioma|2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40151170|Female|Craniopharyngioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40634568|Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40463030|Female|Diffuse astrocytoma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Diffuse astrocytoma|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|34|201297106|Female|Diffuse astrocytoma|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40309832|Female|Diffuse astrocytoma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|40214174|Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|40158900|Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|40151170|Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.5|0.6|0.5|Malignant|216|39865121|Female|Embryonal/primitive/medulloblastoma|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.4|0.5|0.5|Malignant|185|39998876|Female|Embryonal/primitive/medulloblastoma|2005|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.4|0.6|0.5|Malignant|203|40165421|Female|Embryonal/primitive/medulloblastoma|2006|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.5|0.6|0.5|Malignant|221|40382360|Female|Embryonal/primitive/medulloblastoma|2007|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|40576293|Female|Embryonal/primitive/medulloblastoma|2008|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.4|0.6|0.5|Malignant|204|40670476|Female|Embryonal/primitive/medulloblastoma|2009|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.4|0.5|0.4|Malignant|174|40634568|Female|Embryonal/primitive/medulloblastoma|2010|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.4|0.6|0.5|Malignant|196|40463030|Female|Embryonal/primitive/medulloblastoma|2011|0.4|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Embryonal/primitive/medulloblastoma|2011-2015|~|~|~
0-19|0.4|0.5|0.5|Malignant|960|201297106|Female|Embryonal/primitive/medulloblastoma|2011-2015|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.4|0.5|0.4|Malignant|180|40309832|Female|Embryonal/primitive/medulloblastoma|2012|0.4|0.5|0.4
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.4|0.5|0.5|Malignant|187|40214174|Female|Embryonal/primitive/medulloblastoma|2013|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.5|0.6|0.5|Malignant|210|40158900|Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.4|0.5|0.5|Malignant|187|40151170|Female|Embryonal/primitive/medulloblastoma|2015|0.4|0.5|0.5
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Ependymoma variants|2010|~|~|~
0-19|~|~|~|Malignant|~|40634568|Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|21|40463030|Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40463030|Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|74|201297106|Female|Ependymoma variants|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|201297106|Female|Ependymoma variants|2011-2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40309832|Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40309832|Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40214174|Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40214174|Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|40158900|Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Malignant|~|40151170|Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|39865121|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40165421|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40382360|Female|Ependymoma/anaplastic ependymoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|75|40576293|Female|Ependymoma/anaplastic ependymoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|40634568|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|98|40463030|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Ependymoma/anaplastic ependymoma|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|450|201297106|Female|Ependymoma/anaplastic ependymoma|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|88|40309832|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|87|40214174|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|86|40158900|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|40151170|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|33|40382360|Female|Germ Cell Tumors|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|17|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|29|40576293|Female|Germ Cell Tumors|2008|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|19|40670476|Female|Germ Cell Tumors|2009|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|20|40634568|Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|53|40634568|Female|Germ Cell Tumors|2010|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|21|40463030|Female|Germ Cell Tumors|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|38|40463030|Female|Germ Cell Tumors|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|97|201297106|Female|Germ Cell Tumors|2011-2015|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Malignant|185|201297106|Female|Germ Cell Tumors|2011-2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Germ Cell Tumors|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|20|40309832|Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|20|40214174|Female|Germ Cell Tumors|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|47|40214174|Female|Germ Cell Tumors|2013|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|40158900|Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|35|40158900|Female|Germ Cell Tumors|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Benign/Borderline|18|40151170|Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Malignant|45|40151170|Female|Germ Cell Tumors|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.1|Malignant|53|39865121|Female|Glioblastoma|2004|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|40165421|Female|Glioblastoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|60|40382360|Female|Glioblastoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|39|40670476|Female|Glioblastoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|51|40634568|Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Glioblastoma|2011|~|~|~
0-19|0.1|0.2|0.2|Malignant|74|40463030|Female|Glioblastoma|2011|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Glioblastoma|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|352|201297106|Female|Glioblastoma|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|74|40309832|Female|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Glioblastoma|2013|~|~|~
0-19|0.1|0.2|0.2|Malignant|71|40214174|Female|Glioblastoma|2013|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|66|40158900|Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Glioblastoma|2015|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|40151170|Female|Glioblastoma|2015|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.7|0.6|Malignant|232|39865121|Female|Glioma malignant, NOS|2004|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.7|0.6|Malignant|234|39998876|Female|Glioma malignant, NOS|2005|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|246|40165421|Female|Glioma malignant, NOS|2006|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|265|40382360|Female|Glioma malignant, NOS|2007|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.8|0.7|Malignant|274|40576293|Female|Glioma malignant, NOS|2008|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|297|40670476|Female|Glioma malignant, NOS|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.7|0.6|Malignant|260|40634568|Female|Glioma malignant, NOS|2010|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|17|40463030|Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.7|0.9|0.8|Malignant|307|40463030|Female|Glioma malignant, NOS|2011|0.7|0.8|0.8
0-19|0.0|0.0|0.0|Benign/Borderline|76|201297106|Female|Glioma malignant, NOS|2011-2015|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|1330|201297106|Female|Glioma malignant, NOS|2011-2015|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|18|40309832|Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.5|0.6|0.6|Malignant|227|40309832|Female|Glioma malignant, NOS|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Glioma malignant, NOS|2013|~|~|~
0-19|0.6|0.8|0.7|Malignant|287|40214174|Female|Glioma malignant, NOS|2013|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Glioma malignant, NOS|2014|~|~|~
0-19|0.6|0.7|0.6|Malignant|254|40158900|Female|Glioma malignant, NOS|2014|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Glioma malignant, NOS|2015|~|~|~
0-19|0.6|0.7|0.6|Malignant|255|40151170|Female|Glioma malignant, NOS|2015|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|39998876|Female|Hemangioblastoma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40382360|Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|40634568|Female|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Hemangioblastoma|2011|~|~|~
0-19|~|~|~|Malignant|~|40463030|Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|90|201297106|Female|Hemangioblastoma|2011-2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|201297106|Female|Hemangioblastoma|2011-2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Hemangioblastoma|2012|~|~|~
0-19|~|~|~|Malignant|~|40309832|Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40214174|Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40214174|Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|29|40158900|Female|Hemangioblastoma|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40158900|Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40151170|Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40151170|Female|Hemangioblastoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|39998876|Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|40165421|Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40382360|Female|Hemangioma|2007|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|40576293|Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|40670476|Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|40634568|Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40634568|Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40463030|Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40463030|Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|318|201297106|Female|Hemangioma|2011-2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|201297106|Female|Hemangioma|2011-2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|40309832|Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40309832|Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|40214174|Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40214174|Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|63|40158900|Female|Hemangioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40158900|Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40151170|Female|Hemangioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40151170|Female|Hemangioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|40634568|Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|40463030|Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Local Extensions from Regional Tumors|2011-2015|~|~|~
0-19|~|~|~|Malignant|~|201297106|Female|Local Extensions from Regional Tumors|2011-2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|40309832|Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|40214174|Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|40158900|Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|40151170|Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|40634568|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|40463030|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Lymphomas and Hematopoietic Neoplasms|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|201297106|Female|Lymphomas and Hematopoietic Neoplasms|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|40309832|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|40214174|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|40158900|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|40151170|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|46|39865121|Female|Meningioma|2004|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|50|40165421|Female|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|40382360|Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40576293|Female|Meningioma|2008|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|58|40670476|Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|40634568|Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40634568|Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|40463030|Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40463030|Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|331|201297106|Female|Meningioma|2011-2015|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|21|201297106|Female|Meningioma|2011-2015|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|61|40309832|Female|Meningioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40309832|Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|73|40214174|Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40214174|Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|40158900|Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40158900|Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|40151170|Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40151170|Female|Meningioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|40382360|Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40576293|Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|40670476|Female|Mixed glioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Malignant|~|40634568|Female|Mixed glioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|40463030|Female|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Mixed glioma|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|55|201297106|Female|Mixed glioma|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|40309832|Female|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40214174|Female|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|40158900|Female|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|40151170|Female|Mixed glioma|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|39865121|Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|55|39998876|Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165421|Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|26|40165421|Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|52|40382360|Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|79|40576293|Female|Neoplasm, unspecified|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|40670476|Female|Neoplasm, unspecified|2009|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|40670476|Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|87|40634568|Female|Neoplasm, unspecified|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40634568|Female|Neoplasm, unspecified|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|66|40463030|Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|21|40463030|Female|Neoplasm, unspecified|2011|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|358|201297106|Female|Neoplasm, unspecified|2011-2015|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|104|201297106|Female|Neoplasm, unspecified|2011-2015|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|68|40309832|Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|40309832|Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|71|40214174|Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|23|40214174|Female|Neoplasm, unspecified|2013|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|75|40158900|Female|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|22|40158900|Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|78|40151170|Female|Neoplasm, unspecified|2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|40151170|Female|Neoplasm, unspecified|2015|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|113|39865121|Female|Nerve sheath, benign and malignant|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|158|39998876|Female|Nerve sheath, benign and malignant|2005|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40165421|Female|Nerve sheath, benign and malignant|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40382360|Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|40576293|Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|149|40670476|Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|126|40634568|Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40634568|Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|129|40463030|Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40463030|Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|638|201297106|Female|Nerve sheath, benign and malignant|2011-2015|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|201297106|Female|Nerve sheath, benign and malignant|2011-2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40309832|Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40309832|Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|40214174|Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40214174|Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|97|40158900|Female|Nerve sheath, benign and malignant|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40158900|Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40151170|Female|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40151170|Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|40634568|Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|40463030|Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Neuroepithelial|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|33|201297106|Female|Neuroepithelial|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|40309832|Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|40214174|Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|40158900|Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|40151170|Female|Neuroepithelial|2015|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|136|39998876|Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.2|0.4|0.3|Benign/Borderline|121|40165421|Female|Neuronal/glial, neuronal|2006|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40165421|Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|137|40382360|Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|133|40576293|Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|134|40670476|Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|144|40634568|Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|19|40634568|Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|150|40463030|Female|Neuronal/glial, neuronal|2011|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40463030|Female|Neuronal/glial, neuronal|2011|~|~|~
0-19|0.4|0.4|0.4|Benign/Borderline|785|201297106|Female|Neuronal/glial, neuronal|2011-2015|0.4|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|94|201297106|Female|Neuronal/glial, neuronal|2011-2015|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|153|40309832|Female|Neuronal/glial, neuronal|2012|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|16|40309832|Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|159|40214174|Female|Neuronal/glial, neuronal|2013|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|23|40214174|Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|156|40158900|Female|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|25|40158900|Female|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|167|40151170|Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|16|40151170|Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|40382360|Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40576293|Female|Oligodendroglioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40634568|Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40463030|Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Oligodendroglioma|2011-2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|92|201297106|Female|Oligodendroglioma|2011-2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|22|40309832|Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|40214174|Female|Oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|40158900|Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|40151170|Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|39998876|Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|40382360|Female|Other mesenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|40576293|Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|28|40670476|Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|40634568|Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40634568|Female|Other mesenchymal|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|40463030|Female|Other mesenchymal|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40463030|Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|202|201297106|Female|Other mesenchymal|2011-2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|25|201297106|Female|Other mesenchymal|2011-2015|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|51|40309832|Female|Other mesenchymal|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|40309832|Female|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|40214174|Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40214174|Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|40158900|Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40158900|Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|40151170|Female|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40151170|Female|Other mesenchymal|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.7|0.9|0.8|Malignant|330|39865121|Female|Pilocytic astrocytoma|2004|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.7|0.9|0.8|Malignant|321|39998876|Female|Pilocytic astrocytoma|2005|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.7|0.9|0.8|Malignant|315|40165421|Female|Pilocytic astrocytoma|2006|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|334|40382360|Female|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.7|0.9|0.8|Malignant|334|40576293|Female|Pilocytic astrocytoma|2008|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|349|40670476|Female|Pilocytic astrocytoma|2009|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.1|1.0|Malignant|390|40634568|Female|Pilocytic astrocytoma|2010|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|353|40463030|Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|201297106|Female|Pilocytic astrocytoma|2011-2015|~|~|~
0-19|0.9|0.9|0.9|Malignant|1808|201297106|Female|Pilocytic astrocytoma|2011-2015|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.8|1.0|0.9|Malignant|367|40309832|Female|Pilocytic astrocytoma|2012|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.8|1.0|0.9|Malignant|355|40214174|Female|Pilocytic astrocytoma|2013|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.1|1.0|Malignant|390|40158900|Female|Pilocytic astrocytoma|2014|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|343|40151170|Female|Pilocytic astrocytoma|2015|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|40576293|Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|40634568|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|40634568|Female|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|40463030|Female|Pineal parenchymal|2011|~|~|~
0-19|~|~|~|Malignant|~|40463030|Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|26|201297106|Female|Pineal parenchymal|2011-2015|0.0|0.0|0.0
0-19|0.0|0.1|0.0|Malignant|82|201297106|Female|Pineal parenchymal|2011-2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|40309832|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Malignant|~|40309832|Female|Pineal parenchymal|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|40214174|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|40214174|Female|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|40158900|Female|Pineal parenchymal|2014|~|~|~
0-19|~|~|~|Malignant|~|40158900|Female|Pineal parenchymal|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|40151170|Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|40151170|Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|0.6|0.7|0.6|Benign/Borderline|263|39865121|Female|Pituitary|2004|0.6|0.7|0.7
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|299|39998876|Female|Pituitary|2005|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|346|40165421|Female|Pituitary|2006|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|325|40382360|Female|Pituitary|2007|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|387|40576293|Female|Pituitary|2008|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|380|40670476|Female|Pituitary|2009|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|441|40634568|Female|Pituitary|2010|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40634568|Female|Pituitary|2010|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|439|40463030|Female|Pituitary|2011|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40463030|Female|Pituitary|2011|~|~|~
0-19|1.0|1.1|1.1|Benign/Borderline|2205|201297106|Female|Pituitary|2011-2015|1.1|1.1|1.1
0-19|~|~|~|Malignant|~|201297106|Female|Pituitary|2011-2015|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|462|40309832|Female|Pituitary|2012|1.0|1.3|1.1
0-19|~|~|~|Malignant|~|40309832|Female|Pituitary|2012|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|425|40214174|Female|Pituitary|2013|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40214174|Female|Pituitary|2013|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|456|40158900|Female|Pituitary|2014|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40158900|Female|Pituitary|2014|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|423|40151170|Female|Pituitary|2015|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40151170|Female|Pituitary|2015|~|~|~
0-19|1.8|2.1|1.9|Benign/Borderline|773|39865121|Female|Total|2004|1.8|2.1|1.9
0-19|3.1|3.5|3.3|Malignant|1307|39865121|Female|Total|2004|3.1|3.5|3.3
0-19|2.1|2.4|2.3|Benign/Borderline|931|39998876|Female|Total|2005|2.2|2.5|2.3
0-19|2.9|3.3|3.1|Malignant|1232|39998876|Female|Total|2005|2.9|3.3|3.1
0-19|2.2|2.5|2.3|Benign/Borderline|955|40165421|Female|Total|2006|2.2|2.5|2.4
0-19|2.9|3.2|3.1|Malignant|1227|40165421|Female|Total|2006|2.9|3.2|3.1
0-19|2.2|2.5|2.3|Benign/Borderline|955|40382360|Female|Total|2007|2.2|2.5|2.4
0-19|3.1|3.4|3.2|Malignant|1297|40382360|Female|Total|2007|3.0|3.4|3.2
0-19|2.4|2.7|2.5|Benign/Borderline|1045|40576293|Female|Total|2008|2.4|2.7|2.6
0-19|3.0|3.3|3.2|Malignant|1278|40576293|Female|Total|2008|3.0|3.3|3.1
0-19|2.4|2.7|2.6|Benign/Borderline|1061|40670476|Female|Total|2009|2.5|2.8|2.6
0-19|3.0|3.4|3.2|Malignant|1290|40670476|Female|Total|2009|3.0|3.3|3.2
0-19|2.6|2.9|2.7|Benign/Borderline|1131|40634568|Female|Total|2010|2.6|3.0|2.8
0-19|3.0|3.4|3.2|Malignant|1296|40634568|Female|Total|2010|3.0|3.4|3.2
0-19|2.6|3.0|2.8|Benign/Borderline|1149|40463030|Female|Total|2011|2.7|3.0|2.8
0-19|3.1|3.5|3.3|Malignant|1343|40463030|Female|Total|2011|3.1|3.5|3.3
0-19|2.8|3.0|2.9|Benign/Borderline|5885|201297106|Female|Total|2011-2015|2.8|3.0|2.9
0-19|3.1|3.3|3.2|Malignant|6458|201297106|Female|Total|2011-2015|3.1|3.3|3.2
0-19|2.8|3.1|2.9|Benign/Borderline|1194|40309832|Female|Total|2012|2.8|3.1|3.0
0-19|2.9|3.2|3.0|Malignant|1220|40309832|Female|Total|2012|2.9|3.2|3.0
0-19|2.8|3.1|2.9|Benign/Borderline|1181|40214174|Female|Total|2013|2.8|3.1|2.9
0-19|3.1|3.5|3.3|Malignant|1325|40214174|Female|Total|2013|3.1|3.5|3.3
0-19|2.8|3.1|2.9|Benign/Borderline|1180|40158900|Female|Total|2014|2.8|3.1|2.9
0-19|3.2|3.5|3.3|Malignant|1337|40158900|Female|Total|2014|3.2|3.5|3.3
0-19|2.8|3.1|2.9|Benign/Borderline|1181|40151170|Female|Total|2015|2.8|3.1|2.9
0-19|2.9|3.2|3.1|Malignant|1233|40151170|Female|Total|2015|2.9|3.2|3.1
0-19|0.2|0.3|0.3|Benign/Borderline|113|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|158|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|124|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|149|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|126|40634568|Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40634568|Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|129|40463030|Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40463030|Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|638|201297106|Female|Tumors of Cranial and Spinal Nerves|2011-2015|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|201297106|Female|Tumors of Cranial and Spinal Nerves|2011-2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40309832|Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40309832|Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|135|40214174|Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40214174|Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|97|40158900|Female|Tumors of Cranial and Spinal Nerves|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40158900|Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|146|40151170|Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40151170|Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|188|39865121|Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.5
0-19|2.9|3.2|3.0|Malignant|1209|39865121|Female|Tumors of Neuroepthelial Tissue|2004|2.9|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|195|39998876|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.6|0.5
0-19|2.7|3.0|2.9|Malignant|1141|39998876|Female|Tumors of Neuroepthelial Tissue|2005|2.7|3.0|2.9
0-19|0.4|0.6|0.5|Benign/Borderline|200|40165421|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.6|0.5
0-19|2.7|3.1|2.9|Malignant|1157|40165421|Female|Tumors of Neuroepthelial Tissue|2006|2.7|3.1|2.9
0-19|0.5|0.6|0.6|Benign/Borderline|227|40382360|Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|2.9|3.2|3.1|Malignant|1234|40382360|Female|Tumors of Neuroepthelial Tissue|2007|2.9|3.2|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|226|40576293|Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.6
0-19|2.9|3.2|3.0|Malignant|1224|40576293|Female|Tumors of Neuroepthelial Tissue|2008|2.8|3.2|3.0
0-19|0.4|0.6|0.5|Benign/Borderline|209|40670476|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.6|0.5
0-19|2.8|3.2|3.0|Malignant|1208|40670476|Female|Tumors of Neuroepthelial Tissue|2009|2.8|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|230|40634568|Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
0-19|2.8|3.2|3.0|Malignant|1215|40634568|Female|Tumors of Neuroepthelial Tissue|2010|2.8|3.2|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|239|40463030|Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1261|40463030|Female|Tumors of Neuroepthelial Tissue|2011|2.9|3.3|3.1
0-19|0.6|0.6|0.6|Benign/Borderline|1229|201297106|Female|Tumors of Neuroepthelial Tissue|2011-2015|0.6|0.6|0.6
0-19|2.9|3.1|3.0|Malignant|6068|201297106|Female|Tumors of Neuroepthelial Tissue|2011-2015|2.9|3.1|3.0
0-19|0.5|0.7|0.6|Benign/Borderline|249|40309832|Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.7|0.6
0-19|2.7|3.0|2.9|Malignant|1157|40309832|Female|Tumors of Neuroepthelial Tissue|2012|2.7|3.0|2.9
0-19|0.6|0.7|0.6|Benign/Borderline|256|40214174|Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1236|40214174|Female|Tumors of Neuroepthelial Tissue|2013|2.9|3.2|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|241|40158900|Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.7|0.6
0-19|3.0|3.3|3.1|Malignant|1262|40158900|Female|Tumors of Neuroepthelial Tissue|2014|3.0|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|244|40151170|Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.7|0.6
0-19|2.7|3.0|2.9|Malignant|1152|40151170|Female|Tumors of Neuroepthelial Tissue|2015|2.7|3.0|2.9
0-19|0.8|1.0|0.9|Benign/Borderline|345|39865121|Female|Tumors of Sellar Region|2004|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|376|39998876|Female|Tumors of Sellar Region|2005|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|422|40165421|Female|Tumors of Sellar Region|2006|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|420|40382360|Female|Tumors of Sellar Region|2007|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|451|40576293|Female|Tumors of Sellar Region|2008|1.0|1.2|1.1
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008|~|~|~
0-19|1.0|1.2|1.1|Benign/Borderline|471|40670476|Female|Tumors of Sellar Region|2009|1.1|1.3|1.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|532|40634568|Female|Tumors of Sellar Region|2010|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40634568|Female|Tumors of Sellar Region|2010|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|523|40463030|Female|Tumors of Sellar Region|2011|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40463030|Female|Tumors of Sellar Region|2011|~|~|~
0-19|1.2|1.3|1.3|Benign/Borderline|2620|201297106|Female|Tumors of Sellar Region|2011-2015|1.3|1.4|1.3
0-19|~|~|~|Malignant|~|201297106|Female|Tumors of Sellar Region|2011-2015|~|~|~
0-19|1.2|1.4|1.3|Benign/Borderline|540|40309832|Female|Tumors of Sellar Region|2012|1.2|1.5|1.3
0-19|~|~|~|Malignant|~|40309832|Female|Tumors of Sellar Region|2012|~|~|~
0-19|1.1|1.4|1.3|Benign/Borderline|510|40214174|Female|Tumors of Sellar Region|2013|1.2|1.4|1.3
0-19|~|~|~|Malignant|~|40214174|Female|Tumors of Sellar Region|2013|~|~|~
0-19|1.2|1.5|1.3|Benign/Borderline|545|40158900|Female|Tumors of Sellar Region|2014|1.2|1.5|1.4
0-19|~|~|~|Malignant|~|40158900|Female|Tumors of Sellar Region|2014|~|~|~
0-19|1.1|1.4|1.2|Benign/Borderline|502|40151170|Female|Tumors of Sellar Region|2015|1.1|1.4|1.3
0-19|~|~|~|Malignant|~|40151170|Female|Tumors of Sellar Region|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|39865121|Female|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|109|39998876|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|40165421|Female|Tumors of the Meninges|2006|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|40382360|Female|Tumors of the Meninges|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|88|40576293|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|101|40670476|Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|95|40634568|Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|40634568|Female|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|104|40463030|Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|40463030|Female|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|623|201297106|Female|Tumors of the Meninges|2011-2015|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|48|201297106|Female|Tumors of the Meninges|2011-2015|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|126|40309832|Female|Tumors of the Meninges|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40309832|Female|Tumors of the Meninges|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|131|40214174|Female|Tumors of the Meninges|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40214174|Female|Tumors of the Meninges|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|40158900|Female|Tumors of the Meninges|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40158900|Female|Tumors of the Meninges|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|126|40151170|Female|Tumors of the Meninges|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40151170|Female|Tumors of the Meninges|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|44|39865121|Female|Unclassified Tumors|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|79|39998876|Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|20|39998876|Female|Unclassified Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|86|40165421|Female|Unclassified Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|78|40382360|Female|Unclassified Tumors|2007|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Unclassified Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|120|40576293|Female|Unclassified Tumors|2008|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|112|40670476|Female|Unclassified Tumors|2009|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|18|40670476|Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|128|40634568|Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|40634568|Female|Unclassified Tumors|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|133|40463030|Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|21|40463030|Female|Unclassified Tumors|2011|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|677|201297106|Female|Unclassified Tumors|2011-2015|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|108|201297106|Female|Unclassified Tumors|2011-2015|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|133|40309832|Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40309832|Female|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|128|40214174|Female|Unclassified Tumors|2013|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40214174|Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|138|40158900|Female|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|24|40158900|Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|145|40151170|Female|Unclassified Tumors|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|40151170|Female|Unclassified Tumors|2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|23|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|36|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|35|40382360|Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|24|40576293|Female|Unique astrocytoma variants|2008|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|40670476|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|20|40670476|Female|Unique astrocytoma variants|2009|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|28|40634568|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|40634568|Female|Unique astrocytoma variants|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|40463030|Female|Unique astrocytoma variants|2011|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|22|40463030|Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|132|201297106|Female|Unique astrocytoma variants|2011-2015|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|97|201297106|Female|Unique astrocytoma variants|2011-2015|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|30|40309832|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|40309832|Female|Unique astrocytoma variants|2012|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|32|40214174|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|40214174|Female|Unique astrocytoma variants|2013|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|37|40158900|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|40158900|Female|Unique astrocytoma variants|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|40151170|Female|Unique astrocytoma variants|2015|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|25|40151170|Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551249|Male|All other|2010|~|~|~
0-19|~|~|~|Malignant|~|42551249|Male|All other|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42375847|Male|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|42375847|Male|All other|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|210502329|Male|All other|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|44|210502329|Male|All other|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42186292|Male|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|42186292|Male|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42043641|Male|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|42043641|Male|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41963801|Male|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|41963801|Male|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41932748|Male|All other|2015|~|~|~
0-19|~|~|~|Malignant|~|41932748|Male|All other|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|41889233|Male|Anaplastic astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|35|42158997|Male|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.2|0.1|Malignant|54|42367071|Male|Anaplastic astrocytoma|2007|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|42|42541971|Male|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|40|42609915|Male|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42551249|Male|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|34|42375847|Male|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Anaplastic astrocytoma|2011-2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|223|210502329|Male|Anaplastic astrocytoma|2011-2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|43|42186292|Male|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|44|42043641|Male|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.2|0.1|Malignant|57|41963801|Male|Anaplastic astrocytoma|2014|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|45|41932748|Male|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|42551249|Male|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42375847|Male|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Anaplastic oligodendroglioma|2011-2015|~|~|~
0-19|~|~|~|Malignant|~|210502329|Male|Anaplastic oligodendroglioma|2011-2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42186292|Male|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42043641|Male|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41963801|Male|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41932748|Male|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.3|Malignant|110|41889233|Male|Astrocytoma, NOS|2004|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|99|42006384|Male|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|107|42158997|Male|Astrocytoma, NOS|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|96|42367071|Male|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|94|42541971|Male|Astrocytoma, NOS|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|42609915|Male|Astrocytoma, NOS|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42551249|Male|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|102|42375847|Male|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Astrocytoma, NOS|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|470|210502329|Male|Astrocytoma, NOS|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|83|42186292|Male|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|87|42043641|Male|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|108|41963801|Male|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|90|41932748|Male|Astrocytoma, NOS|2015|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42006384|Male|Choroid plexus|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42367071|Male|Choroid plexus|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|38|42551249|Male|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|42551249|Male|Choroid plexus|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|33|42375847|Male|Choroid plexus|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42375847|Male|Choroid plexus|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|178|210502329|Male|Choroid plexus|2011-2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|54|210502329|Male|Choroid plexus|2011-2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|37|42186292|Male|Choroid plexus|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42186292|Male|Choroid plexus|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|37|42043641|Male|Choroid plexus|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42043641|Male|Choroid plexus|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|41963801|Male|Choroid plexus|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41963801|Male|Choroid plexus|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|35|41932748|Male|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|17|41932748|Male|Choroid plexus|2015|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|83|41889233|Male|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|94|42006384|Male|Craniopharyngioma|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|42158997|Male|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|86|42367071|Male|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42541971|Male|Craniopharyngioma|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|81|42609915|Male|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|82|42551249|Male|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42551249|Male|Craniopharyngioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|69|42375847|Male|Craniopharyngioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42375847|Male|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|432|210502329|Male|Craniopharyngioma|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|210502329|Male|Craniopharyngioma|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|80|42186292|Male|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42186292|Male|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|42043641|Male|Craniopharyngioma|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42043641|Male|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|103|41963801|Male|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41963801|Male|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|91|41932748|Male|Craniopharyngioma|2015|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41932748|Male|Craniopharyngioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|42367071|Male|Diffuse astrocytoma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42551249|Male|Diffuse astrocytoma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.1|Malignant|24|42375847|Male|Diffuse astrocytoma|2011|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Diffuse astrocytoma|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|63|210502329|Male|Diffuse astrocytoma|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42186292|Male|Diffuse astrocytoma|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|42043641|Male|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|41963801|Male|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|41932748|Male|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.8|0.7|Malignant|292|41889233|Male|Embryonal/primitive/medulloblastoma|2004|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.6|0.8|0.7|Malignant|279|42006384|Male|Embryonal/primitive/medulloblastoma|2005|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.8|0.7|Malignant|293|42158997|Male|Embryonal/primitive/medulloblastoma|2006|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.8|0.7|Malignant|298|42367071|Male|Embryonal/primitive/medulloblastoma|2007|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.7|0.8|0.8|Malignant|321|42541971|Male|Embryonal/primitive/medulloblastoma|2008|0.7|0.8|0.8
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.7|0.8|0.7|Malignant|310|42609915|Male|Embryonal/primitive/medulloblastoma|2009|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.7|0.8|0.7|Malignant|313|42551249|Male|Embryonal/primitive/medulloblastoma|2010|0.7|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.6|0.8|0.7|Malignant|300|42375847|Male|Embryonal/primitive/medulloblastoma|2011|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Embryonal/primitive/medulloblastoma|2011-2015|~|~|~
0-19|0.6|0.7|0.7|Malignant|1431|210502329|Male|Embryonal/primitive/medulloblastoma|2011-2015|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.6|0.8|0.7|Malignant|287|42186292|Male|Embryonal/primitive/medulloblastoma|2012|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.6|0.7|0.7|Malignant|274|42043641|Male|Embryonal/primitive/medulloblastoma|2013|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.6|0.7|0.7|Malignant|276|41963801|Male|Embryonal/primitive/medulloblastoma|2014|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.6|0.8|0.7|Malignant|294|41932748|Male|Embryonal/primitive/medulloblastoma|2015|0.6|0.8|0.7
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Ependymoma variants|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42609915|Male|Ependymoma variants|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42551249|Male|Ependymoma variants|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42551249|Male|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42375847|Male|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42375847|Male|Ependymoma variants|2011|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|82|210502329|Male|Ependymoma variants|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|210502329|Male|Ependymoma variants|2011-2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42186292|Male|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42186292|Male|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42043641|Male|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42043641|Male|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|41963801|Male|Ependymoma variants|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41932748|Male|Ependymoma variants|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41932748|Male|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|103|41889233|Male|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|106|42006384|Male|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|111|42158997|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42367071|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.3|0.2|Malignant|97|42541971|Male|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|121|42551249|Male|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|116|42375847|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Ependymoma/anaplastic ependymoma|2011-2015|~|~|~
0-19|0.2|0.3|0.3|Malignant|561|210502329|Male|Ependymoma/anaplastic ependymoma|2011-2015|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.3|Malignant|115|42186292|Male|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.3|Malignant|112|42043641|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41963801|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.3|Malignant|109|41932748|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Benign/Borderline|18|41889233|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|106|41889233|Male|Germ Cell Tumors|2004|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|42367071|Male|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|99|42367071|Male|Germ Cell Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|27|42609915|Male|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|97|42609915|Male|Germ Cell Tumors|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|21|42551249|Male|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.3|0.3|Malignant|112|42551249|Male|Germ Cell Tumors|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Germ Cell Tumors|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|100|42375847|Male|Germ Cell Tumors|2011|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|105|210502329|Male|Germ Cell Tumors|2011-2015|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|526|210502329|Male|Germ Cell Tumors|2011-2015|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|22|42186292|Male|Germ Cell Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|110|42186292|Male|Germ Cell Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|26|42043641|Male|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Malignant|109|42043641|Male|Germ Cell Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Benign/Borderline|25|41963801|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Malignant|103|41963801|Male|Germ Cell Tumors|2014|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|17|41932748|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Malignant|104|41932748|Male|Germ Cell Tumors|2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|74|41889233|Male|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005|~|~|~
0-19|0.1|0.2|0.1|Malignant|60|42006384|Male|Glioblastoma|2005|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|69|42367071|Male|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|67|42541971|Male|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009|~|~|~
0-19|0.2|0.2|0.2|Malignant|81|42609915|Male|Glioblastoma|2009|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.2|Malignant|68|42551249|Male|Glioblastoma|2010|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|83|42375847|Male|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Glioblastoma|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|411|210502329|Male|Glioblastoma|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Glioblastoma|2012|~|~|~
0-19|0.1|0.2|0.2|Malignant|79|42186292|Male|Glioblastoma|2012|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Glioblastoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|91|42043641|Male|Glioblastoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|76|41963801|Male|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|82|41932748|Male|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|229|41889233|Male|Glioma malignant, NOS|2004|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.5|Malignant|222|42006384|Male|Glioma malignant, NOS|2005|0.5|0.6|0.5
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|241|42158997|Male|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007|~|~|~
0-19|0.5|0.7|0.6|Malignant|243|42367071|Male|Glioma malignant, NOS|2007|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.6|Malignant|269|42541971|Male|Glioma malignant, NOS|2008|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|271|42609915|Male|Glioma malignant, NOS|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Glioma malignant, NOS|2010|~|~|~
0-19|0.6|0.8|0.7|Malignant|283|42551249|Male|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Glioma malignant, NOS|2011|~|~|~
0-19|0.6|0.7|0.6|Malignant|273|42375847|Male|Glioma malignant, NOS|2011|0.6|0.7|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|78|210502329|Male|Glioma malignant, NOS|2011-2015|0.0|0.0|0.0
0-19|0.6|0.7|0.6|Malignant|1355|210502329|Male|Glioma malignant, NOS|2011-2015|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Glioma malignant, NOS|2012|~|~|~
0-19|0.6|0.7|0.7|Malignant|275|42186292|Male|Glioma malignant, NOS|2012|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|16|42043641|Male|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|268|42043641|Male|Glioma malignant, NOS|2013|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|18|41963801|Male|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.5|0.7|0.6|Malignant|252|41963801|Male|Glioma malignant, NOS|2014|0.5|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|16|41932748|Male|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|287|41932748|Male|Glioma malignant, NOS|2015|0.6|0.8|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42158997|Male|Hemangioblastoma|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42367071|Male|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Hemangioblastoma|2010|~|~|~
0-19|~|~|~|Malignant|~|42551249|Male|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|24|42375847|Male|Hemangioblastoma|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42375847|Male|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|95|210502329|Male|Hemangioblastoma|2011-2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|210502329|Male|Hemangioblastoma|2011-2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|21|42186292|Male|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42186292|Male|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|42043641|Male|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42043641|Male|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|18|41963801|Male|Hemangioblastoma|2014|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41963801|Male|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|16|41932748|Male|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|41932748|Male|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|30|41889233|Male|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|19|42006384|Male|Hemangioma|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42158997|Male|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42367071|Male|Hemangioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|41|42541971|Male|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|42609915|Male|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|52|42551249|Male|Hemangioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42551249|Male|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|65|42375847|Male|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42375847|Male|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|285|210502329|Male|Hemangioma|2011-2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|210502329|Male|Hemangioma|2011-2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|62|42186292|Male|Hemangioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42186292|Male|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|42043641|Male|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42043641|Male|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|54|41963801|Male|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41963801|Male|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|48|41932748|Male|Hemangioma|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41932748|Male|Hemangioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|42551249|Male|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|42375847|Male|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Local Extensions from Regional Tumors|2011-2015|~|~|~
0-19|~|~|~|Malignant|~|210502329|Male|Local Extensions from Regional Tumors|2011-2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|42186292|Male|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|42043641|Male|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|41963801|Male|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|41932748|Male|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|42551249|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|42375847|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Lymphomas and Hematopoietic Neoplasms|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|46|210502329|Male|Lymphomas and Hematopoietic Neoplasms|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Malignant|~|42186292|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|42043641|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|41963801|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|~|~|~|Malignant|~|41932748|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|45|41889233|Male|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42006384|Male|Meningioma|2005|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|51|42158997|Male|Meningioma|2006|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|49|42367071|Male|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|56|42541971|Male|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|42609915|Male|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|53|42551249|Male|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42551249|Male|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|67|42375847|Male|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42375847|Male|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|312|210502329|Male|Meningioma|2011-2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|210502329|Male|Meningioma|2011-2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|42186292|Male|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42186292|Male|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|55|42043641|Male|Meningioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|42043641|Male|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|59|41963801|Male|Meningioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|41963801|Male|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|70|41932748|Male|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41932748|Male|Meningioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42551249|Male|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Malignant|~|42375847|Male|Mixed glioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Mixed glioma|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|51|210502329|Male|Mixed glioma|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Malignant|~|42186292|Male|Mixed glioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Malignant|~|42043641|Male|Mixed glioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Malignant|~|41963801|Male|Mixed glioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|41932748|Male|Mixed glioma|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|55|42006384|Male|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|51|42158997|Male|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|63|42367071|Male|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|22|42367071|Male|Neoplasm, unspecified|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|47|42541971|Male|Neoplasm, unspecified|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|87|42609915|Male|Neoplasm, unspecified|2009|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|23|42609915|Male|Neoplasm, unspecified|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|79|42551249|Male|Neoplasm, unspecified|2010|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42551249|Male|Neoplasm, unspecified|2010|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|70|42375847|Male|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|16|42375847|Male|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|319|210502329|Male|Neoplasm, unspecified|2011-2015|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|110|210502329|Male|Neoplasm, unspecified|2011-2015|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|61|42186292|Male|Neoplasm, unspecified|2012|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|28|42186292|Male|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|66|42043641|Male|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|17|42043641|Male|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|70|41963801|Male|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|25|41963801|Male|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|52|41932748|Male|Neoplasm, unspecified|2015|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|24|41932748|Male|Neoplasm, unspecified|2015|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Nerve sheath, benign and malignant|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|121|42006384|Male|Nerve sheath, benign and malignant|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|169|42158997|Male|Nerve sheath, benign and malignant|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42367071|Male|Nerve sheath, benign and malignant|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42541971|Male|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|42609915|Male|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|137|42551249|Male|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42551249|Male|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|137|42375847|Male|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42375847|Male|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|704|210502329|Male|Nerve sheath, benign and malignant|2011-2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|210502329|Male|Nerve sheath, benign and malignant|2011-2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42186292|Male|Nerve sheath, benign and malignant|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42186292|Male|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42043641|Male|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42043641|Male|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|41963801|Male|Nerve sheath, benign and malignant|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41963801|Male|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|41932748|Male|Nerve sheath, benign and malignant|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41932748|Male|Nerve sheath, benign and malignant|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|42551249|Male|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|42375847|Male|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Neuroepithelial|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|210502329|Male|Neuroepithelial|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|42186292|Male|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|42043641|Male|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|41963801|Male|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|41932748|Male|Neuroepithelial|2015|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|148|41889233|Male|Neuronal/glial, neuronal|2004|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Neuronal/glial, neuronal|2005|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|158|42158997|Male|Neuronal/glial, neuronal|2006|0.3|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|172|42367071|Male|Neuronal/glial, neuronal|2007|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|176|42541971|Male|Neuronal/glial, neuronal|2008|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|28|42541971|Male|Neuronal/glial, neuronal|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|160|42609915|Male|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.5|0.4|Benign/Borderline|172|42551249|Male|Neuronal/glial, neuronal|2010|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42551249|Male|Neuronal/glial, neuronal|2010|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|186|42375847|Male|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|20|42375847|Male|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.5|0.5|Benign/Borderline|952|210502329|Male|Neuronal/glial, neuronal|2011-2015|0.4|0.5|0.5
0-19|0.0|0.1|0.1|Malignant|114|210502329|Male|Neuronal/glial, neuronal|2011-2015|0.0|0.1|0.1
0-19|0.4|0.6|0.5|Benign/Borderline|205|42186292|Male|Neuronal/glial, neuronal|2012|0.4|0.6|0.5
0-19|0.0|0.1|0.0|Malignant|18|42186292|Male|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|188|42043641|Male|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|23|42043641|Male|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.3|0.5|0.4|Benign/Borderline|170|41963801|Male|Neuronal/glial, neuronal|2014|0.3|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|29|41963801|Male|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|0.4|0.6|0.5|Benign/Borderline|203|41932748|Male|Neuronal/glial, neuronal|2015|0.4|0.6|0.5
0-19|0.0|0.1|0.1|Malignant|24|41932748|Male|Neuronal/glial, neuronal|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|27|42158997|Male|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|32|42541971|Male|Oligodendroglioma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42609915|Male|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|21|42551249|Male|Oligodendroglioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|42375847|Male|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Oligodendroglioma|2011-2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|99|210502329|Male|Oligodendroglioma|2011-2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|26|42186292|Male|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42043641|Male|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41963801|Male|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41932748|Male|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|26|42551249|Male|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|42551249|Male|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|34|42375847|Male|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42375847|Male|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|172|210502329|Male|Other mesenchymal|2011-2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|42|210502329|Male|Other mesenchymal|2011-2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|41|42186292|Male|Other mesenchymal|2012|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42186292|Male|Other mesenchymal|2012|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|33|42043641|Male|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42043641|Male|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|41963801|Male|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41963801|Male|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|32|41932748|Male|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41932748|Male|Other mesenchymal|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|1.0|0.9|Malignant|370|41889233|Male|Pilocytic astrocytoma|2004|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|351|42006384|Male|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|356|42158997|Male|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007|~|~|~
0-19|0.7|0.9|0.8|Malignant|346|42367071|Male|Pilocytic astrocytoma|2007|0.7|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|1.0|0.9|Malignant|389|42541971|Male|Pilocytic astrocytoma|2008|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|1.0|0.9|Malignant|364|42609915|Male|Pilocytic astrocytoma|2009|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Pilocytic astrocytoma|2010|~|~|~
0-19|0.8|1.0|0.9|Malignant|375|42551249|Male|Pilocytic astrocytoma|2010|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|394|42375847|Male|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Pilocytic astrocytoma|2011-2015|~|~|~
0-19|0.9|1.0|0.9|Malignant|1970|210502329|Male|Pilocytic astrocytoma|2011-2015|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.1|1.0|Malignant|415|42186292|Male|Pilocytic astrocytoma|2012|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.1|1.0|Malignant|424|42043641|Male|Pilocytic astrocytoma|2013|0.9|1.1|1.0
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Pilocytic astrocytoma|2014|~|~|~
0-19|0.8|1.0|0.9|Malignant|369|41963801|Male|Pilocytic astrocytoma|2014|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|1.0|0.9|Malignant|368|41932748|Male|Pilocytic astrocytoma|2015|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|17|42367071|Male|Pineal parenchymal|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|16|42541971|Male|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|42551249|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Malignant|~|42551249|Male|Pineal parenchymal|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|42375847|Male|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|19|42375847|Male|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|210502329|Male|Pineal parenchymal|2011-2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|95|210502329|Male|Pineal parenchymal|2011-2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42186292|Male|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|20|42186292|Male|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|42043641|Male|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Malignant|~|42043641|Male|Pineal parenchymal|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|41963801|Male|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.1|Malignant|23|41963801|Male|Pineal parenchymal|2014|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|41932748|Male|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|18|41932748|Male|Pineal parenchymal|2015|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|85|41889233|Male|Pituitary|2004|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|118|42006384|Male|Pituitary|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|93|42158997|Male|Pituitary|2006|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|118|42367071|Male|Pituitary|2007|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007|~|~|~
0-19|0.2|0.4|0.3|Benign/Borderline|129|42541971|Male|Pituitary|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|154|42609915|Male|Pituitary|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|136|42551249|Male|Pituitary|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42551249|Male|Pituitary|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|146|42375847|Male|Pituitary|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42375847|Male|Pituitary|2011|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|797|210502329|Male|Pituitary|2011-2015|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|210502329|Male|Pituitary|2011-2015|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|168|42186292|Male|Pituitary|2012|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42186292|Male|Pituitary|2012|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|157|42043641|Male|Pituitary|2013|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42043641|Male|Pituitary|2013|~|~|~
0-19|0.4|0.5|0.4|Benign/Borderline|182|41963801|Male|Pituitary|2014|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|41963801|Male|Pituitary|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|144|41932748|Male|Pituitary|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41932748|Male|Pituitary|2015|~|~|~
0-19|1.5|1.7|1.6|Benign/Borderline|678|41889233|Male|Total|2004|1.5|1.7|1.6
0-19|3.4|3.8|3.6|Malignant|1502|41889233|Male|Total|2004|3.4|3.8|3.6
0-19|1.7|2.0|1.8|Benign/Borderline|774|42006384|Male|Total|2005|1.7|2.0|1.8
0-19|3.2|3.6|3.4|Malignant|1426|42006384|Male|Total|2005|3.2|3.6|3.4
0-19|1.7|2.0|1.9|Benign/Borderline|797|42158997|Male|Total|2006|1.8|2.0|1.9
0-19|3.4|3.8|3.6|Malignant|1500|42158997|Male|Total|2006|3.4|3.7|3.6
0-19|1.8|2.1|1.9|Benign/Borderline|833|42367071|Male|Total|2007|1.8|2.1|2.0
0-19|3.4|3.8|3.6|Malignant|1515|42367071|Male|Total|2007|3.4|3.8|3.6
0-19|1.8|2.1|2.0|Benign/Borderline|837|42541971|Male|Total|2008|1.8|2.1|2.0
0-19|3.6|4.0|3.8|Malignant|1596|42541971|Male|Total|2008|3.6|3.9|3.8
0-19|2.0|2.3|2.2|Benign/Borderline|925|42609915|Male|Total|2009|2.0|2.3|2.2
0-19|3.5|3.8|3.6|Malignant|1550|42609915|Male|Total|2009|3.5|3.8|3.6
0-19|1.9|2.2|2.1|Benign/Borderline|877|42551249|Male|Total|2010|1.9|2.2|2.1
0-19|3.6|4.0|3.8|Malignant|1597|42551249|Male|Total|2010|3.6|3.9|3.8
0-19|2.0|2.3|2.2|Benign/Borderline|926|42375847|Male|Total|2011|2.0|2.3|2.2
0-19|3.5|3.9|3.7|Malignant|1578|42375847|Male|Total|2011|3.5|3.9|3.7
0-19|2.2|2.3|2.2|Benign/Borderline|4704|210502329|Male|Total|2011-2015|2.2|2.3|2.2
0-19|3.6|3.8|3.7|Malignant|7830|210502329|Male|Total|2011-2015|3.6|3.8|3.7
0-19|2.2|2.5|2.3|Benign/Borderline|975|42186292|Male|Total|2012|2.2|2.5|2.3
0-19|3.6|4.0|3.8|Malignant|1600|42186292|Male|Total|2012|3.6|4.0|3.8
0-19|2.1|2.4|2.2|Benign/Borderline|937|42043641|Male|Total|2013|2.1|2.4|2.2
0-19|3.6|3.9|3.7|Malignant|1573|42043641|Male|Total|2013|3.6|3.9|3.7
0-19|2.1|2.4|2.3|Benign/Borderline|956|41963801|Male|Total|2014|2.1|2.4|2.3
0-19|3.5|3.8|3.6|Malignant|1526|41963801|Male|Total|2014|3.5|3.8|3.6
0-19|2.0|2.3|2.2|Benign/Borderline|910|41932748|Male|Total|2015|2.0|2.3|2.2
0-19|3.5|3.9|3.7|Malignant|1553|41932748|Male|Total|2015|3.5|3.9|3.7
0-19|0.3|0.4|0.3|Benign/Borderline|126|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|121|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|169|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|156|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|141|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|152|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|137|42551249|Male|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42551249|Male|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|137|42375847|Male|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42375847|Male|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|707|210502329|Male|Tumors of Cranial and Spinal Nerves|2011-2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|210502329|Male|Tumors of Cranial and Spinal Nerves|2011-2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|148|42186292|Male|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|42186292|Male|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|42043641|Male|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|42043641|Male|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|138|41963801|Male|Tumors of Cranial and Spinal Nerves|2014|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41963801|Male|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|142|41932748|Male|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|41932748|Male|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|229|41889233|Male|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.1|3.4|3.3|Malignant|1360|41889233|Male|Tumors of Neuroepthelial Tissue|2004|3.1|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|260|42006384|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.7|0.6
0-19|2.9|3.3|3.1|Malignant|1292|42006384|Male|Tumors of Neuroepthelial Tissue|2005|2.9|3.2|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|259|42158997|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1352|42158997|Male|Tumors of Neuroepthelial Tissue|2006|3.0|3.4|3.2
0-19|0.5|0.7|0.6|Benign/Borderline|264|42367071|Male|Tumors of Neuroepthelial Tissue|2007|0.6|0.7|0.6
0-19|3.1|3.4|3.2|Malignant|1368|42367071|Male|Tumors of Neuroepthelial Tissue|2007|3.1|3.4|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|276|42541971|Male|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.6
0-19|3.2|3.6|3.4|Malignant|1433|42541971|Male|Tumors of Neuroepthelial Tissue|2008|3.2|3.5|3.4
0-19|0.6|0.7|0.6|Benign/Borderline|269|42609915|Male|Tumors of Neuroepthelial Tissue|2009|0.6|0.7|0.6
0-19|3.1|3.5|3.3|Malignant|1406|42609915|Male|Tumors of Neuroepthelial Tissue|2009|3.1|3.5|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|277|42551249|Male|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.7
0-19|3.2|3.6|3.4|Malignant|1442|42551249|Male|Tumors of Neuroepthelial Tissue|2010|3.2|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|299|42375847|Male|Tumors of Neuroepthelial Tissue|2011|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1442|42375847|Male|Tumors of Neuroepthelial Tissue|2011|3.2|3.6|3.4
0-19|0.7|0.7|0.7|Benign/Borderline|1478|210502329|Male|Tumors of Neuroepthelial Tissue|2011-2015|0.7|0.7|0.7
0-19|3.3|3.4|3.4|Malignant|7062|210502329|Male|Tumors of Neuroepthelial Tissue|2011-2015|3.3|3.4|3.4
0-19|0.7|0.8|0.7|Benign/Borderline|311|42186292|Male|Tumors of Neuroepthelial Tissue|2012|0.7|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1433|42186292|Male|Tumors of Neuroepthelial Tissue|2012|3.2|3.6|3.4
0-19|0.6|0.8|0.7|Benign/Borderline|297|42043641|Male|Tumors of Neuroepthelial Tissue|2013|0.6|0.8|0.7
0-19|3.2|3.6|3.4|Malignant|1417|42043641|Male|Tumors of Neuroepthelial Tissue|2013|3.2|3.6|3.4
0-19|0.6|0.7|0.7|Benign/Borderline|275|41963801|Male|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.7
0-19|3.1|3.5|3.3|Malignant|1375|41963801|Male|Tumors of Neuroepthelial Tissue|2014|3.1|3.5|3.3
0-19|0.6|0.8|0.7|Benign/Borderline|296|41932748|Male|Tumors of Neuroepthelial Tissue|2015|0.6|0.8|0.7
0-19|3.2|3.5|3.3|Malignant|1395|41932748|Male|Tumors of Neuroepthelial Tissue|2015|3.2|3.5|3.3
0-19|0.3|0.5|0.4|Benign/Borderline|168|41889233|Male|Tumors of Sellar Region|2004|0.3|0.5|0.4
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|212|42006384|Male|Tumors of Sellar Region|2005|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005|~|~|~
0-19|0.3|0.5|0.4|Benign/Borderline|173|42158997|Male|Tumors of Sellar Region|2006|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|204|42367071|Male|Tumors of Sellar Region|2007|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|222|42541971|Male|Tumors of Sellar Region|2008|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|235|42609915|Male|Tumors of Sellar Region|2009|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|218|42551249|Male|Tumors of Sellar Region|2010|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42551249|Male|Tumors of Sellar Region|2010|~|~|~
0-19|0.4|0.6|0.5|Benign/Borderline|215|42375847|Male|Tumors of Sellar Region|2011|0.4|0.6|0.5
0-19|~|~|~|Malignant|~|42375847|Male|Tumors of Sellar Region|2011|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|1229|210502329|Male|Tumors of Sellar Region|2011-2015|0.6|0.6|0.6
0-19|~|~|~|Malignant|~|210502329|Male|Tumors of Sellar Region|2011-2015|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|248|42186292|Male|Tumors of Sellar Region|2012|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|42186292|Male|Tumors of Sellar Region|2012|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|246|42043641|Male|Tumors of Sellar Region|2013|0.5|0.7|0.6
0-19|~|~|~|Malignant|~|42043641|Male|Tumors of Sellar Region|2013|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|285|41963801|Male|Tumors of Sellar Region|2014|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|41963801|Male|Tumors of Sellar Region|2014|~|~|~
0-19|0.5|0.6|0.6|Benign/Borderline|235|41932748|Male|Tumors of Sellar Region|2015|0.5|0.6|0.6
0-19|~|~|~|Malignant|~|41932748|Male|Tumors of Sellar Region|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|76|41889233|Male|Tumors of the Meninges|2004|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|85|42006384|Male|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|84|42158997|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|77|42367071|Male|Tumors of the Meninges|2007|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|89|42541971|Male|Tumors of the Meninges|2008|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|96|42609915|Male|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|92|42551249|Male|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42551249|Male|Tumors of the Meninges|2010|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|125|42375847|Male|Tumors of the Meninges|2011|0.2|0.4|0.3
0-19|~|~|~|Malignant|~|42375847|Male|Tumors of the Meninges|2011|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|579|210502329|Male|Tumors of the Meninges|2011-2015|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|54|210502329|Male|Tumors of the Meninges|2011-2015|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|123|42186292|Male|Tumors of the Meninges|2012|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|42186292|Male|Tumors of the Meninges|2012|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|104|42043641|Male|Tumors of the Meninges|2013|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|42043641|Male|Tumors of the Meninges|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|109|41963801|Male|Tumors of the Meninges|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41963801|Male|Tumors of the Meninges|2014|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|118|41932748|Male|Tumors of the Meninges|2015|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|41932748|Male|Tumors of the Meninges|2015|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|61|41889233|Male|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|74|42006384|Male|Unclassified Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|85|42158997|Male|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|24|42158997|Male|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|115|42367071|Male|Unclassified Tumors|2007|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|26|42367071|Male|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|88|42541971|Male|Unclassified Tumors|2008|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|22|42541971|Male|Unclassified Tumors|2008|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|146|42609915|Male|Unclassified Tumors|2009|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|23|42609915|Male|Unclassified Tumors|2009|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|132|42551249|Male|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|18|42551249|Male|Unclassified Tumors|2010|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|135|42375847|Male|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|17|42375847|Male|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|606|210502329|Male|Unclassified Tumors|2011-2015|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|118|210502329|Male|Unclassified Tumors|2011-2015|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|123|42186292|Male|Unclassified Tumors|2012|0.2|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|31|42186292|Male|Unclassified Tumors|2012|0.0|0.1|0.1
0-19|0.2|0.3|0.3|Benign/Borderline|122|42043641|Male|Unclassified Tumors|2013|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|19|42043641|Male|Unclassified Tumors|2013|0.0|0.1|0.0
0-19|0.2|0.4|0.3|Benign/Borderline|124|41963801|Male|Unclassified Tumors|2014|0.2|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|26|41963801|Male|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|102|41932748|Male|Unclassified Tumors|2015|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|25|41932748|Male|Unclassified Tumors|2015|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|36|42006384|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|25|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42158997|Male|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|29|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|39|42541971|Male|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|39|42609915|Male|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|27|42551249|Male|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|16|42551249|Male|Unique astrocytoma variants|2010|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|40|42375847|Male|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|28|42375847|Male|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|171|210502329|Male|Unique astrocytoma variants|2011-2015|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|128|210502329|Male|Unique astrocytoma variants|2011-2015|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|35|42186292|Male|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|42186292|Male|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|34|42043641|Male|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|26|42043641|Male|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|39|41963801|Male|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|24|41963801|Male|Unique astrocytoma variants|2014|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Benign/Borderline|23|41932748|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|25|41932748|Male|Unique astrocytoma variants|2015|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|All other|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|23|83185817|Male and Female|All other|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|All other|2011|~|~|~
0-19|~|~|~|Malignant|~|82838877|Male and Female|All other|2011|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|411799435|Male and Female|All other|2011-2015|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|69|411799435|Male and Female|All other|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Malignant|~|82496124|Male and Female|All other|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Malignant|~|82257815|Male and Female|All other|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Malignant|~|82122701|Male and Female|All other|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|All other|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82083918|Male and Female|All other|2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|81754354|Male and Female|Anaplastic astrocytoma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006|~|~|~
0-19|0.1|0.1|0.1|Malignant|66|82324418|Male and Female|Anaplastic astrocytoma|2006|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007|~|~|~
0-19|0.1|0.1|0.1|Malignant|85|82749431|Male and Female|Anaplastic astrocytoma|2007|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008|~|~|~
0-19|0.1|0.1|0.1|Malignant|74|83118264|Male and Female|Anaplastic astrocytoma|2008|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009|~|~|~
0-19|0.1|0.1|0.1|Malignant|70|83280391|Male and Female|Anaplastic astrocytoma|2009|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Anaplastic astrocytoma|2010|~|~|~
0-19|0.1|0.1|0.1|Malignant|83|83185817|Male and Female|Anaplastic astrocytoma|2010|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Anaplastic astrocytoma|2011|~|~|~
0-19|0.1|0.1|0.1|Malignant|73|82838877|Male and Female|Anaplastic astrocytoma|2011|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Anaplastic astrocytoma|2011-2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|408|411799435|Male and Female|Anaplastic astrocytoma|2011-2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Anaplastic astrocytoma|2012|~|~|~
0-19|0.1|0.1|0.1|Malignant|67|82496124|Male and Female|Anaplastic astrocytoma|2012|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Anaplastic astrocytoma|2013|~|~|~
0-19|0.1|0.1|0.1|Malignant|94|82257815|Male and Female|Anaplastic astrocytoma|2013|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Anaplastic astrocytoma|2014|~|~|~
0-19|0.1|0.1|0.1|Malignant|97|82122701|Male and Female|Anaplastic astrocytoma|2014|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Anaplastic astrocytoma|2015|~|~|~
0-19|0.1|0.1|0.1|Malignant|77|82083918|Male and Female|Anaplastic astrocytoma|2015|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Malignant|~|83185817|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Malignant|~|82838877|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Anaplastic oligodendroglioma|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|411799435|Male and Female|Anaplastic oligodendroglioma|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Malignant|~|82496124|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Malignant|~|82257815|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Malignant|~|82122701|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82083918|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|203|81754354|Male and Female|Astrocytoma, NOS|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005|~|~|~
0-19|0.2|0.3|0.2|Malignant|191|82005260|Male and Female|Astrocytoma, NOS|2005|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006|~|~|~
0-19|0.2|0.3|0.2|Malignant|197|82324418|Male and Female|Astrocytoma, NOS|2006|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|182|82749431|Male and Female|Astrocytoma, NOS|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|179|83118264|Male and Female|Astrocytoma, NOS|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|203|83280391|Male and Female|Astrocytoma, NOS|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Astrocytoma, NOS|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|216|83185817|Male and Female|Astrocytoma, NOS|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Astrocytoma, NOS|2011|~|~|~
0-19|0.2|0.3|0.2|Malignant|183|82838877|Male and Female|Astrocytoma, NOS|2011|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Astrocytoma, NOS|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|902|411799435|Male and Female|Astrocytoma, NOS|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Astrocytoma, NOS|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|166|82496124|Male and Female|Astrocytoma, NOS|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Astrocytoma, NOS|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|186|82257815|Male and Female|Astrocytoma, NOS|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Astrocytoma, NOS|2014|~|~|~
0-19|0.2|0.3|0.3|Malignant|206|82122701|Male and Female|Astrocytoma, NOS|2014|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Astrocytoma, NOS|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|161|82083918|Male and Female|Astrocytoma, NOS|2015|0.2|0.2|0.2
0-19|0.1|0.1|0.1|Benign/Borderline|56|81754354|Male and Female|Choroid plexus|2004|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|55|82005260|Male and Female|Choroid plexus|2005|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|24|82005260|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82324418|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|64|82749431|Male and Female|Choroid plexus|2007|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83118264|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|60|83280391|Male and Female|Choroid plexus|2009|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|66|83185817|Male and Female|Choroid plexus|2010|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|22|83185817|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|59|82838877|Male and Female|Choroid plexus|2011|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|21|82838877|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|307|411799435|Male and Female|Choroid plexus|2011-2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|101|411799435|Male and Female|Choroid plexus|2011-2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|61|82496124|Male and Female|Choroid plexus|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|17|82496124|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82257815|Male and Female|Choroid plexus|2013|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|16|82257815|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|56|82122701|Male and Female|Choroid plexus|2014|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|27|82122701|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|66|82083918|Male and Female|Choroid plexus|2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|20|82083918|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|165|81754354|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|171|82005260|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|156|82324418|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|181|82749431|Male and Female|Craniopharyngioma|2007|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|157|83118264|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|172|83280391|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|173|83185817|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83185817|Male and Female|Craniopharyngioma|2010|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|153|82838877|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82838877|Male and Female|Craniopharyngioma|2011|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|847|411799435|Male and Female|Craniopharyngioma|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|411799435|Male and Female|Craniopharyngioma|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|158|82496124|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82496124|Male and Female|Craniopharyngioma|2012|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|174|82257815|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82257815|Male and Female|Craniopharyngioma|2013|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|192|82122701|Male and Female|Craniopharyngioma|2014|0.2|0.3|0.2
0-19|~|~|~|Malignant|~|82122701|Male and Female|Craniopharyngioma|2014|~|~|~
0-19|0.2|0.2|0.2|Benign/Borderline|170|82083918|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|82083918|Male and Female|Craniopharyngioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|41|82749431|Male and Female|Diffuse astrocytoma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Diffuse astrocytoma|2009|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Diffuse astrocytoma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|31|83185817|Male and Female|Diffuse astrocytoma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Diffuse astrocytoma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82838877|Male and Female|Diffuse astrocytoma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Diffuse astrocytoma|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|97|411799435|Male and Female|Diffuse astrocytoma|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Diffuse astrocytoma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|27|82496124|Male and Female|Diffuse astrocytoma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Malignant|~|82257815|Male and Female|Diffuse astrocytoma|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Malignant|~|82122701|Male and Female|Diffuse astrocytoma|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Malignant|~|82083918|Male and Female|Diffuse astrocytoma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
0-19|0.6|0.7|0.6|Malignant|508|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|464|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
0-19|0.6|0.7|0.6|Malignant|496|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|519|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|550|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
0-19|0.6|0.7|0.6|Malignant|514|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
0-19|0.5|0.6|0.6|Malignant|487|83185817|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
0-19|0.5|0.7|0.6|Malignant|496|82838877|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.5|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Embryonal/primitive/medulloblastoma|2011-2015|~|~|~
0-19|0.6|0.6|0.6|Malignant|2391|411799435|Male and Female|Embryonal/primitive/medulloblastoma|2011-2015|0.6|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
0-19|0.5|0.6|0.6|Malignant|467|82496124|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
0-19|0.5|0.6|0.6|Malignant|461|82257815|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
0-19|0.5|0.6|0.6|Malignant|486|82122701|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
0-19|0.5|0.6|0.6|Malignant|481|82083918|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.5|0.6|0.6
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|82005260|Male and Female|Ependymoma variants|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|83185817|Male and Female|Ependymoma variants|2010|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83185817|Male and Female|Ependymoma variants|2010|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|82838877|Male and Female|Ependymoma variants|2011|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82838877|Male and Female|Ependymoma variants|2011|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|156|411799435|Male and Female|Ependymoma variants|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|411799435|Male and Female|Ependymoma variants|2011-2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|33|82496124|Male and Female|Ependymoma variants|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82496124|Male and Female|Ependymoma variants|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|82257815|Male and Female|Ependymoma variants|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82257815|Male and Female|Ependymoma variants|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Ependymoma variants|2014|~|~|~
0-19|~|~|~|Malignant|~|82122701|Male and Female|Ependymoma variants|2014|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|27|82083918|Male and Female|Ependymoma variants|2015|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82083918|Male and Female|Ependymoma variants|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
0-19|0.2|0.3|0.2|Malignant|200|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
0-19|0.2|0.3|0.3|Malignant|217|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
0-19|0.2|0.3|0.3|Malignant|209|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
0-19|0.2|0.3|0.2|Malignant|185|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
0-19|0.2|0.2|0.2|Malignant|172|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
0-19|0.2|0.3|0.2|Malignant|194|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
0-19|0.2|0.3|0.3|Malignant|212|83185817|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
0-19|0.2|0.3|0.3|Malignant|214|82838877|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Ependymoma/anaplastic ependymoma|2011-2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|1011|411799435|Male and Female|Ependymoma/anaplastic ependymoma|2011-2015|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
0-19|0.2|0.3|0.2|Malignant|203|82496124|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
0-19|0.2|0.3|0.2|Malignant|199|82257815|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
0-19|0.2|0.3|0.2|Malignant|195|82122701|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
0-19|0.2|0.3|0.2|Malignant|200|82083918|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|81754354|Male and Female|Germ Cell Tumors|2004|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|148|81754354|Male and Female|Germ Cell Tumors|2004|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|36|82005260|Male and Female|Germ Cell Tumors|2005|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|44|82324418|Male and Female|Germ Cell Tumors|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Malignant|125|82324418|Male and Female|Germ Cell Tumors|2006|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|31|82749431|Male and Female|Germ Cell Tumors|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|132|82749431|Male and Female|Germ Cell Tumors|2007|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|83118264|Male and Female|Germ Cell Tumors|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|145|83118264|Male and Female|Germ Cell Tumors|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|46|83280391|Male and Female|Germ Cell Tumors|2009|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|140|83280391|Male and Female|Germ Cell Tumors|2009|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|41|83185817|Male and Female|Germ Cell Tumors|2010|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|165|83185817|Male and Female|Germ Cell Tumors|2010|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|36|82838877|Male and Female|Germ Cell Tumors|2011|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|138|82838877|Male and Female|Germ Cell Tumors|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|202|411799435|Male and Female|Germ Cell Tumors|2011-2015|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|711|411799435|Male and Female|Germ Cell Tumors|2011-2015|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|37|82496124|Male and Female|Germ Cell Tumors|2012|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Malignant|130|82496124|Male and Female|Germ Cell Tumors|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|46|82257815|Male and Female|Germ Cell Tumors|2013|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Malignant|156|82257815|Male and Female|Germ Cell Tumors|2013|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Benign/Borderline|48|82122701|Male and Female|Germ Cell Tumors|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Malignant|138|82122701|Male and Female|Germ Cell Tumors|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Benign/Borderline|35|82083918|Male and Female|Germ Cell Tumors|2015|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Malignant|149|82083918|Male and Female|Germ Cell Tumors|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004|~|~|~
0-19|0.1|0.2|0.2|Malignant|127|81754354|Male and Female|Glioblastoma|2004|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005|~|~|~
0-19|0.1|0.1|0.1|Malignant|99|82005260|Male and Female|Glioblastoma|2005|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006|~|~|~
0-19|0.1|0.2|0.1|Malignant|112|82324418|Male and Female|Glioblastoma|2006|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|82749431|Male and Female|Glioblastoma|2007|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008|~|~|~
0-19|0.1|0.2|0.2|Malignant|129|83118264|Male and Female|Glioblastoma|2008|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009|~|~|~
0-19|0.1|0.2|0.1|Malignant|120|83280391|Male and Female|Glioblastoma|2009|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Glioblastoma|2010|~|~|~
0-19|0.1|0.2|0.1|Malignant|119|83185817|Male and Female|Glioblastoma|2010|0.1|0.2|0.1
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Glioblastoma|2011|~|~|~
0-19|0.2|0.2|0.2|Malignant|157|82838877|Male and Female|Glioblastoma|2011|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Glioblastoma|2011-2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|763|411799435|Male and Female|Glioblastoma|2011-2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Glioblastoma|2012|~|~|~
0-19|0.2|0.2|0.2|Malignant|153|82496124|Male and Female|Glioblastoma|2012|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Glioblastoma|2013|~|~|~
0-19|0.2|0.2|0.2|Malignant|162|82257815|Male and Female|Glioblastoma|2013|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Glioblastoma|2014|~|~|~
0-19|0.1|0.2|0.2|Malignant|142|82122701|Male and Female|Glioblastoma|2014|0.1|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Glioblastoma|2015|~|~|~
0-19|0.2|0.2|0.2|Malignant|149|82083918|Male and Female|Glioblastoma|2015|0.2|0.2|0.2
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004|~|~|~
0-19|0.5|0.6|0.6|Malignant|461|81754354|Male and Female|Glioma malignant, NOS|2004|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005|~|~|~
0-19|0.5|0.6|0.6|Malignant|456|82005260|Male and Female|Glioma malignant, NOS|2005|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006|~|~|~
0-19|0.5|0.7|0.6|Malignant|487|82324418|Male and Female|Glioma malignant, NOS|2006|0.5|0.6|0.6
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007|~|~|~
0-19|0.6|0.7|0.6|Malignant|508|82749431|Male and Female|Glioma malignant, NOS|2007|0.6|0.7|0.6
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008|~|~|~
0-19|0.6|0.7|0.7|Malignant|543|83118264|Male and Female|Glioma malignant, NOS|2008|0.6|0.7|0.7
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009|~|~|~
0-19|0.6|0.7|0.7|Malignant|568|83280391|Male and Female|Glioma malignant, NOS|2009|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|20|83185817|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|543|83185817|Male and Female|Glioma malignant, NOS|2010|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|30|82838877|Male and Female|Glioma malignant, NOS|2011|0.0|0.1|0.0
0-19|0.6|0.8|0.7|Malignant|580|82838877|Male and Female|Glioma malignant, NOS|2011|0.6|0.8|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|154|411799435|Male and Female|Glioma malignant, NOS|2011-2015|0.0|0.0|0.0
0-19|0.6|0.7|0.7|Malignant|2685|411799435|Male and Female|Glioma malignant, NOS|2011-2015|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|33|82496124|Male and Female|Glioma malignant, NOS|2012|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|502|82496124|Male and Female|Glioma malignant, NOS|2012|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|29|82257815|Male and Female|Glioma malignant, NOS|2013|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|555|82257815|Male and Female|Glioma malignant, NOS|2013|0.6|0.7|0.7
0-19|0.0|0.1|0.0|Benign/Borderline|33|82122701|Male and Female|Glioma malignant, NOS|2014|0.0|0.1|0.0
0-19|0.6|0.7|0.6|Malignant|506|82122701|Male and Female|Glioma malignant, NOS|2014|0.6|0.7|0.6
0-19|0.0|0.1|0.0|Benign/Borderline|29|82083918|Male and Female|Glioma malignant, NOS|2015|0.0|0.1|0.0
0-19|0.6|0.7|0.7|Malignant|542|82083918|Male and Female|Glioma malignant, NOS|2015|0.6|0.7|0.7
0-19|0.0|0.0|0.0|Benign/Borderline|29|81754354|Male and Female|Hemangioblastoma|2004|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|82005260|Male and Female|Hemangioblastoma|2005|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|24|82324418|Male and Female|Hemangioblastoma|2006|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82749431|Male and Female|Hemangioblastoma|2007|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|22|83118264|Male and Female|Hemangioblastoma|2008|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|30|83280391|Male and Female|Hemangioblastoma|2009|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|25|83185817|Male and Female|Hemangioblastoma|2010|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|83185817|Male and Female|Hemangioblastoma|2010|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|37|82838877|Male and Female|Hemangioblastoma|2011|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82838877|Male and Female|Hemangioblastoma|2011|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|185|411799435|Male and Female|Hemangioblastoma|2011-2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|411799435|Male and Female|Hemangioblastoma|2011-2015|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82496124|Male and Female|Hemangioblastoma|2012|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82496124|Male and Female|Hemangioblastoma|2012|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|34|82257815|Male and Female|Hemangioblastoma|2013|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82257815|Male and Female|Hemangioblastoma|2013|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|47|82122701|Male and Female|Hemangioblastoma|2014|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82122701|Male and Female|Hemangioblastoma|2014|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|32|82083918|Male and Female|Hemangioblastoma|2015|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82083918|Male and Female|Hemangioblastoma|2015|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|42|81754354|Male and Female|Hemangioma|2004|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|43|82005260|Male and Female|Hemangioma|2005|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|69|82324418|Male and Female|Hemangioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|78|82749431|Male and Female|Hemangioma|2007|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|82|83118264|Male and Female|Hemangioma|2008|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|110|83280391|Male and Female|Hemangioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|93|83185817|Male and Female|Hemangioma|2010|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|83185817|Male and Female|Hemangioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|132|82838877|Male and Female|Hemangioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82838877|Male and Female|Hemangioma|2011|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|603|411799435|Male and Female|Hemangioma|2011-2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|411799435|Male and Female|Hemangioma|2011-2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82496124|Male and Female|Hemangioma|2012|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82496124|Male and Female|Hemangioma|2012|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|112|82257815|Male and Female|Hemangioma|2013|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82257815|Male and Female|Hemangioma|2013|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|117|82122701|Male and Female|Hemangioma|2014|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82122701|Male and Female|Hemangioma|2014|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|115|82083918|Male and Female|Hemangioma|2015|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82083918|Male and Female|Hemangioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Malignant|~|83185817|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Malignant|~|82838877|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Local Extensions from Regional Tumors|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|411799435|Male and Female|Local Extensions from Regional Tumors|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Malignant|~|82496124|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Malignant|~|82257815|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Malignant|~|82122701|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Malignant|~|82083918|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Malignant|~|83185817|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Malignant|~|82838877|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|69|411799435|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|17|82496124|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Malignant|~|82257815|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Malignant|~|82122701|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|18|82083918|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|91|81754354|Male and Female|Meningioma|2004|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|127|82005260|Male and Female|Meningioma|2005|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|101|82324418|Male and Female|Meningioma|2006|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|104|82749431|Male and Female|Meningioma|2007|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|117|83118264|Male and Female|Meningioma|2008|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|119|83280391|Male and Female|Meningioma|2009|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009|~|~|~
0-19|0.1|0.2|0.1|Benign/Borderline|112|83185817|Male and Female|Meningioma|2010|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|83185817|Male and Female|Meningioma|2010|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|132|82838877|Male and Female|Meningioma|2011|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82838877|Male and Female|Meningioma|2011|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|643|411799435|Male and Female|Meningioma|2011-2015|0.1|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|33|411799435|Male and Female|Meningioma|2011-2015|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|122|82496124|Male and Female|Meningioma|2012|0.1|0.2|0.1
0-19|~|~|~|Malignant|~|82496124|Male and Female|Meningioma|2012|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|128|82257815|Male and Female|Meningioma|2013|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82257815|Male and Female|Meningioma|2013|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|126|82122701|Male and Female|Meningioma|2014|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82122701|Male and Female|Meningioma|2014|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|135|82083918|Male and Female|Meningioma|2015|0.1|0.2|0.2
0-19|~|~|~|Malignant|~|82083918|Male and Female|Meningioma|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|81754354|Male and Female|Mixed glioma|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|21|82324418|Male and Female|Mixed glioma|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82749431|Male and Female|Mixed glioma|2007|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|83118264|Male and Female|Mixed glioma|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|83280391|Male and Female|Mixed glioma|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Mixed glioma|2010|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|83185817|Male and Female|Mixed glioma|2010|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Mixed glioma|2011|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82838877|Male and Female|Mixed glioma|2011|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Mixed glioma|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|106|411799435|Male and Female|Mixed glioma|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Mixed glioma|2012|~|~|~
0-19|0.0|0.0|0.0|Malignant|25|82496124|Male and Female|Mixed glioma|2012|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Mixed glioma|2013|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82257815|Male and Female|Mixed glioma|2013|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Mixed glioma|2014|~|~|~
0-19|0.0|0.0|0.0|Malignant|19|82122701|Male and Female|Mixed glioma|2014|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Mixed glioma|2015|~|~|~
0-19|~|~|~|Malignant|~|82083918|Male and Female|Mixed glioma|2015|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|63|81754354|Male and Female|Neoplasm, unspecified|2004|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|110|82005260|Male and Female|Neoplasm, unspecified|2005|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Neoplasm, unspecified|2005|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|102|82324418|Male and Female|Neoplasm, unspecified|2006|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|50|82324418|Male and Female|Neoplasm, unspecified|2006|0.0|0.1|0.1
0-19|0.1|0.2|0.1|Benign/Borderline|115|82749431|Male and Female|Neoplasm, unspecified|2007|0.1|0.2|0.1
0-19|0.0|0.1|0.0|Malignant|38|82749431|Male and Female|Neoplasm, unspecified|2007|0.0|0.1|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|126|83118264|Male and Female|Neoplasm, unspecified|2008|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|33|83118264|Male and Female|Neoplasm, unspecified|2008|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|148|83280391|Male and Female|Neoplasm, unspecified|2009|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|39|83280391|Male and Female|Neoplasm, unspecified|2009|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|166|83185817|Male and Female|Neoplasm, unspecified|2010|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|27|83185817|Male and Female|Neoplasm, unspecified|2010|0.0|0.0|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|136|82838877|Male and Female|Neoplasm, unspecified|2011|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|37|82838877|Male and Female|Neoplasm, unspecified|2011|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|677|411799435|Male and Female|Neoplasm, unspecified|2011-2015|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|214|411799435|Male and Female|Neoplasm, unspecified|2011-2015|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|129|82496124|Male and Female|Neoplasm, unspecified|2012|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|52|82496124|Male and Female|Neoplasm, unspecified|2012|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|137|82257815|Male and Female|Neoplasm, unspecified|2013|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|40|82257815|Male and Female|Neoplasm, unspecified|2013|0.0|0.1|0.0
0-19|0.1|0.2|0.2|Benign/Borderline|145|82122701|Male and Female|Neoplasm, unspecified|2014|0.1|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|47|82122701|Male and Female|Neoplasm, unspecified|2014|0.0|0.1|0.1
0-19|0.1|0.2|0.2|Benign/Borderline|130|82083918|Male and Female|Neoplasm, unspecified|2015|0.1|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|38|82083918|Male and Female|Neoplasm, unspecified|2015|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|239|81754354|Male and Female|Nerve sheath, benign and malignant|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|279|82005260|Male and Female|Nerve sheath, benign and malignant|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|323|82324418|Male and Female|Nerve sheath, benign and malignant|2006|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|280|82749431|Male and Female|Nerve sheath, benign and malignant|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|282|83118264|Male and Female|Nerve sheath, benign and malignant|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|301|83280391|Male and Female|Nerve sheath, benign and malignant|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|263|83185817|Male and Female|Nerve sheath, benign and malignant|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83185817|Male and Female|Nerve sheath, benign and malignant|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|266|82838877|Male and Female|Nerve sheath, benign and malignant|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82838877|Male and Female|Nerve sheath, benign and malignant|2011|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1342|411799435|Male and Female|Nerve sheath, benign and malignant|2011-2015|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|23|411799435|Male and Female|Nerve sheath, benign and malignant|2011-2015|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|279|82496124|Male and Female|Nerve sheath, benign and malignant|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82496124|Male and Female|Nerve sheath, benign and malignant|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|276|82257815|Male and Female|Nerve sheath, benign and malignant|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82257815|Male and Female|Nerve sheath, benign and malignant|2013|~|~|~
0-19|0.2|0.3|0.3|Benign/Borderline|233|82122701|Male and Female|Nerve sheath, benign and malignant|2014|0.2|0.3|0.3
0-19|~|~|~|Malignant|~|82122701|Male and Female|Nerve sheath, benign and malignant|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|288|82083918|Male and Female|Nerve sheath, benign and malignant|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82083918|Male and Female|Nerve sheath, benign and malignant|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004|~|~|~
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005|~|~|~
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006|~|~|~
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007|~|~|~
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008|~|~|~
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009|~|~|~
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Malignant|~|83185817|Male and Female|Neuroepithelial|2010|~|~|~
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Malignant|~|82838877|Male and Female|Neuroepithelial|2011|~|~|~
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Neuroepithelial|2011-2015|~|~|~
0-19|0.0|0.0|0.0|Malignant|50|411799435|Male and Female|Neuroepithelial|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Malignant|~|82496124|Male and Female|Neuroepithelial|2012|~|~|~
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Malignant|~|82257815|Male and Female|Neuroepithelial|2013|~|~|~
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Malignant|~|82122701|Male and Female|Neuroepithelial|2014|~|~|~
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Neuroepithelial|2015|~|~|~
0-19|~|~|~|Malignant|~|82083918|Male and Female|Neuroepithelial|2015|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|263|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|295|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|55|82005260|Male and Female|Neuronal/glial, neuronal|2005|0.1|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|279|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|309|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|62|82749431|Male and Female|Neuronal/glial, neuronal|2007|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|309|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.3|0.4|0.4
0-19|0.1|0.1|0.1|Malignant|56|83118264|Male and Female|Neuronal/glial, neuronal|2008|0.1|0.1|0.1
0-19|0.3|0.4|0.4|Benign/Borderline|294|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.4|Benign/Borderline|316|83185817|Male and Female|Neuronal/glial, neuronal|2010|0.3|0.4|0.4
0-19|0.0|0.1|0.0|Malignant|34|83185817|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|336|82838877|Male and Female|Neuronal/glial, neuronal|2011|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|34|82838877|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.1|0.0
0-19|0.4|0.4|0.4|Benign/Borderline|1737|411799435|Male and Female|Neuronal/glial, neuronal|2011-2015|0.4|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|208|411799435|Male and Female|Neuronal/glial, neuronal|2011-2015|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|358|82496124|Male and Female|Neuronal/glial, neuronal|2012|0.4|0.5|0.4
0-19|0.0|0.1|0.0|Malignant|34|82496124|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.1|0.0
0-19|0.4|0.5|0.4|Benign/Borderline|347|82257815|Male and Female|Neuronal/glial, neuronal|2013|0.4|0.5|0.4
0-19|0.0|0.1|0.1|Malignant|46|82257815|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.1|0.1
0-19|0.4|0.4|0.4|Benign/Borderline|326|82122701|Male and Female|Neuronal/glial, neuronal|2014|0.4|0.4|0.4
0-19|0.0|0.1|0.1|Malignant|54|82122701|Male and Female|Neuronal/glial, neuronal|2014|0.0|0.1|0.1
0-19|0.4|0.5|0.5|Benign/Borderline|370|82083918|Male and Female|Neuronal/glial, neuronal|2015|0.4|0.5|0.5
0-19|0.0|0.1|0.0|Malignant|40|82083918|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004|~|~|~
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004|0.1|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006|~|~|~
0-19|0.0|0.1|0.1|Malignant|54|82324418|Male and Female|Oligodendroglioma|2006|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007|~|~|~
0-19|0.0|0.1|0.1|Malignant|52|82749431|Male and Female|Oligodendroglioma|2007|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008|~|~|~
0-19|0.0|0.1|0.1|Malignant|51|83118264|Male and Female|Oligodendroglioma|2008|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009|~|~|~
0-19|0.0|0.1|0.1|Malignant|43|83280391|Male and Female|Oligodendroglioma|2009|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Oligodendroglioma|2010|~|~|~
0-19|0.0|0.1|0.1|Malignant|45|83185817|Male and Female|Oligodendroglioma|2010|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Oligodendroglioma|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|37|82838877|Male and Female|Oligodendroglioma|2011|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Oligodendroglioma|2011-2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|191|411799435|Male and Female|Oligodendroglioma|2011-2015|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Oligodendroglioma|2012|~|~|~
0-19|0.0|0.1|0.1|Malignant|48|82496124|Male and Female|Oligodendroglioma|2012|0.0|0.1|0.1
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Oligodendroglioma|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82257815|Male and Female|Oligodendroglioma|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Oligodendroglioma|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82122701|Male and Female|Oligodendroglioma|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Oligodendroglioma|2015|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|82083918|Male and Female|Oligodendroglioma|2015|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|26|81754354|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|39|82005260|Male and Female|Other mesenchymal|2005|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|35|82324418|Male and Female|Other mesenchymal|2006|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Benign/Borderline|28|82749431|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007|~|~|~
0-19|0.0|0.1|0.0|Benign/Borderline|38|83118264|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|48|83280391|Male and Female|Other mesenchymal|2009|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009|~|~|~
0-19|0.0|0.1|0.1|Benign/Borderline|50|83185817|Male and Female|Other mesenchymal|2010|0.0|0.1|0.1
0-19|~|~|~|Malignant|~|83185817|Male and Female|Other mesenchymal|2010|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|60|82838877|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82838877|Male and Female|Other mesenchymal|2011|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|374|411799435|Male and Female|Other mesenchymal|2011-2015|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|67|411799435|Male and Female|Other mesenchymal|2011-2015|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|92|82496124|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|17|82496124|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|73|82257815|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82257815|Male and Female|Other mesenchymal|2013|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|72|82122701|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82122701|Male and Female|Other mesenchymal|2014|~|~|~
0-19|0.1|0.1|0.1|Benign/Borderline|77|82083918|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
0-19|~|~|~|Malignant|~|82083918|Male and Female|Other mesenchymal|2015|~|~|~
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004|~|~|~
0-19|0.8|0.9|0.9|Malignant|700|81754354|Male and Female|Pilocytic astrocytoma|2004|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005|~|~|~
0-19|0.8|0.9|0.8|Malignant|672|82005260|Male and Female|Pilocytic astrocytoma|2005|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006|~|~|~
0-19|0.8|0.9|0.8|Malignant|671|82324418|Male and Female|Pilocytic astrocytoma|2006|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007|~|~|~
0-19|0.8|0.9|0.8|Malignant|680|82749431|Male and Female|Pilocytic astrocytoma|2007|0.8|0.9|0.8
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008|~|~|~
0-19|0.8|0.9|0.9|Malignant|723|83118264|Male and Female|Pilocytic astrocytoma|2008|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009|~|~|~
0-19|0.8|0.9|0.9|Malignant|713|83280391|Male and Female|Pilocytic astrocytoma|2009|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Pilocytic astrocytoma|2010|~|~|~
0-19|0.9|1.0|0.9|Malignant|765|83185817|Male and Female|Pilocytic astrocytoma|2010|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Pilocytic astrocytoma|2011|~|~|~
0-19|0.8|1.0|0.9|Malignant|747|82838877|Male and Female|Pilocytic astrocytoma|2011|0.8|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|411799435|Male and Female|Pilocytic astrocytoma|2011-2015|~|~|~
0-19|0.9|0.9|0.9|Malignant|3778|411799435|Male and Female|Pilocytic astrocytoma|2011-2015|0.9|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Pilocytic astrocytoma|2012|~|~|~
0-19|0.9|1.0|1.0|Malignant|782|82496124|Male and Female|Pilocytic astrocytoma|2012|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Pilocytic astrocytoma|2013|~|~|~
0-19|0.9|1.0|0.9|Malignant|779|82257815|Male and Female|Pilocytic astrocytoma|2013|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Pilocytic astrocytoma|2014|~|~|~
0-19|0.9|1.0|0.9|Malignant|759|82122701|Male and Female|Pilocytic astrocytoma|2014|0.9|1.0|0.9
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Pilocytic astrocytoma|2015|~|~|~
0-19|0.8|0.9|0.9|Malignant|711|82083918|Male and Female|Pilocytic astrocytoma|2015|0.8|0.9|0.9
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004|~|~|~
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005|~|~|~
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006|~|~|~
0-19|0.0|0.0|0.0|Malignant|24|82324418|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007|~|~|~
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008|~|~|~
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Pineal parenchymal|2008|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|83185817|Male and Female|Pineal parenchymal|2010|~|~|~
0-19|0.0|0.0|0.0|Malignant|26|83185817|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82838877|Male and Female|Pineal parenchymal|2011|~|~|~
0-19|0.0|0.1|0.0|Malignant|33|82838877|Male and Female|Pineal parenchymal|2011|0.0|0.1|0.0
0-19|0.0|0.0|0.0|Benign/Borderline|38|411799435|Male and Female|Pineal parenchymal|2011-2015|0.0|0.0|0.0
0-19|0.0|0.0|0.0|Malignant|177|411799435|Male and Female|Pineal parenchymal|2011-2015|0.0|0.0|0.0
0-19|~|~|~|Benign/Borderline|~|82496124|Male and Female|Pineal parenchymal|2012|~|~|~
0-19|0.0|0.1|0.0|Malignant|34|82496124|Male and Female|Pineal parenchymal|2012|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82257815|Male and Female|Pineal parenchymal|2013|~|~|~
0-19|0.0|0.1|0.0|Malignant|30|82257815|Male and Female|Pineal parenchymal|2013|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82122701|Male and Female|Pineal parenchymal|2014|~|~|~
0-19|0.0|0.1|0.0|Malignant|38|82122701|Male and Female|Pineal parenchymal|2014|0.0|0.1|0.0
0-19|~|~|~|Benign/Borderline|~|82083918|Male and Female|Pineal parenchymal|2015|~|~|~
0-19|0.0|0.1|0.1|Malignant|42|82083918|Male and Female|Pineal parenchymal|2015|0.0|0.1|0.1
0-19|0.4|0.5|0.4|Benign/Borderline|348|81754354|Male and Female|Pituitary|2004|0.4|0.5|0.4
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004|~|~|~
0-19|0.4|0.5|0.5|Benign/Borderline|417|82005260|Male and Female|Pituitary|2005|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|439|82324418|Male and Female|Pituitary|2006|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|443|82749431|Male and Female|Pituitary|2007|0.5|0.6|0.5
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007|~|~|~
0-19|0.5|0.7|0.6|Benign/Borderline|516|83118264|Male and Female|Pituitary|2008|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008|~|~|~
0-19|0.6|0.7|0.6|Benign/Borderline|534|83280391|Male and Female|Pituitary|2009|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|577|83185817|Male and Female|Pituitary|2010|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|83185817|Male and Female|Pituitary|2010|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|585|82838877|Male and Female|Pituitary|2011|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82838877|Male and Female|Pituitary|2011|~|~|~
0-19|0.7|0.7|0.7|Benign/Borderline|3002|411799435|Male and Female|Pituitary|2011-2015|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|411799435|Male and Female|Pituitary|2011-2015|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|630|82496124|Male and Female|Pituitary|2012|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82496124|Male and Female|Pituitary|2012|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|582|82257815|Male and Female|Pituitary|2013|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82257815|Male and Female|Pituitary|2013|~|~|~
0-19|0.7|0.8|0.8|Benign/Borderline|638|82122701|Male and Female|Pituitary|2014|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82122701|Male and Female|Pituitary|2014|~|~|~
0-19|0.6|0.7|0.7|Benign/Borderline|567|82083918|Male and Female|Pituitary|2015|0.6|0.8|0.7
0-19|~|~|~|Malignant|~|82083918|Male and Female|Pituitary|2015|~|~|~
0-19|1.7|1.9|1.8|Benign/Borderline|1451|81754354|Male and Female|Total|2004|1.7|1.9|1.8
0-19|3.3|3.6|3.4|Malignant|2809|81754354|Male and Female|Total|2004|3.3|3.6|3.4
0-19|2.0|2.2|2.1|Benign/Borderline|1705|82005260|Male and Female|Total|2005|2.0|2.2|2.1
0-19|3.1|3.4|3.3|Malignant|2658|82005260|Male and Female|Total|2005|3.1|3.4|3.2
0-19|2.0|2.2|2.1|Benign/Borderline|1752|82324418|Male and Female|Total|2006|2.0|2.2|2.1
0-19|3.2|3.5|3.3|Malignant|2727|82324418|Male and Female|Total|2006|3.2|3.4|3.3
0-19|2.0|2.2|2.1|Benign/Borderline|1788|82749431|Male and Female|Total|2007|2.1|2.3|2.2
0-19|3.3|3.5|3.4|Malignant|2812|82749431|Male and Female|Total|2007|3.3|3.5|3.4
0-19|2.1|2.3|2.2|Benign/Borderline|1882|83118264|Male and Female|Total|2008|2.2|2.4|2.3
0-19|3.3|3.6|3.5|Malignant|2874|83118264|Male and Female|Total|2008|3.3|3.6|3.5
0-19|2.3|2.5|2.4|Benign/Borderline|1986|83280391|Male and Female|Total|2009|2.3|2.5|2.4
0-19|3.3|3.6|3.4|Malignant|2840|83280391|Male and Female|Total|2009|3.3|3.5|3.4
0-19|2.3|2.5|2.4|Benign/Borderline|2008|83185817|Male and Female|Total|2010|2.3|2.5|2.4
0-19|3.4|3.6|3.5|Malignant|2893|83185817|Male and Female|Total|2010|3.4|3.6|3.5
0-19|2.4|2.6|2.5|Benign/Borderline|2075|82838877|Male and Female|Total|2011|2.4|2.6|2.5
0-19|3.4|3.7|3.5|Malignant|2921|82838877|Male and Female|Total|2011|3.4|3.7|3.5
0-19|2.5|2.6|2.6|Benign/Borderline|10589|411799435|Male and Female|Total|2011-2015|2.5|2.6|2.6
0-19|3.4|3.5|3.5|Malignant|14288|411799435|Male and Female|Total|2011-2015|3.4|3.5|3.5
0-19|2.5|2.7|2.6|Benign/Borderline|2169|82496124|Male and Female|Total|2012|2.5|2.7|2.6
0-19|3.3|3.5|3.4|Malignant|2820|82496124|Male and Female|Total|2012|3.3|3.5|3.4
0-19|2.5|2.7|2.6|Benign/Borderline|2118|82257815|Male and Female|Total|2013|2.5|2.7|2.6
0-19|3.4|3.7|3.5|Malignant|2898|82257815|Male and Female|Total|2013|3.4|3.7|3.5
0-19|2.5|2.7|2.6|Benign/Borderline|2136|82122701|Male and Female|Total|2014|2.5|2.7|2.6
0-19|3.4|3.6|3.5|Malignant|2863|82122701|Male and Female|Total|2014|3.4|3.6|3.5
0-19|2.4|2.6|2.5|Benign/Borderline|2091|82083918|Male and Female|Total|2015|2.4|2.7|2.5
0-19|3.3|3.5|3.4|Malignant|2786|82083918|Male and Female|Total|2015|3.3|3.5|3.4
0-19|0.3|0.3|0.3|Benign/Borderline|239|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|279|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|323|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.4|0.4|0.4
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|280|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|282|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008|~|~|~
0-19|0.3|0.4|0.4|Benign/Borderline|301|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|263|83185817|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|83185817|Male and Female|Tumors of Cranial and Spinal Nerves|2010|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|266|82838877|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82838877|Male and Female|Tumors of Cranial and Spinal Nerves|2011|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|1345|411799435|Male and Female|Tumors of Cranial and Spinal Nerves|2011-2015|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|23|411799435|Male and Female|Tumors of Cranial and Spinal Nerves|2011-2015|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|279|82496124|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82496124|Male and Female|Tumors of Cranial and Spinal Nerves|2012|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|277|82257815|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.3|0.4|0.3
0-19|~|~|~|Malignant|~|82257815|Male and Female|Tumors of Cranial and Spinal Nerves|2013|~|~|~
0-19|0.3|0.3|0.3|Benign/Borderline|235|82122701|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.3|0.3|0.3
0-19|~|~|~|Malignant|~|82122701|Male and Female|Tumors of Cranial and Spinal Nerves|2014|~|~|~
0-19|0.3|0.4|0.3|Benign/Borderline|288|82083918|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.3|0.4|0.4
0-19|~|~|~|Malignant|~|82083918|Male and Female|Tumors of Cranial and Spinal Nerves|2015|~|~|~
0-19|0.5|0.6|0.5|Benign/Borderline|417|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.5|0.6|0.5
0-19|3.0|3.3|3.2|Malignant|2569|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004|3.0|3.3|3.1
0-19|0.5|0.6|0.6|Benign/Borderline|455|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.5|0.6|0.6
0-19|2.9|3.1|3.0|Malignant|2433|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005|2.9|3.1|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|459|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.6
0-19|2.9|3.2|3.1|Malignant|2509|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006|2.9|3.2|3.0
0-19|0.5|0.6|0.6|Benign/Borderline|491|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.5|0.6|0.6
0-19|3.0|3.3|3.2|Malignant|2602|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007|3.0|3.3|3.1
0-19|0.5|0.7|0.6|Benign/Borderline|502|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2657|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008|3.1|3.3|3.2
0-19|0.5|0.6|0.6|Benign/Borderline|478|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.6
0-19|3.0|3.3|3.2|Malignant|2614|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009|3.0|3.3|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|507|83185817|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2657|83185817|Male and Female|Tumors of Neuroepthelial Tissue|2010|3.1|3.3|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|538|82838877|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.6|0.7|0.6
0-19|3.1|3.4|3.3|Malignant|2703|82838877|Male and Female|Tumors of Neuroepthelial Tissue|2011|3.1|3.4|3.3
0-19|0.6|0.7|0.7|Benign/Borderline|2707|411799435|Male and Female|Tumors of Neuroepthelial Tissue|2011-2015|0.6|0.7|0.7
0-19|3.1|3.2|3.2|Malignant|13130|411799435|Male and Female|Tumors of Neuroepthelial Tissue|2011-2015|3.1|3.2|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|560|82496124|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.6|0.7|0.7
0-19|3.0|3.3|3.1|Malignant|2590|82496124|Male and Female|Tumors of Neuroepthelial Tissue|2012|3.0|3.3|3.1
0-19|0.6|0.7|0.7|Benign/Borderline|553|82257815|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.6|0.7|0.7
0-19|3.1|3.4|3.2|Malignant|2653|82257815|Male and Female|Tumors of Neuroepthelial Tissue|2013|3.1|3.4|3.2
0-19|0.6|0.7|0.6|Benign/Borderline|516|82122701|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.6|0.7|0.6
0-19|3.1|3.3|3.2|Malignant|2637|82122701|Male and Female|Tumors of Neuroepthelial Tissue|2014|3.1|3.3|3.2
0-19|0.6|0.7|0.7|Benign/Borderline|540|82083918|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.6|0.7|0.7
0-19|3.0|3.2|3.1|Malignant|2547|82083918|Male and Female|Tumors of Neuroepthelial Tissue|2015|3.0|3.2|3.1
0-19|0.6|0.7|0.6|Benign/Borderline|513|81754354|Male and Female|Tumors of Sellar Region|2004|0.6|0.7|0.6
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004|~|~|~
0-19|0.6|0.8|0.7|Benign/Borderline|588|82005260|Male and Female|Tumors of Sellar Region|2005|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|595|82324418|Male and Female|Tumors of Sellar Region|2006|0.7|0.8|0.7
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006|~|~|~
0-19|0.7|0.8|0.7|Benign/Borderline|624|82749431|Male and Female|Tumors of Sellar Region|2007|0.7|0.8|0.8
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007|~|~|~
0-19|0.7|0.9|0.8|Benign/Borderline|673|83118264|Male and Female|Tumors of Sellar Region|2008|0.7|0.9|0.8
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008|~|~|~
0-19|0.8|0.9|0.8|Benign/Borderline|706|83280391|Male and Female|Tumors of Sellar Region|2009|0.8|0.9|0.8
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|750|83185817|Male and Female|Tumors of Sellar Region|2010|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|83185817|Male and Female|Tumors of Sellar Region|2010|~|~|~
0-19|0.8|0.9|0.9|Benign/Borderline|738|82838877|Male and Female|Tumors of Sellar Region|2011|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|82838877|Male and Female|Tumors of Sellar Region|2011|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|3849|411799435|Male and Female|Tumors of Sellar Region|2011-2015|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|411799435|Male and Female|Tumors of Sellar Region|2011-2015|~|~|~
0-19|0.9|1.0|0.9|Benign/Borderline|788|82496124|Male and Female|Tumors of Sellar Region|2012|0.9|1.0|1.0
0-19|~|~|~|Malignant|~|82496124|Male and Female|Tumors of Sellar Region|2012|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|756|82257815|Male and Female|Tumors of Sellar Region|2013|0.9|1.0|0.9
0-19|~|~|~|Malignant|~|82257815|Male and Female|Tumors of Sellar Region|2013|~|~|~
0-19|0.9|1.1|1.0|Benign/Borderline|830|82122701|Male and Female|Tumors of Sellar Region|2014|0.9|1.1|1.0
0-19|~|~|~|Malignant|~|82122701|Male and Female|Tumors of Sellar Region|2014|~|~|~
0-19|0.8|1.0|0.9|Benign/Borderline|737|82083918|Male and Female|Tumors of Sellar Region|2015|0.8|1.0|0.9
0-19|~|~|~|Malignant|~|82083918|Male and Female|Tumors of Sellar Region|2015|~|~|~
0-19|0.1|0.2|0.2|Benign/Borderline|146|81754354|Male and Female|Tumors of the Meninges|2004|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|20|81754354|Male and Female|Tumors of the Meninges|2004|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|194|82005260|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|82005260|Male and Female|Tumors of the Meninges|2005|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|160|82324418|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|169|82749431|Male and Female|Tumors of the Meninges|2007|0.2|0.2|0.2
0-19|0.0|0.0|0.0|Malignant|16|82749431|Male and Female|Tumors of the Meninges|2007|0.0|0.0|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|177|83118264|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008|~|~|~
0-19|0.2|0.3|0.2|Benign/Borderline|197|83280391|Male and Female|Tumors of the Meninges|2009|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|23|83280391|Male and Female|Tumors of the Meninges|2009|0.0|0.0|0.0
0-19|0.2|0.3|0.2|Benign/Borderline|187|83185817|Male and Female|Tumors of the Meninges|2010|0.2|0.3|0.2
0-19|0.0|0.0|0.0|Malignant|21|83185817|Male and Female|Tumors of the Meninges|2010|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|229|82838877|Male and Female|Tumors of the Meninges|2011|0.2|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|17|82838877|Male and Female|Tumors of the Meninges|2011|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1202|411799435|Male and Female|Tumors of the Meninges|2011-2015|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|102|411799435|Male and Female|Tumors of the Meninges|2011-2015|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|249|82496124|Male and Female|Tumors of the Meninges|2012|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|21|82496124|Male and Female|Tumors of the Meninges|2012|0.0|0.0|0.0
0-19|0.2|0.3|0.3|Benign/Borderline|235|82257815|Male and Female|Tumors of the Meninges|2013|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|22|82257815|Male and Female|Tumors of the Meninges|2013|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|245|82122701|Male and Female|Tumors of the Meninges|2014|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|19|82122701|Male and Female|Tumors of the Meninges|2014|0.0|0.0|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|244|82083918|Male and Female|Tumors of the Meninges|2015|0.3|0.3|0.3
0-19|0.0|0.0|0.0|Malignant|23|82083918|Male and Female|Tumors of the Meninges|2015|0.0|0.0|0.0
0-19|0.1|0.2|0.1|Benign/Borderline|105|81754354|Male and Female|Unclassified Tumors|2004|0.1|0.2|0.1
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Unclassified Tumors|2004|0.0|0.1|0.1
0-19|0.2|0.2|0.2|Benign/Borderline|153|82005260|Male and Female|Unclassified Tumors|2005|0.2|0.2|0.2
0-19|0.0|0.1|0.0|Malignant|39|82005260|Male and Female|Unclassified Tumors|2005|0.0|0.1|0.0
0-19|0.2|0.2|0.2|Benign/Borderline|171|82324418|Male and Female|Unclassified Tumors|2006|0.2|0.2|0.2
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Unclassified Tumors|2006|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|193|82749431|Male and Female|Unclassified Tumors|2007|0.2|0.3|0.2
0-19|0.0|0.1|0.1|Malignant|43|82749431|Male and Female|Unclassified Tumors|2007|0.0|0.1|0.1
0-19|0.2|0.3|0.2|Benign/Borderline|208|83118264|Male and Female|Unclassified Tumors|2008|0.2|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|36|83118264|Male and Female|Unclassified Tumors|2008|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|258|83280391|Male and Female|Unclassified Tumors|2009|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|41|83280391|Male and Female|Unclassified Tumors|2009|0.0|0.1|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|260|83185817|Male and Female|Unclassified Tumors|2010|0.3|0.4|0.3
0-19|0.0|0.0|0.0|Malignant|28|83185817|Male and Female|Unclassified Tumors|2010|0.0|0.0|0.0
0-19|0.3|0.4|0.3|Benign/Borderline|268|82838877|Male and Female|Unclassified Tumors|2011|0.3|0.4|0.3
0-19|0.0|0.1|0.0|Malignant|38|82838877|Male and Female|Unclassified Tumors|2011|0.0|0.1|0.0
0-19|0.3|0.3|0.3|Benign/Borderline|1283|411799435|Male and Female|Unclassified Tumors|2011-2015|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|226|411799435|Male and Female|Unclassified Tumors|2011-2015|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|256|82496124|Male and Female|Unclassified Tumors|2012|0.3|0.4|0.3
0-19|0.1|0.1|0.1|Malignant|55|82496124|Male and Female|Unclassified Tumors|2012|0.1|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|250|82257815|Male and Female|Unclassified Tumors|2013|0.3|0.3|0.3
0-19|0.0|0.1|0.1|Malignant|43|82257815|Male and Female|Unclassified Tumors|2013|0.0|0.1|0.1
0-19|0.3|0.4|0.3|Benign/Borderline|262|82122701|Male and Female|Unclassified Tumors|2014|0.3|0.4|0.3
0-19|0.0|0.1|0.1|Malignant|50|82122701|Male and Female|Unclassified Tumors|2014|0.0|0.1|0.1
0-19|0.3|0.3|0.3|Benign/Borderline|247|82083918|Male and Female|Unclassified Tumors|2015|0.3|0.3|0.3
0-19|0.0|0.1|0.0|Malignant|40|82083918|Male and Female|Unclassified Tumors|2015|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|50|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|59|82005260|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|29|82005260|Male and Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Benign/Borderline|49|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|38|82324418|Male and Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|65|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Malignant|58|82749431|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|63|83118264|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|31|83118264|Male and Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|73|83280391|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|83280391|Male and Female|Unique astrocytoma variants|2009|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|55|83185817|Male and Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
0-19|0.0|0.0|0.0|Malignant|26|83185817|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
0-19|0.1|0.1|0.1|Benign/Borderline|57|82838877|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|50|82838877|Male and Female|Unique astrocytoma variants|2011|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|303|411799435|Male and Female|Unique astrocytoma variants|2011-2015|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|225|411799435|Male and Female|Unique astrocytoma variants|2011-2015|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|65|82496124|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|44|82496124|Male and Female|Unique astrocytoma variants|2012|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|66|82257815|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
0-19|0.0|0.1|0.1|Malignant|42|82257815|Male and Female|Unique astrocytoma variants|2013|0.0|0.1|0.1
0-19|0.1|0.1|0.1|Benign/Borderline|76|82122701|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
0-19|0.0|0.1|0.0|Malignant|39|82122701|Male and Female|Unique astrocytoma variants|2014|0.0|0.1|0.0
0-19|0.0|0.1|0.0|Benign/Borderline|39|82083918|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.0
0-19|0.0|0.1|0.1|Malignant|50|82083918|Male and Female|Unique astrocytoma variants|2015|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004|~|~|~
20+|~|~|~|Malignant|~|109112165|Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110320645|Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|111567226|Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|112783993|Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|All other|2007|~|~|~
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008|~|~|~
20+|~|~|~|Malignant|~|114027722|Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|115293599|Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|17|116624882|Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|116624882|Female|All other|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117936968|Female|All other|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|20|117936968|Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|80|601969412|Female|All other|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|104|601969412|Female|All other|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|119221367|Female|All other|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119221367|Female|All other|2012|~|~|~
20+|~|~|~|Benign/Borderline|~|120401170|Female|All other|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|22|120401170|Female|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121624494|Female|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|22|121624494|Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|20|122785413|Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|28|122785413|Female|All other|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|566|109112165|Female|Anaplastic astrocytoma|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|510|111567226|Female|Anaplastic astrocytoma|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|529|112783993|Female|Anaplastic astrocytoma|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|502|114027722|Female|Anaplastic astrocytoma|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|502|115293599|Female|Anaplastic astrocytoma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116624882|Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|565|116624882|Female|Anaplastic astrocytoma|2010|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|117936968|Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|567|117936968|Female|Anaplastic astrocytoma|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|601969412|Female|Anaplastic astrocytoma|2011-2015|~|~|~
20+|0.5|0.5|0.5|Malignant|3086|601969412|Female|Anaplastic astrocytoma|2011-2015|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|119221367|Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|582|119221367|Female|Anaplastic astrocytoma|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|120401170|Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|636|120401170|Female|Anaplastic astrocytoma|2013|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|121624494|Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.4|0.5|0.5|Malignant|611|121624494|Female|Anaplastic astrocytoma|2014|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|122785413|Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.5|0.6|0.5|Malignant|690|122785413|Female|Anaplastic astrocytoma|2015|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.1|0.2|0.2|Malignant|184|109112165|Female|Anaplastic oligodendroglioma|2004|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|166|110320645|Female|Anaplastic oligodendroglioma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|138|111567226|Female|Anaplastic oligodendroglioma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|157|112783993|Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|169|114027722|Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|142|115293599|Female|Anaplastic oligodendroglioma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116624882|Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|132|116624882|Female|Anaplastic oligodendroglioma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117936968|Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|152|117936968|Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|601969412|Female|Anaplastic oligodendroglioma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|777|601969412|Female|Anaplastic oligodendroglioma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119221367|Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|168|119221367|Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|120401170|Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|147|120401170|Female|Anaplastic oligodendroglioma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121624494|Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|149|121624494|Female|Anaplastic oligodendroglioma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122785413|Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|161|122785413|Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|567|109112165|Female|Astrocytoma, NOS|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.5|0.5|Malignant|562|110320645|Female|Astrocytoma, NOS|2005|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006|~|~|~
20+|0.4|0.5|0.5|Malignant|537|111567226|Female|Astrocytoma, NOS|2006|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|534|112783993|Female|Astrocytoma, NOS|2007|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008|~|~|~
20+|0.4|0.5|0.4|Malignant|490|114027722|Female|Astrocytoma, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|481|115293599|Female|Astrocytoma, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116624882|Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|474|116624882|Female|Astrocytoma, NOS|2010|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|117936968|Female|Astrocytoma, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|457|117936968|Female|Astrocytoma, NOS|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|601969412|Female|Astrocytoma, NOS|2011-2015|~|~|~
20+|0.4|0.4|0.4|Malignant|2369|601969412|Female|Astrocytoma, NOS|2011-2015|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|119221367|Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.4|0.4|Malignant|488|119221367|Female|Astrocytoma, NOS|2012|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|120401170|Female|Astrocytoma, NOS|2013|~|~|~
20+|0.3|0.4|0.4|Malignant|441|120401170|Female|Astrocytoma, NOS|2013|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|121624494|Female|Astrocytoma, NOS|2014|~|~|~
20+|0.3|0.4|0.4|Malignant|479|121624494|Female|Astrocytoma, NOS|2014|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|122785413|Female|Astrocytoma, NOS|2015|~|~|~
20+|0.4|0.4|0.4|Malignant|504|122785413|Female|Astrocytoma, NOS|2015|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|39|109112165|Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|38|110320645|Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|42|111567226|Female|Choroid plexus|2006|0.0|0.1|0.0
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|55|112783993|Female|Choroid plexus|2007|0.0|0.1|0.0
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|114027722|Female|Choroid plexus|2008|0.0|0.1|0.0
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|44|115293599|Female|Choroid plexus|2009|0.0|0.1|0.0
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|116624882|Female|Choroid plexus|2010|0.0|0.1|0.0
20+|~|~|~|Malignant|~|116624882|Female|Choroid plexus|2010|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|50|117936968|Female|Choroid plexus|2011|0.0|0.1|0.0
20+|~|~|~|Malignant|~|117936968|Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|226|601969412|Female|Choroid plexus|2011-2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|601969412|Female|Choroid plexus|2011-2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|37|119221367|Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119221367|Female|Choroid plexus|2012|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|48|120401170|Female|Choroid plexus|2013|0.0|0.1|0.0
20+|~|~|~|Malignant|~|120401170|Female|Choroid plexus|2013|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|46|121624494|Female|Choroid plexus|2014|0.0|0.1|0.0
20+|~|~|~|Malignant|~|121624494|Female|Choroid plexus|2014|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|45|122785413|Female|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|122785413|Female|Choroid plexus|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|204|109112165|Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|184|110320645|Female|Craniopharyngioma|2005|0.1|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|200|111567226|Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|112783993|Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|221|114027722|Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|228|115293599|Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|237|116624882|Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116624882|Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|217|117936968|Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117936968|Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1119|601969412|Female|Craniopharyngioma|2011-2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|601969412|Female|Craniopharyngioma|2011-2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|119221367|Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119221367|Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|237|120401170|Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120401170|Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|220|121624494|Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121624494|Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|225|122785413|Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122785413|Female|Craniopharyngioma|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|113|109112165|Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|130|110320645|Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|93|111567226|Female|Diffuse astrocytoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|132|112783993|Female|Diffuse astrocytoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|132|114027722|Female|Diffuse astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116624882|Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|162|116624882|Female|Diffuse astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117936968|Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|114|117936968|Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|601969412|Female|Diffuse astrocytoma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|374|601969412|Female|Diffuse astrocytoma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119221367|Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|94|119221367|Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120401170|Female|Diffuse astrocytoma|2013|~|~|~
20+|0.0|0.1|0.1|Malignant|71|120401170|Female|Diffuse astrocytoma|2013|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121624494|Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.0|Malignant|61|121624494|Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122785413|Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|34|122785413|Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|85|110320645|Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|92|112783993|Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|89|114027722|Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|104|115293599|Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116624882|Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|72|116624882|Female|Embryonal/primitive/medulloblastoma|2010|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|117936968|Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.0|0.1|0.1|Malignant|69|117936968|Female|Embryonal/primitive/medulloblastoma|2011|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|601969412|Female|Embryonal/primitive/medulloblastoma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|375|601969412|Female|Embryonal/primitive/medulloblastoma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119221367|Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|81|119221367|Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120401170|Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|88|120401170|Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|121624494|Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|72|121624494|Female|Embryonal/primitive/medulloblastoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122785413|Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.0|0.1|0.1|Malignant|65|122785413|Female|Embryonal/primitive/medulloblastoma|2015|0.0|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|105|109112165|Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|121|110320645|Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|148|111567226|Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|112783993|Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|111|114027722|Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|112|115293599|Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|122|116624882|Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|116624882|Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|117|117936968|Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|117936968|Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|627|601969412|Female|Ependymoma variants|2011-2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|601969412|Female|Ependymoma variants|2011-2015|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|130|119221367|Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|119221367|Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|118|120401170|Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|120401170|Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|129|121624494|Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|121624494|Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|133|122785413|Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|122785413|Female|Ependymoma variants|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.2|0.3|0.3|Malignant|293|109112165|Female|Ependymoma/anaplastic ependymoma|2004|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|302|110320645|Female|Ependymoma/anaplastic ependymoma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|293|111567226|Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|295|112783993|Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.2|0.3|0.3|Malignant|312|114027722|Female|Ependymoma/anaplastic ependymoma|2008|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|343|115293599|Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116624882|Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.2|0.3|0.3|Malignant|294|116624882|Female|Ependymoma/anaplastic ependymoma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117936968|Female|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|298|117936968|Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|33|601969412|Female|Ependymoma/anaplastic ependymoma|2011-2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Malignant|1375|601969412|Female|Ependymoma/anaplastic ependymoma|2011-2015|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|119221367|Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|302|119221367|Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|120401170|Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|271|120401170|Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|121624494|Female|Ependymoma/anaplastic ependymoma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|239|121624494|Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|122785413|Female|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.2|Malignant|265|122785413|Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Benign/Borderline|17|109112165|Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|110320645|Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|35|111567226|Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|112783993|Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|114027722|Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|41|115293599|Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|116624882|Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116624882|Female|Germ Cell Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|117936968|Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|117936968|Female|Germ Cell Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|151|601969412|Female|Germ Cell Tumors|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|601969412|Female|Germ Cell Tumors|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|119221367|Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|119221367|Female|Germ Cell Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|24|120401170|Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|120401170|Female|Germ Cell Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|121624494|Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|121624494|Female|Germ Cell Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|122785413|Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|122785413|Female|Germ Cell Tumors|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004|~|~|~
20+|3.4|3.6|3.5|Malignant|4090|109112165|Female|Glioblastoma|2004|3.6|3.9|3.7
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005|~|~|~
20+|3.4|3.6|3.5|Malignant|4159|110320645|Female|Glioblastoma|2005|3.7|3.9|3.8
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006|~|~|~
20+|3.5|3.7|3.6|Malignant|4289|111567226|Female|Glioblastoma|2006|3.7|4.0|3.8
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007|~|~|~
20+|3.5|3.7|3.6|Malignant|4366|112783993|Female|Glioblastoma|2007|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008|~|~|~
20+|3.4|3.6|3.5|Malignant|4405|114027722|Female|Glioblastoma|2008|3.7|4.0|3.9
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009|~|~|~
20+|3.4|3.6|3.5|Malignant|4473|115293599|Female|Glioblastoma|2009|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|116624882|Female|Glioblastoma|2010|~|~|~
20+|3.4|3.6|3.5|Malignant|4607|116624882|Female|Glioblastoma|2010|3.8|4.1|4.0
20+|~|~|~|Benign/Borderline|~|117936968|Female|Glioblastoma|2011|~|~|~
20+|3.4|3.6|3.5|Malignant|4584|117936968|Female|Glioblastoma|2011|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|601969412|Female|Glioblastoma|2011-2015|~|~|~
20+|3.4|3.5|3.5|Malignant|24161|601969412|Female|Glioblastoma|2011-2015|4.0|4.1|4.0
20+|~|~|~|Benign/Borderline|~|119221367|Female|Glioblastoma|2012|~|~|~
20+|3.5|3.7|3.6|Malignant|4857|119221367|Female|Glioblastoma|2012|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|120401170|Female|Glioblastoma|2013|~|~|~
20+|3.4|3.6|3.5|Malignant|4907|120401170|Female|Glioblastoma|2013|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|121624494|Female|Glioblastoma|2014|~|~|~
20+|3.3|3.5|3.4|Malignant|4770|121624494|Female|Glioblastoma|2014|3.8|4.0|3.9
20+|~|~|~|Benign/Borderline|~|122785413|Female|Glioblastoma|2015|~|~|~
20+|3.4|3.6|3.5|Malignant|5043|122785413|Female|Glioblastoma|2015|4.0|4.2|4.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004|~|~|~
20+|0.3|0.4|0.4|Malignant|422|109112165|Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|392|110320645|Female|Glioma malignant, NOS|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|396|111567226|Female|Glioma malignant, NOS|2006|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|411|112783993|Female|Glioma malignant, NOS|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|441|114027722|Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|514|115293599|Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|116624882|Female|Glioma malignant, NOS|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|409|116624882|Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|117936968|Female|Glioma malignant, NOS|2011|~|~|~
20+|0.3|0.4|0.4|Malignant|440|117936968|Female|Glioma malignant, NOS|2011|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|93|601969412|Female|Glioma malignant, NOS|2011-2015|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|2238|601969412|Female|Glioma malignant, NOS|2011-2015|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|119221367|Female|Glioma malignant, NOS|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|432|119221367|Female|Glioma malignant, NOS|2012|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|120401170|Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|453|120401170|Female|Glioma malignant, NOS|2013|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|24|121624494|Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.3|0.4|0.3|Malignant|432|121624494|Female|Glioma malignant, NOS|2014|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|26|122785413|Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|481|122785413|Female|Glioma malignant, NOS|2015|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|206|109112165|Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|226|110320645|Female|Hemangioblastoma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|222|111567226|Female|Hemangioblastoma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|215|112783993|Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|238|114027722|Female|Hemangioblastoma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|233|115293599|Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|116624882|Female|Hemangioblastoma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116624882|Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|239|117936968|Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|117936968|Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1170|601969412|Female|Hemangioblastoma|2011-2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|601969412|Female|Hemangioblastoma|2011-2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|253|119221367|Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|119221367|Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|120401170|Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|120401170|Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|214|121624494|Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121624494|Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|234|122785413|Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122785413|Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|109112165|Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|283|110320645|Female|Hemangioma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|308|111567226|Female|Hemangioma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|363|112783993|Female|Hemangioma|2007|0.3|0.4|0.3
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|459|114027722|Female|Hemangioma|2008|0.4|0.4|0.4
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|507|115293599|Female|Hemangioma|2009|0.4|0.5|0.4
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|651|116624882|Female|Hemangioma|2010|0.5|0.6|0.6
20+|~|~|~|Malignant|~|116624882|Female|Hemangioma|2010|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|702|117936968|Female|Hemangioma|2011|0.6|0.6|0.6
20+|~|~|~|Malignant|~|117936968|Female|Hemangioma|2011|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|3228|601969412|Female|Hemangioma|2011-2015|0.5|0.6|0.5
20+|~|~|~|Malignant|~|601969412|Female|Hemangioma|2011-2015|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|692|119221367|Female|Hemangioma|2012|0.5|0.6|0.6
20+|~|~|~|Malignant|~|119221367|Female|Hemangioma|2012|~|~|~
20+|0.5|0.6|0.6|Benign/Borderline|699|120401170|Female|Hemangioma|2013|0.5|0.6|0.6
20+|~|~|~|Malignant|~|120401170|Female|Hemangioma|2013|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|619|121624494|Female|Hemangioma|2014|0.5|0.6|0.5
20+|~|~|~|Malignant|~|121624494|Female|Hemangioma|2014|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|516|122785413|Female|Hemangioma|2015|0.4|0.5|0.4
20+|~|~|~|Malignant|~|122785413|Female|Hemangioma|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|25|112783993|Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|115293599|Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116624882|Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|23|116624882|Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117936968|Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|21|117936968|Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|601969412|Female|Local Extensions from Regional Tumors|2011-2015|~|~|~
20+|0.0|0.0|0.0|Malignant|102|601969412|Female|Local Extensions from Regional Tumors|2011-2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119221367|Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|20|119221367|Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120401170|Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|16|120401170|Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121624494|Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|26|121624494|Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122785413|Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|19|122785413|Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.5|0.6|0.5|Malignant|594|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|661|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|675|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|638|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|701|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|666|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|116624882|Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|749|116624882|Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|117936968|Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.5|0.6|0.6|Malignant|719|117936968|Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|601969412|Female|Lymphomas and Hematopoietic Neoplasms|2011-2015|~|~|~
20+|0.5|0.6|0.5|Malignant|3719|601969412|Female|Lymphomas and Hematopoietic Neoplasms|2011-2015|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|119221367|Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.5|0.6|0.5|Malignant|700|119221367|Female|Lymphomas and Hematopoietic Neoplasms|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|120401170|Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.5|0.6|0.5|Malignant|738|120401170|Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|121624494|Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.5|0.6|0.6|Malignant|814|121624494|Female|Lymphomas and Hematopoietic Neoplasms|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|122785413|Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.5|0.6|0.5|Malignant|748|122785413|Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.6
20+|11.9|12.3|12.1|Benign/Borderline|14009|109112165|Female|Meningioma|2004|12.6|13.1|12.8
20+|0.2|0.3|0.2|Malignant|273|109112165|Female|Meningioma|2004|0.2|0.3|0.3
20+|13.4|13.8|13.6|Benign/Borderline|16059|110320645|Female|Meningioma|2005|14.3|14.8|14.6
20+|0.2|0.3|0.2|Malignant|278|110320645|Female|Meningioma|2005|0.2|0.3|0.3
20+|14.0|14.4|14.2|Benign/Borderline|17081|111567226|Female|Meningioma|2006|15.1|15.5|15.3
20+|0.2|0.2|0.2|Malignant|252|111567226|Female|Meningioma|2006|0.2|0.3|0.2
20+|14.4|14.9|14.7|Benign/Borderline|17908|112783993|Female|Meningioma|2007|15.6|16.1|15.9
20+|0.2|0.2|0.2|Malignant|269|112783993|Female|Meningioma|2007|0.2|0.3|0.2
20+|15.1|15.6|15.3|Benign/Borderline|19101|114027722|Female|Meningioma|2008|16.5|17.0|16.8
20+|0.1|0.2|0.2|Malignant|214|114027722|Female|Meningioma|2008|0.2|0.2|0.2
20+|16.1|16.5|16.3|Benign/Borderline|20653|115293599|Female|Meningioma|2009|17.7|18.2|17.9
20+|0.1|0.2|0.2|Malignant|200|115293599|Female|Meningioma|2009|0.2|0.2|0.2
20+|15.5|15.9|15.7|Benign/Borderline|20180|116624882|Female|Meningioma|2010|17.1|17.5|17.3
20+|0.1|0.2|0.2|Malignant|205|116624882|Female|Meningioma|2010|0.2|0.2|0.2
20+|15.5|16.0|15.7|Benign/Borderline|20520|117936968|Female|Meningioma|2011|17.2|17.6|17.4
20+|0.1|0.2|0.1|Malignant|184|117936968|Female|Meningioma|2011|0.1|0.2|0.2
20+|15.7|15.9|15.8|Benign/Borderline|106608|601969412|Female|Meningioma|2011-2015|17.6|17.8|17.7
20+|0.1|0.2|0.1|Malignant|1006|601969412|Female|Meningioma|2011-2015|0.2|0.2|0.2
20+|15.6|16.1|15.9|Benign/Borderline|21057|119221367|Female|Meningioma|2012|17.4|17.9|17.7
20+|0.1|0.2|0.2|Malignant|201|119221367|Female|Meningioma|2012|0.1|0.2|0.2
20+|15.6|16.1|15.8|Benign/Borderline|21304|120401170|Female|Meningioma|2013|17.5|17.9|17.7
20+|0.1|0.2|0.2|Malignant|227|120401170|Female|Meningioma|2013|0.2|0.2|0.2
20+|15.7|16.1|15.9|Benign/Borderline|21783|121624494|Female|Meningioma|2014|17.7|18.1|17.9
20+|0.1|0.2|0.2|Malignant|214|121624494|Female|Meningioma|2014|0.2|0.2|0.2
20+|15.5|15.9|15.7|Benign/Borderline|21944|122785413|Female|Meningioma|2015|17.6|18.1|17.9
20+|0.1|0.2|0.1|Malignant|180|122785413|Female|Meningioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|197|109112165|Female|Mixed glioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.2|Malignant|237|110320645|Female|Mixed glioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006|~|~|~
20+|0.2|0.3|0.2|Malignant|272|111567226|Female|Mixed glioma|2006|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007|~|~|~
20+|0.2|0.3|0.2|Malignant|241|112783993|Female|Mixed glioma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008|~|~|~
20+|0.2|0.3|0.2|Malignant|264|114027722|Female|Mixed glioma|2008|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009|~|~|~
20+|0.2|0.3|0.3|Malignant|283|115293599|Female|Mixed glioma|2009|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116624882|Female|Mixed glioma|2010|~|~|~
20+|0.2|0.3|0.2|Malignant|268|116624882|Female|Mixed glioma|2010|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|117936968|Female|Mixed glioma|2011|~|~|~
20+|0.2|0.3|0.2|Malignant|270|117936968|Female|Mixed glioma|2011|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|601969412|Female|Mixed glioma|2011-2015|~|~|~
20+|0.2|0.2|0.2|Malignant|1085|601969412|Female|Mixed glioma|2011-2015|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|119221367|Female|Mixed glioma|2012|~|~|~
20+|0.2|0.2|0.2|Malignant|237|119221367|Female|Mixed glioma|2012|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|120401170|Female|Mixed glioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|248|120401170|Female|Mixed glioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|121624494|Female|Mixed glioma|2014|~|~|~
20+|0.1|0.2|0.2|Malignant|198|121624494|Female|Mixed glioma|2014|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|122785413|Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|132|122785413|Female|Mixed glioma|2015|0.1|0.1|0.1
20+|0.5|0.6|0.6|Benign/Borderline|685|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|703|109112165|Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.8|0.7|Benign/Borderline|866|110320645|Female|Neoplasm, unspecified|2005|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|719|110320645|Female|Neoplasm, unspecified|2005|0.6|0.7|0.7
20+|0.6|0.7|0.7|Benign/Borderline|797|111567226|Female|Neoplasm, unspecified|2006|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|720|111567226|Female|Neoplasm, unspecified|2006|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|832|112783993|Female|Neoplasm, unspecified|2007|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|648|112783993|Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|829|114027722|Female|Neoplasm, unspecified|2008|0.7|0.8|0.7
20+|0.5|0.6|0.6|Malignant|751|114027722|Female|Neoplasm, unspecified|2008|0.6|0.7|0.7
20+|0.7|0.8|0.7|Benign/Borderline|909|115293599|Female|Neoplasm, unspecified|2009|0.7|0.8|0.8
20+|0.5|0.6|0.6|Malignant|783|115293599|Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.7|0.6|Benign/Borderline|813|116624882|Female|Neoplasm, unspecified|2010|0.7|0.7|0.7
20+|0.4|0.5|0.5|Malignant|643|116624882|Female|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|830|117936968|Female|Neoplasm, unspecified|2011|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|644|117936968|Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|4089|601969412|Female|Neoplasm, unspecified|2011-2015|0.7|0.7|0.7
20+|0.4|0.5|0.5|Malignant|3382|601969412|Female|Neoplasm, unspecified|2011-2015|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|851|119221367|Female|Neoplasm, unspecified|2012|0.7|0.8|0.7
20+|0.4|0.5|0.5|Malignant|665|119221367|Female|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|783|120401170|Female|Neoplasm, unspecified|2013|0.6|0.7|0.7
20+|0.4|0.5|0.5|Malignant|665|120401170|Female|Neoplasm, unspecified|2013|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|853|121624494|Female|Neoplasm, unspecified|2014|0.7|0.8|0.7
20+|0.5|0.5|0.5|Malignant|725|121624494|Female|Neoplasm, unspecified|2014|0.6|0.6|0.6
20+|0.5|0.6|0.6|Benign/Borderline|772|122785413|Female|Neoplasm, unspecified|2015|0.6|0.7|0.6
20+|0.4|0.5|0.5|Malignant|683|122785413|Female|Neoplasm, unspecified|2015|0.5|0.6|0.6
20+|2.2|2.4|2.3|Benign/Borderline|2540|109112165|Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2799|110320645|Female|Nerve sheath, benign and malignant|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2920|111567226|Female|Nerve sheath, benign and malignant|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2916|112783993|Female|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3031|114027722|Female|Nerve sheath, benign and malignant|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3179|115293599|Female|Nerve sheath, benign and malignant|2009|2.7|2.9|2.8
20+|~|~|~|Malignant|~|115293599|Female|Nerve sheath, benign and malignant|2009|~|~|~
20+|2.3|2.5|2.4|Benign/Borderline|2967|116624882|Female|Nerve sheath, benign and malignant|2010|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|116624882|Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3216|117936968|Female|Nerve sheath, benign and malignant|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|117936968|Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|17038|601969412|Female|Nerve sheath, benign and malignant|2011-2015|2.8|2.9|2.8
20+|0.0|0.0|0.0|Malignant|105|601969412|Female|Nerve sheath, benign and malignant|2011-2015|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3363|119221367|Female|Nerve sheath, benign and malignant|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|25|119221367|Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3488|120401170|Female|Nerve sheath, benign and malignant|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|23|120401170|Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3548|121624494|Female|Nerve sheath, benign and malignant|2014|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|16|121624494|Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3423|122785413|Female|Nerve sheath, benign and malignant|2015|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|122785413|Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|16|111567226|Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116624882|Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|116624882|Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|117936968|Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|23|117936968|Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|601969412|Female|Neuroepithelial|2011-2015|~|~|~
20+|0.0|0.0|0.0|Malignant|129|601969412|Female|Neuroepithelial|2011-2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|119221367|Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|119221367|Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|120401170|Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|22|120401170|Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|121624494|Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|22|121624494|Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|122785413|Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|35|122785413|Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|153|109112165|Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|183|110320645|Female|Neuronal/glial, neuronal|2005|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|110320645|Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|186|111567226|Female|Neuronal/glial, neuronal|2006|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|112783993|Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|112783993|Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|114027722|Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|24|114027722|Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|221|115293599|Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.3|0.2|Benign/Borderline|248|116624882|Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|19|116624882|Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|239|117936968|Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|18|117936968|Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1076|601969412|Female|Neuronal/glial, neuronal|2011-2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|78|601969412|Female|Neuronal/glial, neuronal|2011-2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|209|119221367|Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|119221367|Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|180|120401170|Female|Neuronal/glial, neuronal|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|120401170|Female|Neuronal/glial, neuronal|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|230|121624494|Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|121624494|Female|Neuronal/glial, neuronal|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|218|122785413|Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|122785413|Female|Neuronal/glial, neuronal|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004|~|~|~
20+|0.3|0.4|0.3|Malignant|353|109112165|Female|Oligodendroglioma|2004|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|357|110320645|Female|Oligodendroglioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006|~|~|~
20+|0.3|0.4|0.3|Malignant|377|111567226|Female|Oligodendroglioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|370|112783993|Female|Oligodendroglioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.3|Malignant|358|114027722|Female|Oligodendroglioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009|~|~|~
20+|0.3|0.4|0.3|Malignant|361|115293599|Female|Oligodendroglioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116624882|Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|329|116624882|Female|Oligodendroglioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|117936968|Female|Oligodendroglioma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|317|117936968|Female|Oligodendroglioma|2011|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|601969412|Female|Oligodendroglioma|2011-2015|~|~|~
20+|0.3|0.3|0.3|Malignant|1543|601969412|Female|Oligodendroglioma|2011-2015|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|119221367|Female|Oligodendroglioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|293|119221367|Female|Oligodendroglioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|120401170|Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|335|120401170|Female|Oligodendroglioma|2013|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|121624494|Female|Oligodendroglioma|2014|~|~|~
20+|0.2|0.3|0.3|Malignant|301|121624494|Female|Oligodendroglioma|2014|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|122785413|Female|Oligodendroglioma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|297|122785413|Female|Oligodendroglioma|2015|0.2|0.3|0.2
20+|0.0|0.1|0.1|Benign/Borderline|68|109112165|Female|Other mesenchymal|2004|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|110320645|Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|27|110320645|Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|87|111567226|Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|112783993|Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|112783993|Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|102|114027722|Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|52|114027722|Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|115293599|Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|25|115293599|Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|95|116624882|Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|116624882|Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|93|117936968|Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|117936968|Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|475|601969412|Female|Other mesenchymal|2011-2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|176|601969412|Female|Other mesenchymal|2011-2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|111|119221367|Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|119221367|Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|97|120401170|Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|39|120401170|Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|89|121624494|Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|121624494|Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|85|122785413|Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|122785413|Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|124|109112165|Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|110320645|Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|149|111567226|Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|162|112783993|Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|145|114027722|Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|135|115293599|Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116624882|Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|166|116624882|Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|117936968|Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|160|117936968|Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|601969412|Female|Pilocytic astrocytoma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|722|601969412|Female|Pilocytic astrocytoma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|119221367|Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|122|119221367|Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|120401170|Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.2|0.1|Malignant|156|120401170|Female|Pilocytic astrocytoma|2013|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|121624494|Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|144|121624494|Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|122785413|Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|140|122785413|Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|18|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|110320645|Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|112783993|Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|44|114027722|Female|Pineal parenchymal|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|27|115293599|Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|116624882|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|23|116624882|Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|44|117936968|Female|Pineal parenchymal|2011|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|25|117936968|Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|222|601969412|Female|Pineal parenchymal|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|131|601969412|Female|Pineal parenchymal|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|36|119221367|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|22|119221367|Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|52|120401170|Female|Pineal parenchymal|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|34|120401170|Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|40|121624494|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|121624494|Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|50|122785413|Female|Pineal parenchymal|2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|32|122785413|Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|3.6|3.8|3.7|Benign/Borderline|4039|109112165|Female|Pituitary|2004|3.6|3.8|3.7
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Pituitary|2004|0.0|0.0|0.0
20+|4.2|4.4|4.3|Benign/Borderline|4706|110320645|Female|Pituitary|2005|4.1|4.4|4.3
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Pituitary|2005|0.0|0.0|0.0
20+|4.6|4.8|4.7|Benign/Borderline|5202|111567226|Female|Pituitary|2006|4.5|4.8|4.7
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006|~|~|~
20+|4.7|4.9|4.8|Benign/Borderline|5350|112783993|Female|Pituitary|2007|4.6|4.9|4.7
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007|~|~|~
20+|5.0|5.2|5.1|Benign/Borderline|5757|114027722|Female|Pituitary|2008|4.9|5.2|5.0
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008|~|~|~
20+|5.4|5.7|5.6|Benign/Borderline|6355|115293599|Female|Pituitary|2009|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Pituitary|2009|0.0|0.0|0.0
20+|5.3|5.6|5.5|Benign/Borderline|6301|116624882|Female|Pituitary|2010|5.3|5.5|5.4
20+|~|~|~|Malignant|~|116624882|Female|Pituitary|2010|~|~|~
20+|5.4|5.7|5.6|Benign/Borderline|6457|117936968|Female|Pituitary|2011|5.3|5.6|5.5
20+|~|~|~|Malignant|~|117936968|Female|Pituitary|2011|~|~|~
20+|5.6|5.7|5.6|Benign/Borderline|33232|601969412|Female|Pituitary|2011-2015|5.5|5.6|5.5
20+|0.0|0.0|0.0|Malignant|71|601969412|Female|Pituitary|2011-2015|0.0|0.0|0.0
20+|5.7|6.0|5.8|Benign/Borderline|6819|119221367|Female|Pituitary|2012|5.6|5.9|5.7
20+|~|~|~|Malignant|~|119221367|Female|Pituitary|2012|~|~|~
20+|5.5|5.8|5.6|Benign/Borderline|6678|120401170|Female|Pituitary|2013|5.4|5.7|5.5
20+|0.0|0.0|0.0|Malignant|16|120401170|Female|Pituitary|2013|0.0|0.0|0.0
20+|5.4|5.7|5.6|Benign/Borderline|6657|121624494|Female|Pituitary|2014|5.3|5.6|5.5
20+|~|~|~|Malignant|~|121624494|Female|Pituitary|2014|~|~|~
20+|5.4|5.6|5.5|Benign/Borderline|6621|122785413|Female|Pituitary|2015|5.3|5.5|5.4
20+|~|~|~|Malignant|~|122785413|Female|Pituitary|2015|~|~|~
20+|19.4|19.9|19.6|Benign/Borderline|22382|109112165|Female|Total|2004|20.2|20.8|20.5
20+|7.5|7.8|7.6|Malignant|8732|109112165|Female|Total|2004|7.8|8.2|8.0
20+|21.9|22.5|22.2|Benign/Borderline|25692|110320645|Female|Total|2005|23.0|23.6|23.3
20+|7.5|7.8|7.6|Malignant|8908|110320645|Female|Total|2005|7.9|8.2|8.1
20+|23.0|23.6|23.3|Benign/Borderline|27342|111567226|Female|Total|2006|24.2|24.8|24.5
20+|7.4|7.8|7.6|Malignant|8971|111567226|Female|Total|2006|7.9|8.2|8.0
20+|23.6|24.1|23.8|Benign/Borderline|28404|112783993|Female|Total|2007|24.9|25.5|25.2
20+|7.4|7.7|7.6|Malignant|9055|112783993|Female|Total|2007|7.9|8.2|8.0
20+|24.7|25.3|25.0|Benign/Borderline|30265|114027722|Female|Total|2008|26.2|26.8|26.5
20+|7.4|7.7|7.6|Malignant|9209|114027722|Female|Total|2008|7.9|8.2|8.1
20+|26.3|26.9|26.6|Benign/Borderline|32715|115293599|Female|Total|2009|28.1|28.7|28.4
20+|7.4|7.7|7.5|Malignant|9351|115293599|Female|Total|2009|7.9|8.3|8.1
20+|25.5|26.0|25.8|Benign/Borderline|32051|116624882|Female|Total|2010|27.2|27.8|27.5
20+|7.2|7.5|7.3|Malignant|9278|116624882|Female|Total|2010|7.8|8.1|8.0
20+|25.8|26.4|26.1|Benign/Borderline|32870|117936968|Female|Total|2011|27.6|28.2|27.9
20+|7.0|7.3|7.2|Malignant|9174|117936968|Female|Total|2011|7.6|7.9|7.8
20+|26.0|26.3|26.2|Benign/Borderline|169901|601969412|Female|Total|2011-2015|28.1|28.4|28.2
20+|7.1|7.2|7.1|Malignant|47258|601969412|Female|Total|2011-2015|7.8|7.9|7.9
20+|26.2|26.8|26.5|Benign/Borderline|33932|119221367|Female|Total|2012|28.2|28.8|28.5
20+|7.1|7.4|7.3|Malignant|9440|119221367|Female|Total|2012|7.8|8.1|7.9
20+|26.0|26.5|26.3|Benign/Borderline|34065|120401170|Female|Total|2013|28.0|28.6|28.3
20+|7.1|7.4|7.2|Malignant|9593|120401170|Female|Total|2013|7.8|8.1|8.0
20+|26.0|26.5|26.2|Benign/Borderline|34594|121624494|Female|Total|2014|28.1|28.7|28.4
20+|6.8|7.1|7.0|Malignant|9413|121624494|Female|Total|2014|7.6|7.9|7.7
20+|25.4|26.0|25.7|Benign/Borderline|34440|122785413|Female|Total|2015|27.8|28.3|28.0
20+|6.9|7.2|7.0|Malignant|9638|122785413|Female|Total|2015|7.7|8.0|7.8
20+|2.2|2.4|2.3|Benign/Borderline|2540|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2802|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2921|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2917|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|3033|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3182|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|2.7|2.9|2.8
20+|~|~|~|Malignant|~|115293599|Female|Tumors of Cranial and Spinal Nerves|2009|~|~|~
20+|2.3|2.5|2.4|Benign/Borderline|2970|116624882|Female|Tumors of Cranial and Spinal Nerves|2010|2.5|2.6|2.5
20+|0.0|0.0|0.0|Malignant|22|116624882|Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3218|117936968|Female|Tumors of Cranial and Spinal Nerves|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|20|117936968|Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|17049|601969412|Female|Tumors of Cranial and Spinal Nerves|2011-2015|2.8|2.9|2.8
20+|0.0|0.0|0.0|Malignant|105|601969412|Female|Tumors of Cranial and Spinal Nerves|2011-2015|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3363|119221367|Female|Tumors of Cranial and Spinal Nerves|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|25|119221367|Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3489|120401170|Female|Tumors of Cranial and Spinal Nerves|2013|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|23|120401170|Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.6|2.8|2.7|Benign/Borderline|3553|121624494|Female|Tumors of Cranial and Spinal Nerves|2014|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|16|121624494|Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3426|122785413|Female|Tumors of Cranial and Spinal Nerves|2015|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|21|122785413|Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|0.3|0.4|0.4|Benign/Borderline|380|109112165|Female|Tumors of Neuroepthelial Tissue|2004|0.3|0.4|0.3
20+|6.1|6.3|6.2|Malignant|7048|109112165|Female|Tumors of Neuroepthelial Tissue|2004|6.3|6.6|6.5
20+|0.4|0.4|0.4|Benign/Borderline|441|110320645|Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.4|0.4
20+|6.0|6.3|6.2|Malignant|7138|110320645|Female|Tumors of Neuroepthelial Tissue|2005|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|481|111567226|Female|Tumors of Neuroepthelial Tissue|2006|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7218|111567226|Female|Tumors of Neuroepthelial Tissue|2006|6.3|6.6|6.5
20+|0.4|0.5|0.4|Benign/Borderline|478|112783993|Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.4
20+|6.1|6.4|6.2|Malignant|7380|112783993|Female|Tumors of Neuroepthelial Tissue|2007|6.4|6.7|6.5
20+|0.4|0.5|0.4|Benign/Borderline|486|114027722|Female|Tumors of Neuroepthelial Tissue|2008|0.4|0.5|0.4
20+|6.0|6.3|6.1|Malignant|7408|114027722|Female|Tumors of Neuroepthelial Tissue|2008|6.3|6.6|6.5
20+|0.4|0.5|0.5|Benign/Borderline|509|115293599|Female|Tumors of Neuroepthelial Tissue|2009|0.4|0.5|0.4
20+|6.0|6.3|6.2|Malignant|7604|115293599|Female|Tumors of Neuroepthelial Tissue|2009|6.4|6.7|6.6
20+|0.4|0.5|0.5|Benign/Borderline|545|116624882|Female|Tumors of Neuroepthelial Tissue|2010|0.4|0.5|0.5
20+|5.9|6.2|6.0|Malignant|7571|116624882|Female|Tumors of Neuroepthelial Tissue|2010|6.3|6.6|6.5
20+|0.4|0.5|0.5|Benign/Borderline|554|117936968|Female|Tumors of Neuroepthelial Tissue|2011|0.4|0.5|0.5
20+|5.8|6.1|5.9|Malignant|7527|117936968|Female|Tumors of Neuroepthelial Tissue|2011|6.2|6.5|6.4
20+|0.5|0.5|0.5|Benign/Borderline|2763|601969412|Female|Tumors of Neuroepthelial Tissue|2011-2015|0.4|0.5|0.5
20+|5.8|5.9|5.9|Malignant|38615|601969412|Female|Tumors of Neuroepthelial Tissue|2011-2015|6.4|6.5|6.4
20+|0.4|0.5|0.5|Benign/Borderline|530|119221367|Female|Tumors of Neuroepthelial Tissue|2012|0.4|0.5|0.4
20+|5.9|6.2|6.0|Malignant|7764|119221367|Female|Tumors of Neuroepthelial Tissue|2012|6.4|6.7|6.5
20+|0.4|0.5|0.4|Benign/Borderline|520|120401170|Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.5|0.4
20+|5.8|6.1|6.0|Malignant|7854|120401170|Female|Tumors of Neuroepthelial Tissue|2013|6.4|6.7|6.5
20+|0.4|0.5|0.5|Benign/Borderline|573|121624494|Female|Tumors of Neuroepthelial Tissue|2014|0.4|0.5|0.5
20+|5.5|5.8|5.6|Malignant|7552|121624494|Female|Tumors of Neuroepthelial Tissue|2014|6.1|6.4|6.2
20+|0.5|0.5|0.5|Benign/Borderline|586|122785413|Female|Tumors of Neuroepthelial Tissue|2015|0.4|0.5|0.5
20+|5.7|6.0|5.9|Malignant|7918|122785413|Female|Tumors of Neuroepthelial Tissue|2015|6.3|6.6|6.4
20+|3.8|4.0|3.9|Benign/Borderline|4243|109112165|Female|Tumors of Sellar Region|2004|3.8|4.0|3.9
20+|0.0|0.0|0.0|Malignant|25|109112165|Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.3|4.6|4.5|Benign/Borderline|4890|110320645|Female|Tumors of Sellar Region|2005|4.3|4.6|4.4
20+|0.0|0.0|0.0|Malignant|25|110320645|Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.7|5.0|4.9|Benign/Borderline|5402|111567226|Female|Tumors of Sellar Region|2006|4.7|5.0|4.8
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006|~|~|~
20+|4.8|5.1|5.0|Benign/Borderline|5567|112783993|Female|Tumors of Sellar Region|2007|4.8|5.1|4.9
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007|~|~|~
20+|5.2|5.4|5.3|Benign/Borderline|5978|114027722|Female|Tumors of Sellar Region|2008|5.1|5.4|5.2
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008|~|~|~
20+|5.6|5.9|5.8|Benign/Borderline|6583|115293599|Female|Tumors of Sellar Region|2009|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|17|115293599|Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.5|5.8|5.7|Benign/Borderline|6538|116624882|Female|Tumors of Sellar Region|2010|5.5|5.7|5.6
20+|~|~|~|Malignant|~|116624882|Female|Tumors of Sellar Region|2010|~|~|~
20+|5.6|5.9|5.8|Benign/Borderline|6674|117936968|Female|Tumors of Sellar Region|2011|5.5|5.8|5.7
20+|~|~|~|Malignant|~|117936968|Female|Tumors of Sellar Region|2011|~|~|~
20+|5.7|5.9|5.8|Benign/Borderline|34351|601969412|Female|Tumors of Sellar Region|2011-2015|5.6|5.8|5.7
20+|0.0|0.0|0.0|Malignant|75|601969412|Female|Tumors of Sellar Region|2011-2015|0.0|0.0|0.0
20+|5.9|6.2|6.0|Benign/Borderline|7039|119221367|Female|Tumors of Sellar Region|2012|5.8|6.0|5.9
20+|~|~|~|Malignant|~|119221367|Female|Tumors of Sellar Region|2012|~|~|~
20+|5.7|5.9|5.8|Benign/Borderline|6915|120401170|Female|Tumors of Sellar Region|2013|5.6|5.9|5.7
20+|0.0|0.0|0.0|Malignant|17|120401170|Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.6|5.9|5.8|Benign/Borderline|6877|121624494|Female|Tumors of Sellar Region|2014|5.5|5.8|5.7
20+|~|~|~|Malignant|~|121624494|Female|Tumors of Sellar Region|2014|~|~|~
20+|5.5|5.8|5.7|Benign/Borderline|6846|122785413|Female|Tumors of Sellar Region|2015|5.4|5.7|5.6
20+|0.0|0.0|0.0|Malignant|16|122785413|Female|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|12.1|12.5|12.3|Benign/Borderline|14283|109112165|Female|Tumors of the Meninges|2004|12.9|13.3|13.1
20+|0.2|0.3|0.3|Malignant|299|109112165|Female|Tumors of the Meninges|2004|0.2|0.3|0.3
20+|13.6|14.1|13.9|Benign/Borderline|16368|110320645|Female|Tumors of the Meninges|2005|14.6|15.1|14.8
20+|0.2|0.3|0.3|Malignant|305|110320645|Female|Tumors of the Meninges|2005|0.2|0.3|0.3
20+|14.3|14.7|14.5|Benign/Borderline|17390|111567226|Female|Tumors of the Meninges|2006|15.4|15.8|15.6
20+|0.2|0.3|0.2|Malignant|283|111567226|Female|Tumors of the Meninges|2006|0.2|0.3|0.3
20+|14.7|15.1|14.9|Benign/Borderline|18206|112783993|Female|Tumors of the Meninges|2007|15.9|16.4|16.1
20+|0.2|0.3|0.3|Malignant|308|112783993|Female|Tumors of the Meninges|2007|0.2|0.3|0.3
20+|15.4|15.9|15.6|Benign/Borderline|19441|114027722|Female|Tumors of the Meninges|2008|16.8|17.3|17.0
20+|0.2|0.2|0.2|Malignant|266|114027722|Female|Tumors of the Meninges|2008|0.2|0.3|0.2
20+|16.4|16.8|16.6|Benign/Borderline|20981|115293599|Female|Tumors of the Meninges|2009|18.0|18.4|18.2
20+|0.2|0.2|0.2|Malignant|227|115293599|Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|15.7|16.2|16.0|Benign/Borderline|20498|116624882|Female|Tumors of the Meninges|2010|17.3|17.8|17.6
20+|0.2|0.2|0.2|Malignant|240|116624882|Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|15.8|16.2|16.0|Benign/Borderline|20852|117936968|Female|Tumors of the Meninges|2011|17.4|17.9|17.7
20+|0.1|0.2|0.2|Malignant|215|117936968|Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|16.0|16.2|16.1|Benign/Borderline|108253|601969412|Female|Tumors of the Meninges|2011-2015|17.9|18.1|18.0
20+|0.2|0.2|0.2|Malignant|1195|601969412|Female|Tumors of the Meninges|2011-2015|0.2|0.2|0.2
20+|15.9|16.4|16.2|Benign/Borderline|21421|119221367|Female|Tumors of the Meninges|2012|17.7|18.2|18.0
20+|0.2|0.2|0.2|Malignant|238|119221367|Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|15.9|16.3|16.1|Benign/Borderline|21631|120401170|Female|Tumors of the Meninges|2013|17.7|18.2|18.0
20+|0.2|0.2|0.2|Malignant|270|120401170|Female|Tumors of the Meninges|2013|0.2|0.3|0.2
20+|15.9|16.3|16.1|Benign/Borderline|22086|121624494|Female|Tumors of the Meninges|2014|17.9|18.4|18.2
20+|0.2|0.2|0.2|Malignant|251|121624494|Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|15.7|16.2|15.9|Benign/Borderline|22263|122785413|Female|Tumors of the Meninges|2015|17.9|18.4|18.1
20+|0.1|0.2|0.2|Malignant|221|122785413|Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|0.7|0.8|0.8|Benign/Borderline|918|109112165|Female|Unclassified Tumors|2004|0.8|0.9|0.8
20+|0.5|0.6|0.6|Malignant|709|109112165|Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1153|110320645|Female|Unclassified Tumors|2005|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|723|110320645|Female|Unclassified Tumors|2005|0.6|0.7|0.7
20+|0.9|1.0|0.9|Benign/Borderline|1113|111567226|Female|Unclassified Tumors|2006|0.9|1.1|1.0
20+|0.5|0.6|0.6|Malignant|725|111567226|Female|Unclassified Tumors|2006|0.6|0.7|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1199|112783993|Female|Unclassified Tumors|2007|1.0|1.1|1.1
20+|0.5|0.5|0.5|Malignant|651|112783993|Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|1294|114027722|Female|Unclassified Tumors|2008|1.1|1.2|1.1
20+|0.5|0.6|0.6|Malignant|765|114027722|Female|Unclassified Tumors|2008|0.6|0.7|0.7
20+|1.1|1.2|1.2|Benign/Borderline|1417|115293599|Female|Unclassified Tumors|2009|1.2|1.3|1.2
20+|0.5|0.6|0.6|Malignant|790|115293599|Female|Unclassified Tumors|2009|0.6|0.7|0.7
20+|1.1|1.3|1.2|Benign/Borderline|1467|116624882|Female|Unclassified Tumors|2010|1.2|1.3|1.3
20+|0.4|0.5|0.5|Malignant|650|116624882|Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.2|1.3|1.2|Benign/Borderline|1536|117936968|Female|Unclassified Tumors|2011|1.2|1.4|1.3
20+|0.4|0.5|0.5|Malignant|649|117936968|Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|7329|601969412|Female|Unclassified Tumors|2011-2015|1.2|1.2|1.2
20+|0.5|0.5|0.5|Malignant|3411|601969412|Female|Unclassified Tumors|2011-2015|0.5|0.6|0.6
20+|1.1|1.3|1.2|Benign/Borderline|1544|119221367|Female|Unclassified Tumors|2012|1.2|1.4|1.3
20+|0.4|0.5|0.5|Malignant|670|119221367|Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.2|1.2|Benign/Borderline|1486|120401170|Female|Unclassified Tumors|2013|1.2|1.3|1.2
20+|0.4|0.5|0.5|Malignant|669|120401170|Female|Unclassified Tumors|2013|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|1473|121624494|Female|Unclassified Tumors|2014|1.2|1.3|1.2
20+|0.5|0.5|0.5|Malignant|732|121624494|Female|Unclassified Tumors|2014|0.6|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|1290|122785413|Female|Unclassified Tumors|2015|1.0|1.1|1.1
20+|0.4|0.5|0.5|Malignant|691|122785413|Female|Unclassified Tumors|2015|0.5|0.6|0.6
20+|0.0|0.1|0.0|Benign/Borderline|54|109112165|Female|Unique astrocytoma variants|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|110320645|Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Benign/Borderline|49|111567226|Female|Unique astrocytoma variants|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|24|111567226|Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|62|112783993|Female|Unique astrocytoma variants|2007|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|19|112783993|Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|57|114027722|Female|Unique astrocytoma variants|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|75|115293599|Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|28|115293599|Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|69|116624882|Female|Unique astrocytoma variants|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Malignant|20|116624882|Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|79|117936968|Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|117936968|Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|462|601969412|Female|Unique astrocytoma variants|2011-2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|149|601969412|Female|Unique astrocytoma variants|2011-2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|98|119221367|Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|119221367|Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|94|120401170|Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|120401170|Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|92|121624494|Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|37|121624494|Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|99|122785413|Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|22|122785413|Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|All other|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005|~|~|~
20+|~|~|~|Malignant|~|103190694|Male|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|16|104488268|Male|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|All other|2006|~|~|~
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007|~|~|~
20+|~|~|~|Malignant|~|105697783|Male|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|21|106947980|Male|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|All other|2008|~|~|~
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Malignant|~|108197539|Male|All other|2009|~|~|~
20+|~|~|~|Benign/Borderline|~|109537494|Male|All other|2010|~|~|~
20+|~|~|~|Malignant|~|109537494|Male|All other|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|18|110887513|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|110887513|Male|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|85|567557872|Male|All other|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|123|567557872|Male|All other|2011-2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112280888|Male|All other|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|21|112280888|Male|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|18|113545923|Male|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|113545923|Male|All other|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114816261|Male|All other|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|25|114816261|Male|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|23|116027287|Male|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|24|116027287|Male|All other|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.7|0.7|Malignant|670|101938779|Male|Anaplastic astrocytoma|2004|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|698|103190694|Male|Anaplastic astrocytoma|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|698|104488268|Male|Anaplastic astrocytoma|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|671|105697783|Male|Anaplastic astrocytoma|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|708|106947980|Male|Anaplastic astrocytoma|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009|~|~|~
20+|0.6|0.7|0.7|Malignant|710|108197539|Male|Anaplastic astrocytoma|2009|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|109537494|Male|Anaplastic astrocytoma|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|700|109537494|Male|Anaplastic astrocytoma|2010|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|110887513|Male|Anaplastic astrocytoma|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|707|110887513|Male|Anaplastic astrocytoma|2011|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|567557872|Male|Anaplastic astrocytoma|2011-2015|~|~|~
20+|0.6|0.7|0.7|Malignant|3797|567557872|Male|Anaplastic astrocytoma|2011-2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|112280888|Male|Anaplastic astrocytoma|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|751|112280888|Male|Anaplastic astrocytoma|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113545923|Male|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.7|0.7|Malignant|784|113545923|Male|Anaplastic astrocytoma|2013|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|114816261|Male|Anaplastic astrocytoma|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|785|114816261|Male|Anaplastic astrocytoma|2014|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|116027287|Male|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|770|116027287|Male|Anaplastic astrocytoma|2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|210|101938779|Male|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|208|103190694|Male|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|214|104488268|Male|Anaplastic oligodendroglioma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|182|105697783|Male|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|188|106947980|Male|Anaplastic oligodendroglioma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|188|108197539|Male|Anaplastic oligodendroglioma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109537494|Male|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.2|0.2|0.2|Malignant|189|109537494|Male|Anaplastic oligodendroglioma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110887513|Male|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|181|110887513|Male|Anaplastic oligodendroglioma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|567557872|Male|Anaplastic oligodendroglioma|2011-2015|~|~|~
20+|0.2|0.2|0.2|Malignant|971|567557872|Male|Anaplastic oligodendroglioma|2011-2015|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|112280888|Male|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|184|112280888|Male|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|113545923|Male|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.2|0.2|0.2|Malignant|218|113545923|Male|Anaplastic oligodendroglioma|2013|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|114816261|Male|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|202|114816261|Male|Anaplastic oligodendroglioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|116027287|Male|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.2|Malignant|186|116027287|Male|Anaplastic oligodendroglioma|2015|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|635|101938779|Male|Astrocytoma, NOS|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005|~|~|~
20+|0.6|0.7|0.6|Malignant|630|103190694|Male|Astrocytoma, NOS|2005|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006|~|~|~
20+|0.6|0.7|0.6|Malignant|646|104488268|Male|Astrocytoma, NOS|2006|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|625|105697783|Male|Astrocytoma, NOS|2007|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.6|0.6|Malignant|623|106947980|Male|Astrocytoma, NOS|2008|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|571|108197539|Male|Astrocytoma, NOS|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|109537494|Male|Astrocytoma, NOS|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|611|109537494|Male|Astrocytoma, NOS|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|110887513|Male|Astrocytoma, NOS|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|577|110887513|Male|Astrocytoma, NOS|2011|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|567557872|Male|Astrocytoma, NOS|2011-2015|~|~|~
20+|0.5|0.5|0.5|Malignant|2920|567557872|Male|Astrocytoma, NOS|2011-2015|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|112280888|Male|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.5|Malignant|549|112280888|Male|Astrocytoma, NOS|2012|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|113545923|Male|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.5|0.5|Malignant|553|113545923|Male|Astrocytoma, NOS|2013|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|114816261|Male|Astrocytoma, NOS|2014|~|~|~
20+|0.5|0.6|0.5|Malignant|586|114816261|Male|Astrocytoma, NOS|2014|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|116027287|Male|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.6|0.6|Malignant|655|116027287|Male|Astrocytoma, NOS|2015|0.5|0.6|0.6
20+|0.0|0.0|0.0|Benign/Borderline|24|101938779|Male|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004|~|~|~
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|105697783|Male|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|27|106947980|Male|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|108197539|Male|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|109537494|Male|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|109537494|Male|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|32|110887513|Male|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|110887513|Male|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|171|567557872|Male|Choroid plexus|2011-2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|567557872|Male|Choroid plexus|2011-2015|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|33|112280888|Male|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|112280888|Male|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|113545923|Male|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|113545923|Male|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|41|114816261|Male|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|114816261|Male|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|116027287|Male|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|116027287|Male|Choroid plexus|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|184|101938779|Male|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|230|103190694|Male|Craniopharyngioma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|190|104488268|Male|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|198|105697783|Male|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|199|106947980|Male|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|200|108197539|Male|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|200|109537494|Male|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109537494|Male|Craniopharyngioma|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|193|110887513|Male|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|110887513|Male|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|1045|567557872|Male|Craniopharyngioma|2011-2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|567557872|Male|Craniopharyngioma|2011-2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|214|112280888|Male|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|112280888|Male|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|223|113545923|Male|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|113545923|Male|Craniopharyngioma|2013|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|200|114816261|Male|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|114816261|Male|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|215|116027287|Male|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|116027287|Male|Craniopharyngioma|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|143|101938779|Male|Diffuse astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|150|103190694|Male|Diffuse astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006|~|~|~
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007|~|~|~
20+|0.2|0.2|0.2|Malignant|185|105697783|Male|Diffuse astrocytoma|2007|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008|~|~|~
20+|0.2|0.2|0.2|Malignant|209|106947980|Male|Diffuse astrocytoma|2008|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009|~|~|~
20+|0.2|0.2|0.2|Malignant|208|108197539|Male|Diffuse astrocytoma|2009|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|109537494|Male|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|186|109537494|Male|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|110887513|Male|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|136|110887513|Male|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|567557872|Male|Diffuse astrocytoma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|468|567557872|Male|Diffuse astrocytoma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112280888|Male|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|113|112280888|Male|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113545923|Male|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|102|113545923|Male|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114816261|Male|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|69|114816261|Male|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116027287|Male|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.1|0.0|Malignant|48|116027287|Male|Diffuse astrocytoma|2015|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|98|101938779|Male|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|104|103190694|Male|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|97|104488268|Male|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|124|106947980|Male|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|132|108197539|Male|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109537494|Male|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|125|109537494|Male|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|110887513|Male|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|118|110887513|Male|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|567557872|Male|Embryonal/primitive/medulloblastoma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|514|567557872|Male|Embryonal/primitive/medulloblastoma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112280888|Male|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|92|112280888|Male|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|113545923|Male|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|97|113545923|Male|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114816261|Male|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|108|114816261|Male|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|116027287|Male|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|99|116027287|Male|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|0.1|0.2|0.1|Benign/Borderline|141|101938779|Male|Ependymoma variants|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|150|103190694|Male|Ependymoma variants|2005|0.1|0.2|0.1
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|158|104488268|Male|Ependymoma variants|2006|0.1|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|136|105697783|Male|Ependymoma variants|2007|0.1|0.2|0.1
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|145|106947980|Male|Ependymoma variants|2008|0.1|0.2|0.1
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|146|108197539|Male|Ependymoma variants|2009|0.1|0.2|0.1
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|154|109537494|Male|Ependymoma variants|2010|0.1|0.2|0.1
20+|~|~|~|Malignant|~|109537494|Male|Ependymoma variants|2010|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|150|110887513|Male|Ependymoma variants|2011|0.1|0.2|0.1
20+|~|~|~|Malignant|~|110887513|Male|Ependymoma variants|2011|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|786|567557872|Male|Ependymoma variants|2011-2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|22|567557872|Male|Ependymoma variants|2011-2015|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|161|112280888|Male|Ependymoma variants|2012|0.1|0.2|0.1
20+|~|~|~|Malignant|~|112280888|Male|Ependymoma variants|2012|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|155|113545923|Male|Ependymoma variants|2013|0.1|0.2|0.1
20+|~|~|~|Malignant|~|113545923|Male|Ependymoma variants|2013|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|165|114816261|Male|Ependymoma variants|2014|0.1|0.2|0.1
20+|~|~|~|Malignant|~|114816261|Male|Ependymoma variants|2014|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|155|116027287|Male|Ependymoma variants|2015|0.1|0.2|0.1
20+|~|~|~|Malignant|~|116027287|Male|Ependymoma variants|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|300|101938779|Male|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|299|103190694|Male|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|291|104488268|Male|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|288|105697783|Male|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|322|106947980|Male|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|335|108197539|Male|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|109537494|Male|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|330|109537494|Male|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110887513|Male|Ependymoma/anaplastic ependymoma|2011|~|~|~
20+|0.2|0.3|0.3|Malignant|296|110887513|Male|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|59|567557872|Male|Ependymoma/anaplastic ependymoma|2011-2015|0.0|0.0|0.0
20+|0.3|0.3|0.3|Malignant|1535|567557872|Male|Ependymoma/anaplastic ependymoma|2011-2015|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112280888|Male|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|324|112280888|Male|Ependymoma/anaplastic ependymoma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113545923|Male|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.3|Malignant|299|113545923|Male|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|22|114816261|Male|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|315|114816261|Male|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|116027287|Male|Ependymoma/anaplastic ependymoma|2015|~|~|~
20+|0.2|0.3|0.3|Malignant|301|116027287|Male|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|21|101938779|Male|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|42|101938779|Male|Germ Cell Tumors|2004|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|31|103190694|Male|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|103190694|Male|Germ Cell Tumors|2005|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|29|104488268|Male|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|45|104488268|Male|Germ Cell Tumors|2006|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|105697783|Male|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Malignant|76|105697783|Male|Germ Cell Tumors|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|32|106947980|Male|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|34|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|109537494|Male|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|56|109537494|Male|Germ Cell Tumors|2010|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|24|110887513|Male|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.1|0.1|Malignant|59|110887513|Male|Germ Cell Tumors|2011|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|127|567557872|Male|Germ Cell Tumors|2011-2015|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|260|567557872|Male|Germ Cell Tumors|2011-2015|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|112280888|Male|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|112280888|Male|Germ Cell Tumors|2012|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|25|113545923|Male|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|45|113545923|Male|Germ Cell Tumors|2013|0.0|0.1|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|114816261|Male|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|59|114816261|Male|Germ Cell Tumors|2014|0.0|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|23|116027287|Male|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.1|0.0|Malignant|55|116027287|Male|Germ Cell Tumors|2015|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004|~|~|~
20+|5.5|5.8|5.6|Malignant|5467|101938779|Male|Glioblastoma|2004|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005|~|~|~
20+|5.5|5.8|5.6|Malignant|5542|103190694|Male|Glioblastoma|2005|5.2|5.5|5.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006|~|~|~
20+|5.3|5.6|5.4|Malignant|5511|104488268|Male|Glioblastoma|2006|5.1|5.4|5.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007|~|~|~
20+|5.4|5.7|5.6|Malignant|5816|105697783|Male|Glioblastoma|2007|5.4|5.6|5.5
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008|~|~|~
20+|5.5|5.8|5.7|Malignant|6000|106947980|Male|Glioblastoma|2008|5.5|5.8|5.6
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009|~|~|~
20+|5.4|5.7|5.6|Malignant|6008|108197539|Male|Glioblastoma|2009|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|109537494|Male|Glioblastoma|2010|~|~|~
20+|5.4|5.6|5.5|Malignant|6119|109537494|Male|Glioblastoma|2010|5.4|5.7|5.6
20+|~|~|~|Benign/Borderline|~|110887513|Male|Glioblastoma|2011|~|~|~
20+|5.4|5.7|5.5|Malignant|6295|110887513|Male|Glioblastoma|2011|5.5|5.8|5.7
20+|~|~|~|Benign/Borderline|~|567557872|Male|Glioblastoma|2011-2015|~|~|~
20+|5.5|5.6|5.5|Malignant|33014|567557872|Male|Glioblastoma|2011-2015|5.8|5.9|5.8
20+|~|~|~|Benign/Borderline|~|112280888|Male|Glioblastoma|2012|~|~|~
20+|5.5|5.7|5.6|Malignant|6525|112280888|Male|Glioblastoma|2012|5.7|6.0|5.8
20+|~|~|~|Benign/Borderline|~|113545923|Male|Glioblastoma|2013|~|~|~
20+|5.4|5.7|5.6|Malignant|6621|113545923|Male|Glioblastoma|2013|5.7|6.0|5.8
20+|~|~|~|Benign/Borderline|~|114816261|Male|Glioblastoma|2014|~|~|~
20+|5.4|5.7|5.6|Malignant|6773|114816261|Male|Glioblastoma|2014|5.8|6.0|5.9
20+|~|~|~|Benign/Borderline|~|116027287|Male|Glioblastoma|2015|~|~|~
20+|5.3|5.6|5.5|Malignant|6800|116027287|Male|Glioblastoma|2015|5.7|6.0|5.9
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.5|0.4|Malignant|421|101938779|Male|Glioma malignant, NOS|2004|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.5|0.5|Malignant|439|103190694|Male|Glioma malignant, NOS|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|442|104488268|Male|Glioma malignant, NOS|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.5|0.5|Malignant|460|105697783|Male|Glioma malignant, NOS|2007|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|16|106947980|Male|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.5|0.5|Malignant|474|106947980|Male|Glioma malignant, NOS|2008|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioma malignant, NOS|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|455|108197539|Male|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109537494|Male|Glioma malignant, NOS|2010|~|~|~
20+|0.4|0.4|0.4|Malignant|409|109537494|Male|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|110887513|Male|Glioma malignant, NOS|2011|~|~|~
20+|0.4|0.5|0.5|Malignant|488|110887513|Male|Glioma malignant, NOS|2011|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|73|567557872|Male|Glioma malignant, NOS|2011-2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|2370|567557872|Male|Glioma malignant, NOS|2011-2015|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|112280888|Male|Glioma malignant, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|481|112280888|Male|Glioma malignant, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|113545923|Male|Glioma malignant, NOS|2013|~|~|~
20+|0.4|0.4|0.4|Malignant|447|113545923|Male|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|114816261|Male|Glioma malignant, NOS|2014|~|~|~
20+|0.4|0.5|0.4|Malignant|491|114816261|Male|Glioma malignant, NOS|2014|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|18|116027287|Male|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|463|116027287|Male|Glioma malignant, NOS|2015|0.4|0.4|0.4
20+|0.2|0.3|0.2|Benign/Borderline|249|101938779|Male|Hemangioblastoma|2004|0.2|0.3|0.2
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|285|103190694|Male|Hemangioblastoma|2005|0.2|0.3|0.3
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|276|104488268|Male|Hemangioblastoma|2006|0.2|0.3|0.3
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|256|105697783|Male|Hemangioblastoma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|290|106947980|Male|Hemangioblastoma|2008|0.2|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|272|108197539|Male|Hemangioblastoma|2009|0.2|0.3|0.3
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009|~|~|~
20+|0.2|0.3|0.3|Benign/Borderline|302|109537494|Male|Hemangioblastoma|2010|0.2|0.3|0.3
20+|~|~|~|Malignant|~|109537494|Male|Hemangioblastoma|2010|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|271|110887513|Male|Hemangioblastoma|2011|0.2|0.3|0.2
20+|~|~|~|Malignant|~|110887513|Male|Hemangioblastoma|2011|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|1360|567557872|Male|Hemangioblastoma|2011-2015|0.2|0.3|0.2
20+|~|~|~|Malignant|~|567557872|Male|Hemangioblastoma|2011-2015|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|274|112280888|Male|Hemangioblastoma|2012|0.2|0.3|0.2
20+|~|~|~|Malignant|~|112280888|Male|Hemangioblastoma|2012|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|272|113545923|Male|Hemangioblastoma|2013|0.2|0.3|0.2
20+|~|~|~|Malignant|~|113545923|Male|Hemangioblastoma|2013|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|265|114816261|Male|Hemangioblastoma|2014|0.2|0.3|0.2
20+|~|~|~|Malignant|~|114816261|Male|Hemangioblastoma|2014|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|278|116027287|Male|Hemangioblastoma|2015|0.2|0.3|0.2
20+|~|~|~|Malignant|~|116027287|Male|Hemangioblastoma|2015|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|138|101938779|Male|Hemangioma|2004|0.1|0.2|0.1
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|194|103190694|Male|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|228|104488268|Male|Hemangioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|262|105697783|Male|Hemangioma|2007|0.2|0.3|0.2
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|314|106947980|Male|Hemangioma|2008|0.3|0.3|0.3
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|417|108197539|Male|Hemangioma|2009|0.3|0.4|0.4
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|432|109537494|Male|Hemangioma|2010|0.4|0.4|0.4
20+|~|~|~|Malignant|~|109537494|Male|Hemangioma|2010|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|494|110887513|Male|Hemangioma|2011|0.4|0.5|0.4
20+|~|~|~|Malignant|~|110887513|Male|Hemangioma|2011|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|2372|567557872|Male|Hemangioma|2011-2015|0.4|0.4|0.4
20+|~|~|~|Malignant|~|567557872|Male|Hemangioma|2011-2015|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|495|112280888|Male|Hemangioma|2012|0.4|0.5|0.4
20+|~|~|~|Malignant|~|112280888|Male|Hemangioma|2012|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|497|113545923|Male|Hemangioma|2013|0.4|0.5|0.4
20+|~|~|~|Malignant|~|113545923|Male|Hemangioma|2013|~|~|~
20+|0.4|0.5|0.4|Benign/Borderline|477|114816261|Male|Hemangioma|2014|0.4|0.5|0.4
20+|~|~|~|Malignant|~|114816261|Male|Hemangioma|2014|~|~|~
20+|0.3|0.4|0.4|Benign/Borderline|409|116027287|Male|Hemangioma|2015|0.3|0.4|0.4
20+|~|~|~|Malignant|~|116027287|Male|Hemangioma|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|25|101938779|Male|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|23|103190694|Male|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|34|104488268|Male|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|30|106947980|Male|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|29|108197539|Male|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109537494|Male|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|29|109537494|Male|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110887513|Male|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|21|110887513|Male|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|567557872|Male|Local Extensions from Regional Tumors|2011-2015|~|~|~
20+|0.0|0.0|0.0|Malignant|127|567557872|Male|Local Extensions from Regional Tumors|2011-2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112280888|Male|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|28|112280888|Male|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113545923|Male|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|29|113545923|Male|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114816261|Male|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|25|114816261|Male|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116027287|Male|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|24|116027287|Male|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.7|0.8|0.8|Malignant|749|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.7|0.8|0.8|Malignant|779|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005|0.7|0.8|0.8
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.7|0.8|0.8|Malignant|759|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.7|0.8|0.7|Malignant|734|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.7|0.8|0.8|Malignant|774|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.7|0.8|0.7|Malignant|762|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|109537494|Male|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.8|0.7|Malignant|759|109537494|Male|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|110887513|Male|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.7|0.8|0.7|Malignant|809|110887513|Male|Lymphomas and Hematopoietic Neoplasms|2011|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|567557872|Male|Lymphomas and Hematopoietic Neoplasms|2011-2015|~|~|~
20+|0.7|0.7|0.7|Malignant|3927|567557872|Male|Lymphomas and Hematopoietic Neoplasms|2011-2015|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|112280888|Male|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.7|0.7|Malignant|756|112280888|Male|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|113545923|Male|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.7|0.6|Malignant|729|113545923|Male|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|114816261|Male|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.7|Malignant|816|114816261|Male|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.8|0.7
20+|~|~|~|Benign/Borderline|~|116027287|Male|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.7|0.7|Malignant|817|116027287|Male|Lymphomas and Hematopoietic Neoplasms|2015|0.7|0.8|0.7
20+|5.0|5.3|5.2|Benign/Borderline|4862|101938779|Male|Meningioma|2004|4.6|4.9|4.8
20+|0.2|0.2|0.2|Malignant|168|101938779|Male|Meningioma|2004|0.1|0.2|0.2
20+|5.6|5.9|5.7|Benign/Borderline|5427|103190694|Male|Meningioma|2005|5.1|5.4|5.3
20+|0.1|0.2|0.2|Malignant|157|103190694|Male|Meningioma|2005|0.1|0.2|0.2
20+|5.9|6.2|6.0|Benign/Borderline|5828|104488268|Male|Meningioma|2006|5.4|5.7|5.6
20+|0.1|0.2|0.2|Malignant|152|104488268|Male|Meningioma|2006|0.1|0.2|0.1
20+|5.9|6.2|6.1|Benign/Borderline|6030|105697783|Male|Meningioma|2007|5.6|5.9|5.7
20+|0.2|0.2|0.2|Malignant|178|105697783|Male|Meningioma|2007|0.1|0.2|0.2
20+|6.3|6.7|6.5|Benign/Borderline|6603|106947980|Male|Meningioma|2008|6.0|6.3|6.2
20+|0.1|0.2|0.1|Malignant|147|106947980|Male|Meningioma|2008|0.1|0.2|0.1
20+|6.8|7.1|6.9|Benign/Borderline|7119|108197539|Male|Meningioma|2009|6.4|6.7|6.6
20+|0.1|0.2|0.1|Malignant|151|108197539|Male|Meningioma|2009|0.1|0.2|0.1
20+|6.6|7.0|6.8|Benign/Borderline|7140|109537494|Male|Meningioma|2010|6.4|6.7|6.5
20+|0.1|0.1|0.1|Malignant|120|109537494|Male|Meningioma|2010|0.1|0.1|0.1
20+|6.6|6.9|6.8|Benign/Borderline|7319|110887513|Male|Meningioma|2011|6.5|6.8|6.6
20+|0.1|0.2|0.1|Malignant|143|110887513|Male|Meningioma|2011|0.1|0.2|0.1
20+|6.8|6.9|6.8|Benign/Borderline|38566|567557872|Male|Meningioma|2011-2015|6.7|6.9|6.8
20+|0.1|0.1|0.1|Malignant|747|567557872|Male|Meningioma|2011-2015|0.1|0.1|0.1
20+|6.5|6.9|6.7|Benign/Borderline|7385|112280888|Male|Meningioma|2012|6.4|6.7|6.6
20+|0.1|0.2|0.1|Malignant|147|112280888|Male|Meningioma|2012|0.1|0.2|0.1
20+|6.8|7.2|7.0|Benign/Borderline|7894|113545923|Male|Meningioma|2013|6.8|7.1|7.0
20+|0.1|0.2|0.1|Malignant|155|113545923|Male|Meningioma|2013|0.1|0.2|0.1
20+|6.7|7.0|6.9|Benign/Borderline|7893|114816261|Male|Meningioma|2014|6.7|7.0|6.9
20+|0.1|0.2|0.1|Malignant|162|114816261|Male|Meningioma|2014|0.1|0.2|0.1
20+|6.7|7.0|6.8|Benign/Borderline|8075|116027287|Male|Meningioma|2015|6.8|7.1|7.0
20+|0.1|0.1|0.1|Malignant|140|116027287|Male|Meningioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|294|101938779|Male|Mixed glioma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005|~|~|~
20+|0.3|0.4|0.3|Malignant|329|103190694|Male|Mixed glioma|2005|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006|~|~|~
20+|0.3|0.4|0.4|Malignant|364|104488268|Male|Mixed glioma|2006|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007|~|~|~
20+|0.3|0.4|0.3|Malignant|347|105697783|Male|Mixed glioma|2007|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|336|106947980|Male|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009|~|~|~
20+|0.3|0.4|0.4|Malignant|394|108197539|Male|Mixed glioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|109537494|Male|Mixed glioma|2010|~|~|~
20+|0.3|0.4|0.3|Malignant|343|109537494|Male|Mixed glioma|2010|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|110887513|Male|Mixed glioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|361|110887513|Male|Mixed glioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|567557872|Male|Mixed glioma|2011-2015|~|~|~
20+|0.3|0.3|0.3|Malignant|1470|567557872|Male|Mixed glioma|2011-2015|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|112280888|Male|Mixed glioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|330|112280888|Male|Mixed glioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|113545923|Male|Mixed glioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|372|113545923|Male|Mixed glioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114816261|Male|Mixed glioma|2014|~|~|~
20+|0.2|0.3|0.2|Malignant|265|114816261|Male|Mixed glioma|2014|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|116027287|Male|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|142|116027287|Male|Mixed glioma|2015|0.1|0.1|0.1
20+|0.5|0.6|0.6|Benign/Borderline|502|101938779|Male|Neoplasm, unspecified|2004|0.5|0.5|0.5
20+|0.6|0.7|0.7|Malignant|611|101938779|Male|Neoplasm, unspecified|2004|0.6|0.6|0.6
20+|0.6|0.7|0.7|Benign/Borderline|627|103190694|Male|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.7|Malignant|601|103190694|Male|Neoplasm, unspecified|2005|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|609|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|563|104488268|Male|Neoplasm, unspecified|2006|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|591|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|568|105697783|Male|Neoplasm, unspecified|2007|0.5|0.6|0.5
20+|0.6|0.7|0.6|Benign/Borderline|602|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.7|Malignant|616|106947980|Male|Neoplasm, unspecified|2008|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|607|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|639|108197539|Male|Neoplasm, unspecified|2009|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|651|109537494|Male|Neoplasm, unspecified|2010|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|595|109537494|Male|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.5|0.6|0.6|Benign/Borderline|618|110887513|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.5|0.6|0.6|Malignant|611|110887513|Male|Neoplasm, unspecified|2011|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|3211|567557872|Male|Neoplasm, unspecified|2011-2015|0.5|0.6|0.6
20+|0.6|0.6|0.6|Malignant|3093|567557872|Male|Neoplasm, unspecified|2011-2015|0.5|0.6|0.5
20+|0.6|0.7|0.7|Benign/Borderline|702|112280888|Male|Neoplasm, unspecified|2012|0.6|0.7|0.6
20+|0.5|0.6|0.6|Malignant|620|112280888|Male|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|676|113545923|Male|Neoplasm, unspecified|2013|0.6|0.6|0.6
20+|0.5|0.6|0.6|Malignant|607|113545923|Male|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.5|0.6|0.5|Benign/Borderline|616|114816261|Male|Neoplasm, unspecified|2014|0.5|0.6|0.5
20+|0.5|0.6|0.6|Malignant|657|114816261|Male|Neoplasm, unspecified|2014|0.5|0.6|0.6
20+|0.5|0.6|0.5|Benign/Borderline|599|116027287|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|0.5|0.6|0.5|Malignant|598|116027287|Male|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|2.2|2.4|2.3|Benign/Borderline|2307|101938779|Male|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2661|103190694|Male|Nerve sheath, benign and malignant|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2624|104488268|Male|Nerve sheath, benign and malignant|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2704|105697783|Male|Nerve sheath, benign and malignant|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2670|106947980|Male|Nerve sheath, benign and malignant|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2835|108197539|Male|Nerve sheath, benign and malignant|2009|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2839|109537494|Male|Nerve sheath, benign and malignant|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|109537494|Male|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|2927|110887513|Male|Nerve sheath, benign and malignant|2011|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|16|110887513|Male|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|15632|567557872|Male|Nerve sheath, benign and malignant|2011-2015|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|98|567557872|Male|Nerve sheath, benign and malignant|2011-2015|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|3093|112280888|Male|Nerve sheath, benign and malignant|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|25|112280888|Male|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3124|113545923|Male|Nerve sheath, benign and malignant|2013|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|20|113545923|Male|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3336|114816261|Male|Nerve sheath, benign and malignant|2014|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|21|114816261|Male|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3152|116027287|Male|Nerve sheath, benign and malignant|2015|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|16|116027287|Male|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|32|105697783|Male|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|24|108197539|Male|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109537494|Male|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|26|109537494|Male|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|110887513|Male|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|28|110887513|Male|Neuroepithelial|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|567557872|Male|Neuroepithelial|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|145|567557872|Male|Neuroepithelial|2011-2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|112280888|Male|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|27|112280888|Male|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113545923|Male|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|27|113545923|Male|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|114816261|Male|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|34|114816261|Male|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116027287|Male|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|29|116027287|Male|Neuroepithelial|2015|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|161|101938779|Male|Neuronal/glial, neuronal|2004|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|101938779|Male|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|188|103190694|Male|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|36|103190694|Male|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|200|104488268|Male|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|182|105697783|Male|Neuronal/glial, neuronal|2007|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|216|106947980|Male|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|23|106947980|Male|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|215|108197539|Male|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|234|109537494|Male|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|109537494|Male|Neuronal/glial, neuronal|2010|~|~|~
20+|0.1|0.2|0.2|Benign/Borderline|185|110887513|Male|Neuronal/glial, neuronal|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|22|110887513|Male|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|1062|567557872|Male|Neuronal/glial, neuronal|2011-2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|96|567557872|Male|Neuronal/glial, neuronal|2011-2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|203|112280888|Male|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|21|112280888|Male|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|210|113545923|Male|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|113545923|Male|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|217|114816261|Male|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|20|114816261|Male|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|247|116027287|Male|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|16|116027287|Male|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004|~|~|~
20+|0.4|0.5|0.5|Malignant|472|101938779|Male|Oligodendroglioma|2004|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005|~|~|~
20+|0.4|0.5|0.4|Malignant|439|103190694|Male|Oligodendroglioma|2005|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006|~|~|~
20+|0.4|0.5|0.4|Malignant|464|104488268|Male|Oligodendroglioma|2006|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007|~|~|~
20+|0.4|0.5|0.4|Malignant|438|105697783|Male|Oligodendroglioma|2007|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|403|106947980|Male|Oligodendroglioma|2008|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009|~|~|~
20+|0.4|0.5|0.4|Malignant|467|108197539|Male|Oligodendroglioma|2009|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|109537494|Male|Oligodendroglioma|2010|~|~|~
20+|0.4|0.5|0.4|Malignant|465|109537494|Male|Oligodendroglioma|2010|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|110887513|Male|Oligodendroglioma|2011|~|~|~
20+|0.4|0.4|0.4|Malignant|438|110887513|Male|Oligodendroglioma|2011|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|567557872|Male|Oligodendroglioma|2011-2015|~|~|~
20+|0.3|0.4|0.4|Malignant|1956|567557872|Male|Oligodendroglioma|2011-2015|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|112280888|Male|Oligodendroglioma|2012|~|~|~
20+|0.3|0.4|0.3|Malignant|364|112280888|Male|Oligodendroglioma|2012|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|113545923|Male|Oligodendroglioma|2013|~|~|~
20+|0.3|0.4|0.3|Malignant|362|113545923|Male|Oligodendroglioma|2013|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|114816261|Male|Oligodendroglioma|2014|~|~|~
20+|0.3|0.4|0.4|Malignant|400|114816261|Male|Oligodendroglioma|2014|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|116027287|Male|Oligodendroglioma|2015|~|~|~
20+|0.3|0.4|0.3|Malignant|392|116027287|Male|Oligodendroglioma|2015|0.3|0.4|0.3
20+|0.1|0.1|0.1|Benign/Borderline|81|101938779|Male|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|73|103190694|Male|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|36|103190694|Male|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|68|104488268|Male|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|104488268|Male|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|83|105697783|Male|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|38|105697783|Male|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|100|106947980|Male|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|46|106947980|Male|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|103|108197539|Male|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|47|108197539|Male|Other mesenchymal|2009|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|77|109537494|Male|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|32|109537494|Male|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|66|110887513|Male|Other mesenchymal|2011|0.0|0.1|0.1
20+|0.0|0.1|0.0|Malignant|43|110887513|Male|Other mesenchymal|2011|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|412|567557872|Male|Other mesenchymal|2011-2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|208|567557872|Male|Other mesenchymal|2011-2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|91|112280888|Male|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|30|112280888|Male|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.0|0.1|0.1|Benign/Borderline|73|113545923|Male|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|44|113545923|Male|Other mesenchymal|2013|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|82|114816261|Male|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|47|114816261|Male|Other mesenchymal|2014|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|100|116027287|Male|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|44|116027287|Male|Other mesenchymal|2015|0.0|0.1|0.0
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.2|0.1|Malignant|150|101938779|Male|Pilocytic astrocytoma|2004|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|155|103190694|Male|Pilocytic astrocytoma|2005|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|158|104488268|Male|Pilocytic astrocytoma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|142|105697783|Male|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.2|0.1|Malignant|144|106947980|Male|Pilocytic astrocytoma|2008|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|137|108197539|Male|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|109537494|Male|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|162|109537494|Male|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|110887513|Male|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.2|Malignant|171|110887513|Male|Pilocytic astrocytoma|2011|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|567557872|Male|Pilocytic astrocytoma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|750|567557872|Male|Pilocytic astrocytoma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|112280888|Male|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.2|0.1|Malignant|145|112280888|Male|Pilocytic astrocytoma|2012|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|113545923|Male|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|142|113545923|Male|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|114816261|Male|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|149|114816261|Male|Pilocytic astrocytoma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|116027287|Male|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|143|116027287|Male|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004|~|~|~
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|17|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|105697783|Male|Pineal parenchymal|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|105697783|Male|Pineal parenchymal|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|23|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|21|106947980|Male|Pineal parenchymal|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|109537494|Male|Pineal parenchymal|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|18|109537494|Male|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|16|110887513|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|18|110887513|Male|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|88|567557872|Male|Pineal parenchymal|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|118|567557872|Male|Pineal parenchymal|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|112280888|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|20|112280888|Male|Pineal parenchymal|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|113545923|Male|Pineal parenchymal|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|36|113545923|Male|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|21|114816261|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|17|114816261|Male|Pineal parenchymal|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|116027287|Male|Pineal parenchymal|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|27|116027287|Male|Pineal parenchymal|2015|0.0|0.0|0.0
20+|3.3|3.5|3.4|Benign/Borderline|3383|101938779|Male|Pituitary|2004|3.2|3.4|3.3
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Pituitary|2004|0.0|0.0|0.0
20+|3.6|3.8|3.7|Benign/Borderline|3722|103190694|Male|Pituitary|2005|3.5|3.7|3.6
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005|~|~|~
20+|3.8|4.0|3.9|Benign/Borderline|4011|104488268|Male|Pituitary|2006|3.7|4.0|3.8
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006|0.0|0.0|0.0
20+|4.1|4.3|4.2|Benign/Borderline|4378|105697783|Male|Pituitary|2007|4.0|4.3|4.1
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Pituitary|2007|0.0|0.0|0.0
20+|4.4|4.6|4.5|Benign/Borderline|4763|106947980|Male|Pituitary|2008|4.3|4.6|4.5
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008|~|~|~
20+|4.6|4.8|4.7|Benign/Borderline|5094|108197539|Male|Pituitary|2009|4.6|4.8|4.7
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009|~|~|~
20+|4.6|4.9|4.8|Benign/Borderline|5252|109537494|Male|Pituitary|2010|4.7|4.9|4.8
20+|~|~|~|Malignant|~|109537494|Male|Pituitary|2010|~|~|~
20+|4.6|4.9|4.8|Benign/Borderline|5334|110887513|Male|Pituitary|2011|4.7|4.9|4.8
20+|0.0|0.0|0.0|Malignant|23|110887513|Male|Pituitary|2011|0.0|0.0|0.0
20+|4.9|5.0|4.9|Benign/Borderline|28394|567557872|Male|Pituitary|2011-2015|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|104|567557872|Male|Pituitary|2011-2015|0.0|0.0|0.0
20+|4.9|5.2|5.1|Benign/Borderline|5766|112280888|Male|Pituitary|2012|5.0|5.3|5.1
20+|0.0|0.0|0.0|Malignant|19|112280888|Male|Pituitary|2012|0.0|0.0|0.0
20+|4.9|5.1|5.0|Benign/Borderline|5781|113545923|Male|Pituitary|2013|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|25|113545923|Male|Pituitary|2013|0.0|0.0|0.0
20+|4.8|5.0|4.9|Benign/Borderline|5767|114816261|Male|Pituitary|2014|4.9|5.2|5.0
20+|0.0|0.0|0.0|Malignant|21|114816261|Male|Pituitary|2014|0.0|0.0|0.0
20+|4.7|4.9|4.8|Benign/Borderline|5746|116027287|Male|Pituitary|2015|4.8|5.1|5.0
20+|0.0|0.0|0.0|Malignant|16|116027287|Male|Pituitary|2015|0.0|0.0|0.0
20+|12.3|12.7|12.5|Benign/Borderline|12176|101938779|Male|Total|2004|11.7|12.2|11.9
20+|10.7|11.1|10.9|Malignant|10628|101938779|Male|Total|2004|10.2|10.6|10.4
20+|13.7|14.2|13.9|Benign/Borderline|13771|103190694|Male|Total|2005|13.1|13.6|13.3
20+|10.7|11.1|10.9|Malignant|10793|103190694|Male|Total|2005|10.3|10.7|10.5
20+|14.1|14.5|14.3|Benign/Borderline|14422|104488268|Male|Total|2006|13.6|14.0|13.8
20+|10.5|10.9|10.7|Malignant|10814|104488268|Male|Total|2006|10.2|10.5|10.3
20+|14.4|14.9|14.7|Benign/Borderline|15053|105697783|Male|Total|2007|14.0|14.5|14.2
20+|10.5|10.9|10.7|Malignant|11055|105697783|Male|Total|2007|10.3|10.7|10.5
20+|15.2|15.7|15.5|Benign/Borderline|16161|106947980|Male|Total|2008|14.9|15.3|15.1
20+|10.6|11.0|10.8|Malignant|11343|106947980|Male|Total|2008|10.4|10.8|10.6
20+|16.0|16.5|16.3|Benign/Borderline|17272|108197539|Male|Total|2009|15.7|16.2|16.0
20+|10.5|10.8|10.6|Malignant|11411|108197539|Male|Total|2009|10.4|10.7|10.5
20+|16.0|16.5|16.2|Benign/Borderline|17567|109537494|Male|Total|2010|15.8|16.3|16.0
20+|10.2|10.6|10.4|Malignant|11375|109537494|Male|Total|2010|10.2|10.6|10.4
20+|15.9|16.4|16.2|Benign/Borderline|17846|110887513|Male|Total|2011|15.9|16.3|16.1
20+|10.2|10.6|10.4|Malignant|11619|110887513|Male|Total|2011|10.3|10.7|10.5
20+|16.3|16.6|16.5|Benign/Borderline|94277|567557872|Male|Total|2011-2015|16.5|16.7|16.6
20+|10.0|10.2|10.1|Malignant|58954|567557872|Male|Total|2011-2015|10.3|10.5|10.4
20+|16.4|16.8|16.6|Benign/Borderline|18669|112280888|Male|Total|2012|16.4|16.9|16.6
20+|10.0|10.4|10.2|Malignant|11639|112280888|Male|Total|2012|10.2|10.6|10.4
20+|16.5|17.0|16.7|Benign/Borderline|19170|113545923|Male|Total|2013|16.6|17.1|16.9
20+|9.9|10.3|10.1|Malignant|11788|113545923|Male|Total|2013|10.2|10.6|10.4
20+|16.4|16.8|16.6|Benign/Borderline|19329|114816261|Male|Total|2014|16.6|17.1|16.8
20+|10.0|10.4|10.2|Malignant|12085|114816261|Male|Total|2014|10.3|10.7|10.5
20+|16.0|16.4|16.2|Benign/Borderline|19263|116027287|Male|Total|2015|16.4|16.8|16.6
20+|9.6|9.9|9.8|Malignant|11823|116027287|Male|Total|2015|10.0|10.4|10.2
20+|2.2|2.4|2.3|Benign/Borderline|2307|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2661|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2625|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2705|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2672|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|2.4|2.6|2.5
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|2839|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|20|108197539|Male|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|2840|109537494|Male|Tumors of Cranial and Spinal Nerves|2010|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|22|109537494|Male|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.6|2.5|Benign/Borderline|2930|110887513|Male|Tumors of Cranial and Spinal Nerves|2011|2.5|2.7|2.6
20+|0.0|0.0|0.0|Malignant|16|110887513|Male|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|15651|567557872|Male|Tumors of Cranial and Spinal Nerves|2011-2015|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|98|567557872|Male|Tumors of Cranial and Spinal Nerves|2011-2015|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|3095|112280888|Male|Tumors of Cranial and Spinal Nerves|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|25|112280888|Male|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3128|113545923|Male|Tumors of Cranial and Spinal Nerves|2013|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|20|113545923|Male|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.7|2.9|2.8|Benign/Borderline|3339|114816261|Male|Tumors of Cranial and Spinal Nerves|2014|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|21|114816261|Male|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|3159|116027287|Male|Tumors of Cranial and Spinal Nerves|2015|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|16|116027287|Male|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|0.4|0.5|0.4|Benign/Borderline|445|101938779|Male|Tumors of Neuroepthelial Tissue|2004|0.4|0.5|0.4
20+|8.9|9.3|9.1|Malignant|8951|101938779|Male|Tumors of Neuroepthelial Tissue|2004|8.6|9.0|8.8
20+|0.5|0.5|0.5|Benign/Borderline|520|103190694|Male|Tumors of Neuroepthelial Tissue|2005|0.5|0.5|0.5
20+|8.9|9.3|9.1|Malignant|9087|103190694|Male|Tumors of Neuroepthelial Tissue|2005|8.6|9.0|8.8
20+|0.5|0.6|0.5|Benign/Borderline|554|104488268|Male|Tumors of Neuroepthelial Tissue|2006|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9182|104488268|Male|Tumors of Neuroepthelial Tissue|2006|8.6|9.0|8.8
20+|0.4|0.5|0.5|Benign/Borderline|513|105697783|Male|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|8.8|9.2|9.0|Malignant|9381|105697783|Male|Tumors of Neuroepthelial Tissue|2007|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|581|106947980|Male|Tumors of Neuroepthelial Tissue|2008|0.5|0.6|0.5
20+|8.9|9.3|9.1|Malignant|9633|106947980|Male|Tumors of Neuroepthelial Tissue|2008|8.8|9.2|9.0
20+|0.5|0.6|0.5|Benign/Borderline|584|108197539|Male|Tumors of Neuroepthelial Tissue|2009|0.5|0.6|0.5
20+|8.8|9.2|9.0|Malignant|9708|108197539|Male|Tumors of Neuroepthelial Tissue|2009|8.8|9.2|9.0
20+|0.5|0.6|0.6|Benign/Borderline|644|109537494|Male|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.6
20+|8.6|9.0|8.8|Malignant|9731|109537494|Male|Tumors of Neuroepthelial Tissue|2010|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|594|110887513|Male|Tumors of Neuroepthelial Tissue|2011|0.5|0.6|0.5
20+|8.6|8.9|8.8|Malignant|9875|110887513|Male|Tumors of Neuroepthelial Tissue|2011|8.7|9.1|8.9
20+|0.5|0.6|0.5|Benign/Borderline|3127|567557872|Male|Tumors of Neuroepthelial Tissue|2011-2015|0.5|0.6|0.6
20+|8.5|8.7|8.6|Malignant|50324|567557872|Male|Tumors of Neuroepthelial Tissue|2011-2015|8.8|8.9|8.9
20+|0.5|0.6|0.5|Benign/Borderline|618|112280888|Male|Tumors of Neuroepthelial Tissue|2012|0.5|0.6|0.6
20+|8.5|8.8|8.7|Malignant|9960|112280888|Male|Tumors of Neuroepthelial Tissue|2012|8.7|9.0|8.9
20+|0.5|0.6|0.5|Benign/Borderline|597|113545923|Male|Tumors of Neuroepthelial Tissue|2013|0.5|0.6|0.5
20+|8.5|8.8|8.6|Malignant|10124|113545923|Male|Tumors of Neuroepthelial Tissue|2013|8.7|9.1|8.9
20+|0.5|0.6|0.6|Benign/Borderline|661|114816261|Male|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.6
20+|8.5|8.8|8.6|Malignant|10261|114816261|Male|Tumors of Neuroepthelial Tissue|2014|8.8|9.1|8.9
20+|0.5|0.6|0.6|Benign/Borderline|657|116027287|Male|Tumors of Neuroepthelial Tissue|2015|0.5|0.6|0.6
20+|8.1|8.5|8.3|Malignant|10104|116027287|Male|Tumors of Neuroepthelial Tissue|2015|8.5|8.9|8.7
20+|3.5|3.7|3.6|Benign/Borderline|3567|101938779|Male|Tumors of Sellar Region|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|3.8|4.0|3.9|Benign/Borderline|3952|103190694|Male|Tumors of Sellar Region|2005|3.7|4.0|3.8
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005|~|~|~
20+|4.0|4.2|4.1|Benign/Borderline|4201|104488268|Male|Tumors of Sellar Region|2006|3.9|4.1|4.0
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.2|4.5|4.4|Benign/Borderline|4576|105697783|Male|Tumors of Sellar Region|2007|4.2|4.5|4.3
20+|0.0|0.0|0.0|Malignant|24|105697783|Male|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.5|4.8|4.7|Benign/Borderline|4962|106947980|Male|Tumors of Sellar Region|2008|4.5|4.8|4.6
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008|~|~|~
20+|4.8|5.0|4.9|Benign/Borderline|5294|108197539|Male|Tumors of Sellar Region|2009|4.8|5.0|4.9
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009|~|~|~
20+|4.8|5.1|4.9|Benign/Borderline|5452|109537494|Male|Tumors of Sellar Region|2010|4.8|5.1|5.0
20+|~|~|~|Malignant|~|109537494|Male|Tumors of Sellar Region|2010|~|~|~
20+|4.8|5.1|4.9|Benign/Borderline|5527|110887513|Male|Tumors of Sellar Region|2011|4.9|5.1|5.0
20+|0.0|0.0|0.0|Malignant|24|110887513|Male|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.0|5.2|5.1|Benign/Borderline|29439|567557872|Male|Tumors of Sellar Region|2011-2015|5.1|5.2|5.2
20+|0.0|0.0|0.0|Malignant|109|567557872|Male|Tumors of Sellar Region|2011-2015|0.0|0.0|0.0
20+|5.1|5.4|5.3|Benign/Borderline|5980|112280888|Male|Tumors of Sellar Region|2012|5.2|5.5|5.3
20+|0.0|0.0|0.0|Malignant|19|112280888|Male|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|6004|113545923|Male|Tumors of Sellar Region|2013|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|25|113545923|Male|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|4.9|5.2|5.1|Benign/Borderline|5967|114816261|Male|Tumors of Sellar Region|2014|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|25|114816261|Male|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|4.9|5.1|5.0|Benign/Borderline|5961|116027287|Male|Tumors of Sellar Region|2015|5.0|5.3|5.1
20+|0.0|0.0|0.0|Malignant|16|116027287|Male|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|5.4|5.7|5.5|Benign/Borderline|5192|101938779|Male|Tumors of the Meninges|2004|5.0|5.2|5.1
20+|0.2|0.2|0.2|Malignant|198|101938779|Male|Tumors of the Meninges|2004|0.2|0.2|0.2
20+|5.9|6.2|6.1|Benign/Borderline|5785|103190694|Male|Tumors of the Meninges|2005|5.5|5.8|5.6
20+|0.2|0.2|0.2|Malignant|196|103190694|Male|Tumors of the Meninges|2005|0.2|0.2|0.2
20+|6.2|6.5|6.3|Benign/Borderline|6172|104488268|Male|Tumors of the Meninges|2006|5.8|6.1|5.9
20+|0.2|0.2|0.2|Malignant|184|104488268|Male|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|6.2|6.6|6.4|Benign/Borderline|6369|105697783|Male|Tumors of the Meninges|2007|5.9|6.2|6.0
20+|0.2|0.2|0.2|Malignant|221|105697783|Male|Tumors of the Meninges|2007|0.2|0.2|0.2
20+|6.7|7.0|6.9|Benign/Borderline|6993|106947980|Male|Tumors of the Meninges|2008|6.4|6.7|6.5
20+|0.2|0.2|0.2|Malignant|197|106947980|Male|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|7.1|7.4|7.3|Benign/Borderline|7494|108197539|Male|Tumors of the Meninges|2009|6.8|7.1|6.9
20+|0.2|0.2|0.2|Malignant|199|108197539|Male|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|7.0|7.3|7.1|Benign/Borderline|7519|109537494|Male|Tumors of the Meninges|2010|6.7|7.0|6.9
20+|0.1|0.2|0.1|Malignant|154|109537494|Male|Tumors of the Meninges|2010|0.1|0.2|0.1
20+|6.9|7.3|7.1|Benign/Borderline|7656|110887513|Male|Tumors of the Meninges|2011|6.8|7.1|6.9
20+|0.1|0.2|0.2|Malignant|187|110887513|Male|Tumors of the Meninges|2011|0.1|0.2|0.2
20+|7.1|7.2|7.1|Benign/Borderline|40338|567557872|Male|Tumors of the Meninges|2011-2015|7.0|7.2|7.1
20+|0.2|0.2|0.2|Malignant|959|567557872|Male|Tumors of the Meninges|2011-2015|0.2|0.2|0.2
20+|6.9|7.2|7.0|Benign/Borderline|7750|112280888|Male|Tumors of the Meninges|2012|6.7|7.1|6.9
20+|0.1|0.2|0.2|Malignant|177|112280888|Male|Tumors of the Meninges|2012|0.1|0.2|0.2
20+|7.1|7.5|7.3|Benign/Borderline|8239|113545923|Male|Tumors of the Meninges|2013|7.1|7.4|7.3
20+|0.1|0.2|0.2|Malignant|199|113545923|Male|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|7.0|7.3|7.2|Benign/Borderline|8240|114816261|Male|Tumors of the Meninges|2014|7.0|7.3|7.2
20+|0.2|0.2|0.2|Malignant|211|114816261|Male|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|7.0|7.3|7.2|Benign/Borderline|8453|116027287|Male|Tumors of the Meninges|2015|7.1|7.4|7.3
20+|0.1|0.2|0.2|Malignant|185|116027287|Male|Tumors of the Meninges|2015|0.1|0.2|0.2
20+|0.6|0.7|0.7|Benign/Borderline|642|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.6|0.8|0.7|Malignant|618|101938779|Male|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.8|0.9|0.9|Benign/Borderline|822|103190694|Male|Unclassified Tumors|2005|0.7|0.9|0.8
20+|0.6|0.7|0.7|Malignant|610|103190694|Male|Unclassified Tumors|2005|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|839|104488268|Male|Unclassified Tumors|2006|0.7|0.9|0.8
20+|0.6|0.7|0.6|Malignant|574|104488268|Male|Unclassified Tumors|2006|0.5|0.6|0.5
20+|0.8|0.9|0.9|Benign/Borderline|855|105697783|Male|Unclassified Tumors|2007|0.8|0.9|0.8
20+|0.6|0.7|0.6|Malignant|576|105697783|Male|Unclassified Tumors|2007|0.5|0.6|0.5
20+|0.9|1.0|0.9|Benign/Borderline|920|106947980|Male|Unclassified Tumors|2008|0.8|0.9|0.9
20+|0.6|0.7|0.7|Malignant|626|106947980|Male|Unclassified Tumors|2008|0.5|0.6|0.6
20+|0.9|1.1|1.0|Benign/Borderline|1026|108197539|Male|Unclassified Tumors|2009|0.9|1.0|0.9
20+|0.6|0.7|0.7|Malignant|650|108197539|Male|Unclassified Tumors|2009|0.6|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1085|109537494|Male|Unclassified Tumors|2010|0.9|1.1|1.0
20+|0.6|0.7|0.6|Malignant|609|109537494|Male|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1114|110887513|Male|Unclassified Tumors|2011|0.9|1.1|1.0
20+|0.6|0.7|0.6|Malignant|628|110887513|Male|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.0|1.0|1.0|Benign/Borderline|5591|567557872|Male|Unclassified Tumors|2011-2015|1.0|1.0|1.0
20+|0.6|0.6|0.6|Malignant|3150|567557872|Male|Unclassified Tumors|2011-2015|0.5|0.6|0.6
20+|1.0|1.2|1.1|Benign/Borderline|1197|112280888|Male|Unclassified Tumors|2012|1.0|1.1|1.1
20+|0.6|0.7|0.6|Malignant|632|112280888|Male|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.0|1.1|1.0|Benign/Borderline|1176|113545923|Male|Unclassified Tumors|2013|1.0|1.1|1.0
20+|0.5|0.6|0.6|Malignant|617|113545923|Male|Unclassified Tumors|2013|0.5|0.6|0.5
20+|0.9|1.0|1.0|Benign/Borderline|1095|114816261|Male|Unclassified Tumors|2014|0.9|1.0|1.0
20+|0.6|0.7|0.6|Malignant|667|114816261|Male|Unclassified Tumors|2014|0.5|0.6|0.6
20+|0.8|0.9|0.9|Benign/Borderline|1009|116027287|Male|Unclassified Tumors|2015|0.8|0.9|0.9
20+|0.5|0.6|0.5|Malignant|606|116027287|Male|Unclassified Tumors|2015|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|97|101938779|Male|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|101938779|Male|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|112|103190694|Male|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|136|104488268|Male|Unique astrocytoma variants|2006|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|24|104488268|Male|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|121|105697783|Male|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|29|105697783|Male|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|149|106947980|Male|Unique astrocytoma variants|2008|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|36|106947980|Male|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|159|108197539|Male|Unique astrocytoma variants|2009|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|108197539|Male|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|184|109537494|Male|Unique astrocytoma variants|2010|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|109537494|Male|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.2|0.2|Benign/Borderline|183|110887513|Male|Unique astrocytoma variants|2011|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|31|110887513|Male|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|856|567557872|Male|Unique astrocytoma variants|2011-2015|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|163|567557872|Male|Unique astrocytoma variants|2011-2015|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|172|112280888|Male|Unique astrocytoma variants|2012|0.1|0.2|0.2
20+|0.0|0.0|0.0|Malignant|26|112280888|Male|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|165|113545923|Male|Unique astrocytoma variants|2013|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|39|113545923|Male|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|170|114816261|Male|Unique astrocytoma variants|2014|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|40|114816261|Male|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|166|116027287|Male|Unique astrocytoma variants|2015|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|27|116027287|Male|Unique astrocytoma variants|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|24|211050944|Male and Female|All other|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|30|213511339|Male and Female|All other|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|39|216055494|Male and Female|All other|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|31|218481776|Male and Female|All other|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|36|220975702|Male and Female|All other|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|28|223491138|Male and Female|All other|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|29|226162376|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|32|226162376|Male and Female|All other|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|228824481|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|228824481|Male and Female|All other|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|165|1169527284|Male and Female|All other|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|227|1169527284|Male and Female|All other|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|231502255|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|33|231502255|Male and Female|All other|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|32|233947093|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|233947093|Male and Female|All other|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|26|236440755|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|47|236440755|Male and Female|All other|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|238812700|Male and Female|All other|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|238812700|Male and Female|All other|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004|~|~|~
20+|0.6|0.6|0.6|Malignant|1236|211050944|Male and Female|Anaplastic astrocytoma|2004|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1212|213511339|Male and Female|Anaplastic astrocytoma|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1208|216055494|Male and Female|Anaplastic astrocytoma|2006|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1200|218481776|Male and Female|Anaplastic astrocytoma|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008|~|~|~
20+|0.5|0.6|0.5|Malignant|1210|220975702|Male and Female|Anaplastic astrocytoma|2008|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009|~|~|~
20+|0.5|0.6|0.5|Malignant|1212|223491138|Male and Female|Anaplastic astrocytoma|2009|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Anaplastic astrocytoma|2010|~|~|~
20+|0.5|0.6|0.6|Malignant|1265|226162376|Male and Female|Anaplastic astrocytoma|2010|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Anaplastic astrocytoma|2011|~|~|~
20+|0.5|0.6|0.5|Malignant|1274|228824481|Male and Female|Anaplastic astrocytoma|2011|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Anaplastic astrocytoma|2011-2015|~|~|~
20+|0.6|0.6|0.6|Malignant|6883|1169527284|Male and Female|Anaplastic astrocytoma|2011-2015|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Anaplastic astrocytoma|2012|~|~|~
20+|0.5|0.6|0.6|Malignant|1333|231502255|Male and Female|Anaplastic astrocytoma|2012|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Anaplastic astrocytoma|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1420|233947093|Male and Female|Anaplastic astrocytoma|2013|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Anaplastic astrocytoma|2014|~|~|~
20+|0.5|0.6|0.6|Malignant|1396|236440755|Male and Female|Anaplastic astrocytoma|2014|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Anaplastic astrocytoma|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1460|238812700|Male and Female|Anaplastic astrocytoma|2015|0.6|0.6|0.6
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004|~|~|~
20+|0.2|0.2|0.2|Malignant|394|211050944|Male and Female|Anaplastic oligodendroglioma|2004|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005|~|~|~
20+|0.2|0.2|0.2|Malignant|374|213511339|Male and Female|Anaplastic oligodendroglioma|2005|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006|~|~|~
20+|0.1|0.2|0.2|Malignant|352|216055494|Male and Female|Anaplastic oligodendroglioma|2006|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007|~|~|~
20+|0.1|0.2|0.2|Malignant|339|218481776|Male and Female|Anaplastic oligodendroglioma|2007|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|357|220975702|Male and Female|Anaplastic oligodendroglioma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009|~|~|~
20+|0.1|0.2|0.1|Malignant|330|223491138|Male and Female|Anaplastic oligodendroglioma|2009|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Anaplastic oligodendroglioma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|321|226162376|Male and Female|Anaplastic oligodendroglioma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Anaplastic oligodendroglioma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|333|228824481|Male and Female|Anaplastic oligodendroglioma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Anaplastic oligodendroglioma|2011-2015|~|~|~
20+|0.1|0.2|0.1|Malignant|1748|1169527284|Male and Female|Anaplastic oligodendroglioma|2011-2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Anaplastic oligodendroglioma|2012|~|~|~
20+|0.1|0.2|0.2|Malignant|352|231502255|Male and Female|Anaplastic oligodendroglioma|2012|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Anaplastic oligodendroglioma|2013|~|~|~
20+|0.1|0.2|0.2|Malignant|365|233947093|Male and Female|Anaplastic oligodendroglioma|2013|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Anaplastic oligodendroglioma|2014|~|~|~
20+|0.1|0.2|0.1|Malignant|351|236440755|Male and Female|Anaplastic oligodendroglioma|2014|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Anaplastic oligodendroglioma|2015|~|~|~
20+|0.1|0.2|0.1|Malignant|347|238812700|Male and Female|Anaplastic oligodendroglioma|2015|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004|~|~|~
20+|0.5|0.6|0.6|Malignant|1202|211050944|Male and Female|Astrocytoma, NOS|2004|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005|~|~|~
20+|0.5|0.6|0.6|Malignant|1192|213511339|Male and Female|Astrocytoma, NOS|2005|0.5|0.6|0.6
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006|~|~|~
20+|0.5|0.6|0.6|Malignant|1183|216055494|Male and Female|Astrocytoma, NOS|2006|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007|~|~|~
20+|0.5|0.6|0.5|Malignant|1159|218481776|Male and Female|Astrocytoma, NOS|2007|0.5|0.6|0.5
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008|~|~|~
20+|0.5|0.5|0.5|Malignant|1113|220975702|Male and Female|Astrocytoma, NOS|2008|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009|~|~|~
20+|0.4|0.5|0.5|Malignant|1052|223491138|Male and Female|Astrocytoma, NOS|2009|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Astrocytoma, NOS|2010|~|~|~
20+|0.4|0.5|0.5|Malignant|1085|226162376|Male and Female|Astrocytoma, NOS|2010|0.5|0.5|0.5
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Astrocytoma, NOS|2011|~|~|~
20+|0.4|0.5|0.4|Malignant|1034|228824481|Male and Female|Astrocytoma, NOS|2011|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Astrocytoma, NOS|2011-2015|~|~|~
20+|0.4|0.5|0.4|Malignant|5289|1169527284|Male and Female|Astrocytoma, NOS|2011-2015|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Astrocytoma, NOS|2012|~|~|~
20+|0.4|0.5|0.4|Malignant|1037|231502255|Male and Female|Astrocytoma, NOS|2012|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Astrocytoma, NOS|2013|~|~|~
20+|0.4|0.4|0.4|Malignant|994|233947093|Male and Female|Astrocytoma, NOS|2013|0.4|0.5|0.4
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Astrocytoma, NOS|2014|~|~|~
20+|0.4|0.5|0.4|Malignant|1065|236440755|Male and Female|Astrocytoma, NOS|2014|0.4|0.5|0.5
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Astrocytoma, NOS|2015|~|~|~
20+|0.5|0.5|0.5|Malignant|1159|238812700|Male and Female|Astrocytoma, NOS|2015|0.5|0.5|0.5
20+|0.0|0.0|0.0|Benign/Borderline|63|211050944|Male and Female|Choroid plexus|2004|0.0|0.0|0.0
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|75|213511339|Male and Female|Choroid plexus|2005|0.0|0.0|0.0
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|68|216055494|Male and Female|Choroid plexus|2006|0.0|0.0|0.0
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|87|218481776|Male and Female|Choroid plexus|2007|0.0|0.0|0.0
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|75|220975702|Male and Female|Choroid plexus|2008|0.0|0.0|0.0
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|72|223491138|Male and Female|Choroid plexus|2009|0.0|0.0|0.0
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|84|226162376|Male and Female|Choroid plexus|2010|0.0|0.0|0.0
20+|~|~|~|Malignant|~|226162376|Male and Female|Choroid plexus|2010|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|82|228824481|Male and Female|Choroid plexus|2011|0.0|0.0|0.0
20+|~|~|~|Malignant|~|228824481|Male and Female|Choroid plexus|2011|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|397|1169527284|Male and Female|Choroid plexus|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|29|1169527284|Male and Female|Choroid plexus|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|70|231502255|Male and Female|Choroid plexus|2012|0.0|0.0|0.0
20+|~|~|~|Malignant|~|231502255|Male and Female|Choroid plexus|2012|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|77|233947093|Male and Female|Choroid plexus|2013|0.0|0.0|0.0
20+|~|~|~|Malignant|~|233947093|Male and Female|Choroid plexus|2013|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|87|236440755|Male and Female|Choroid plexus|2014|0.0|0.0|0.0
20+|~|~|~|Malignant|~|236440755|Male and Female|Choroid plexus|2014|~|~|~
20+|0.0|0.0|0.0|Benign/Borderline|81|238812700|Male and Female|Choroid plexus|2015|0.0|0.0|0.0
20+|~|~|~|Malignant|~|238812700|Male and Female|Choroid plexus|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|388|211050944|Male and Female|Craniopharyngioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|414|213511339|Male and Female|Craniopharyngioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|390|216055494|Male and Female|Craniopharyngioma|2006|0.2|0.2|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|415|218481776|Male and Female|Craniopharyngioma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|420|220975702|Male and Female|Craniopharyngioma|2008|0.2|0.2|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|428|223491138|Male and Female|Craniopharyngioma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|437|226162376|Male and Female|Craniopharyngioma|2010|0.2|0.2|0.2
20+|~|~|~|Malignant|~|226162376|Male and Female|Craniopharyngioma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|410|228824481|Male and Female|Craniopharyngioma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|228824481|Male and Female|Craniopharyngioma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2164|1169527284|Male and Female|Craniopharyngioma|2011-2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|1169527284|Male and Female|Craniopharyngioma|2011-2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|434|231502255|Male and Female|Craniopharyngioma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|231502255|Male and Female|Craniopharyngioma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|460|233947093|Male and Female|Craniopharyngioma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233947093|Male and Female|Craniopharyngioma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|420|236440755|Male and Female|Craniopharyngioma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236440755|Male and Female|Craniopharyngioma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|440|238812700|Male and Female|Craniopharyngioma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238812700|Male and Female|Craniopharyngioma|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|256|211050944|Male and Female|Diffuse astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|280|213511339|Male and Female|Diffuse astrocytoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|293|216055494|Male and Female|Diffuse astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|317|218481776|Male and Female|Diffuse astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008|~|~|~
20+|0.1|0.2|0.2|Malignant|341|220975702|Male and Female|Diffuse astrocytoma|2008|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009|~|~|~
20+|0.1|0.2|0.2|Malignant|369|223491138|Male and Female|Diffuse astrocytoma|2009|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Diffuse astrocytoma|2010|~|~|~
20+|0.1|0.2|0.2|Malignant|348|226162376|Male and Female|Diffuse astrocytoma|2010|0.1|0.2|0.2
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Diffuse astrocytoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|250|228824481|Male and Female|Diffuse astrocytoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Diffuse astrocytoma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|842|1169527284|Male and Female|Diffuse astrocytoma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Diffuse astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|207|231502255|Male and Female|Diffuse astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Diffuse astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|173|233947093|Male and Female|Diffuse astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Diffuse astrocytoma|2014|~|~|~
20+|0.0|0.1|0.1|Malignant|130|236440755|Male and Female|Diffuse astrocytoma|2014|0.0|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Diffuse astrocytoma|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|82|238812700|Male and Female|Diffuse astrocytoma|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|167|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|~|~|~
20+|0.1|0.1|0.1|Malignant|189|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|~|~|~
20+|0.1|0.1|0.1|Malignant|171|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|~|~|~
20+|0.1|0.1|0.1|Malignant|216|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|213|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|236|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Embryonal/primitive/medulloblastoma|2010|~|~|~
20+|0.1|0.1|0.1|Malignant|197|226162376|Male and Female|Embryonal/primitive/medulloblastoma|2010|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Embryonal/primitive/medulloblastoma|2011|~|~|~
20+|0.1|0.1|0.1|Malignant|187|228824481|Male and Female|Embryonal/primitive/medulloblastoma|2011|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Embryonal/primitive/medulloblastoma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|889|1169527284|Male and Female|Embryonal/primitive/medulloblastoma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Embryonal/primitive/medulloblastoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|173|231502255|Male and Female|Embryonal/primitive/medulloblastoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Embryonal/primitive/medulloblastoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|185|233947093|Male and Female|Embryonal/primitive/medulloblastoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Embryonal/primitive/medulloblastoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|180|236440755|Male and Female|Embryonal/primitive/medulloblastoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Embryonal/primitive/medulloblastoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|164|238812700|Male and Female|Embryonal/primitive/medulloblastoma|2015|0.1|0.1|0.1
20+|0.1|0.1|0.1|Benign/Borderline|246|211050944|Male and Female|Ependymoma variants|2004|0.1|0.1|0.1
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|271|213511339|Male and Female|Ependymoma variants|2005|0.1|0.1|0.1
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005|~|~|~
20+|0.1|0.2|0.1|Benign/Borderline|306|216055494|Male and Female|Ependymoma variants|2006|0.1|0.2|0.1
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|247|218481776|Male and Female|Ependymoma variants|2007|0.1|0.1|0.1
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|256|220975702|Male and Female|Ependymoma variants|2008|0.1|0.1|0.1
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|258|223491138|Male and Female|Ependymoma variants|2009|0.1|0.1|0.1
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|276|226162376|Male and Female|Ependymoma variants|2010|0.1|0.1|0.1
20+|~|~|~|Malignant|~|226162376|Male and Female|Ependymoma variants|2010|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|267|228824481|Male and Female|Ependymoma variants|2011|0.1|0.1|0.1
20+|~|~|~|Malignant|~|228824481|Male and Female|Ependymoma variants|2011|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|1413|1169527284|Male and Female|Ependymoma variants|2011-2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|31|1169527284|Male and Female|Ependymoma variants|2011-2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|291|231502255|Male and Female|Ependymoma variants|2012|0.1|0.1|0.1
20+|~|~|~|Malignant|~|231502255|Male and Female|Ependymoma variants|2012|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|273|233947093|Male and Female|Ependymoma variants|2013|0.1|0.1|0.1
20+|~|~|~|Malignant|~|233947093|Male and Female|Ependymoma variants|2013|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|294|236440755|Male and Female|Ependymoma variants|2014|0.1|0.1|0.1
20+|~|~|~|Malignant|~|236440755|Male and Female|Ependymoma variants|2014|~|~|~
20+|0.1|0.1|0.1|Benign/Borderline|288|238812700|Male and Female|Ependymoma variants|2015|0.1|0.1|0.1
20+|~|~|~|Malignant|~|238812700|Male and Female|Ependymoma variants|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|~|~|~
20+|0.3|0.3|0.3|Malignant|593|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|~|~|~
20+|0.3|0.3|0.3|Malignant|601|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|~|~|~
20+|0.2|0.3|0.3|Malignant|584|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|~|~|~
20+|0.2|0.3|0.3|Malignant|583|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|634|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|678|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Ependymoma/anaplastic ependymoma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|624|226162376|Male and Female|Ependymoma/anaplastic ependymoma|2010|0.3|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|17|228824481|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.0|0.0|0.0
20+|0.2|0.3|0.3|Malignant|594|228824481|Male and Female|Ependymoma/anaplastic ependymoma|2011|0.2|0.3|0.3
20+|0.0|0.0|0.0|Benign/Borderline|92|1169527284|Male and Female|Ependymoma/anaplastic ependymoma|2011-2015|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|2910|1169527284|Male and Female|Ependymoma/anaplastic ependymoma|2011-2015|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Ependymoma/anaplastic ependymoma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|626|231502255|Male and Female|Ependymoma/anaplastic ependymoma|2012|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Ependymoma/anaplastic ependymoma|2013|~|~|~
20+|0.2|0.3|0.2|Malignant|570|233947093|Male and Female|Ependymoma/anaplastic ependymoma|2013|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|29|236440755|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|554|236440755|Male and Female|Ependymoma/anaplastic ependymoma|2014|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|25|238812700|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.0|0.0|0.0
20+|0.2|0.3|0.2|Malignant|566|238812700|Male and Female|Ependymoma/anaplastic ependymoma|2015|0.2|0.3|0.2
20+|0.0|0.0|0.0|Benign/Borderline|38|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|56|211050944|Male and Female|Germ Cell Tumors|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|67|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|213511339|Male and Female|Germ Cell Tumors|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|64|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|60|216055494|Male and Female|Germ Cell Tumors|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|70|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|75|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|226162376|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|64|226162376|Male and Female|Germ Cell Tumors|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|228824481|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|68|228824481|Male and Female|Germ Cell Tumors|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|278|1169527284|Male and Female|Germ Cell Tumors|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|296|1169527284|Male and Female|Germ Cell Tumors|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|231502255|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|52|231502255|Male and Female|Germ Cell Tumors|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|49|233947093|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|51|233947093|Male and Female|Germ Cell Tumors|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|58|236440755|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|66|236440755|Male and Female|Germ Cell Tumors|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|51|238812700|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|59|238812700|Male and Female|Germ Cell Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004|~|~|~
20+|4.4|4.6|4.5|Malignant|9557|211050944|Male and Female|Glioblastoma|2004|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005|~|~|~
20+|4.4|4.5|4.5|Malignant|9701|213511339|Male and Female|Glioblastoma|2005|4.5|4.6|4.5
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006|~|~|~
20+|4.3|4.5|4.4|Malignant|9800|216055494|Male and Female|Glioblastoma|2006|4.4|4.6|4.5
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007|~|~|~
20+|4.4|4.6|4.5|Malignant|10182|218481776|Male and Female|Glioblastoma|2007|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008|~|~|~
20+|4.4|4.6|4.5|Malignant|10405|220975702|Male and Female|Glioblastoma|2008|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009|~|~|~
20+|4.3|4.5|4.4|Malignant|10481|223491138|Male and Female|Glioblastoma|2009|4.6|4.8|4.7
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Glioblastoma|2010|~|~|~
20+|4.3|4.5|4.4|Malignant|10726|226162376|Male and Female|Glioblastoma|2010|4.7|4.8|4.7
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Glioblastoma|2011|~|~|~
20+|4.3|4.5|4.4|Malignant|10879|228824481|Male and Female|Glioblastoma|2011|4.7|4.8|4.8
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Glioblastoma|2011-2015|~|~|~
20+|4.4|4.5|4.4|Malignant|57175|1169527284|Male and Female|Glioblastoma|2011-2015|4.8|4.9|4.9
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Glioblastoma|2012|~|~|~
20+|4.4|4.6|4.5|Malignant|11382|231502255|Male and Female|Glioblastoma|2012|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Glioblastoma|2013|~|~|~
20+|4.4|4.6|4.5|Malignant|11528|233947093|Male and Female|Glioblastoma|2013|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Glioblastoma|2014|~|~|~
20+|4.3|4.5|4.4|Malignant|11543|236440755|Male and Female|Glioblastoma|2014|4.8|5.0|4.9
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Glioblastoma|2015|~|~|~
20+|4.3|4.5|4.4|Malignant|11843|238812700|Male and Female|Glioblastoma|2015|4.9|5.0|5.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|843|211050944|Male and Female|Glioma malignant, NOS|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|831|213511339|Male and Female|Glioma malignant, NOS|2005|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|216055494|Male and Female|Glioma malignant, NOS|2006|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|838|216055494|Male and Female|Glioma malignant, NOS|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioma malignant, NOS|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|871|218481776|Male and Female|Glioma malignant, NOS|2007|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|24|220975702|Male and Female|Glioma malignant, NOS|2008|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|915|220975702|Male and Female|Glioma malignant, NOS|2008|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|23|223491138|Male and Female|Glioma malignant, NOS|2009|0.0|0.0|0.0
20+|0.4|0.5|0.4|Malignant|969|223491138|Male and Female|Glioma malignant, NOS|2009|0.4|0.5|0.4
20+|0.0|0.0|0.0|Benign/Borderline|19|226162376|Male and Female|Glioma malignant, NOS|2010|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|818|226162376|Male and Female|Glioma malignant, NOS|2010|0.3|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|25|228824481|Male and Female|Glioma malignant, NOS|2011|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|928|228824481|Male and Female|Glioma malignant, NOS|2011|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|166|1169527284|Male and Female|Glioma malignant, NOS|2011-2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|4608|1169527284|Male and Female|Glioma malignant, NOS|2011-2015|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|27|231502255|Male and Female|Glioma malignant, NOS|2012|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|913|231502255|Male and Female|Glioma malignant, NOS|2012|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|31|233947093|Male and Female|Glioma malignant, NOS|2013|0.0|0.0|0.0
20+|0.3|0.4|0.4|Malignant|900|233947093|Male and Female|Glioma malignant, NOS|2013|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|39|236440755|Male and Female|Glioma malignant, NOS|2014|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|923|236440755|Male and Female|Glioma malignant, NOS|2014|0.4|0.4|0.4
20+|0.0|0.0|0.0|Benign/Borderline|44|238812700|Male and Female|Glioma malignant, NOS|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Malignant|944|238812700|Male and Female|Glioma malignant, NOS|2015|0.4|0.4|0.4
20+|0.2|0.2|0.2|Benign/Borderline|455|211050944|Male and Female|Hemangioblastoma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|511|213511339|Male and Female|Hemangioblastoma|2005|0.2|0.3|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|498|216055494|Male and Female|Hemangioblastoma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|471|218481776|Male and Female|Hemangioblastoma|2007|0.2|0.2|0.2
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|528|220975702|Male and Female|Hemangioblastoma|2008|0.2|0.3|0.2
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|505|223491138|Male and Female|Hemangioblastoma|2009|0.2|0.2|0.2
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|525|226162376|Male and Female|Hemangioblastoma|2010|0.2|0.3|0.2
20+|~|~|~|Malignant|~|226162376|Male and Female|Hemangioblastoma|2010|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|510|228824481|Male and Female|Hemangioblastoma|2011|0.2|0.2|0.2
20+|~|~|~|Malignant|~|228824481|Male and Female|Hemangioblastoma|2011|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|2530|1169527284|Male and Female|Hemangioblastoma|2011-2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|17|1169527284|Male and Female|Hemangioblastoma|2011-2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|527|231502255|Male and Female|Hemangioblastoma|2012|0.2|0.2|0.2
20+|~|~|~|Malignant|~|231502255|Male and Female|Hemangioblastoma|2012|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|502|233947093|Male and Female|Hemangioblastoma|2013|0.2|0.2|0.2
20+|~|~|~|Malignant|~|233947093|Male and Female|Hemangioblastoma|2013|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|479|236440755|Male and Female|Hemangioblastoma|2014|0.2|0.2|0.2
20+|~|~|~|Malignant|~|236440755|Male and Female|Hemangioblastoma|2014|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|512|238812700|Male and Female|Hemangioblastoma|2015|0.2|0.2|0.2
20+|~|~|~|Malignant|~|238812700|Male and Female|Hemangioblastoma|2015|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|368|211050944|Male and Female|Hemangioma|2004|0.2|0.2|0.2
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004|~|~|~
20+|0.2|0.2|0.2|Benign/Borderline|477|213511339|Male and Female|Hemangioma|2005|0.2|0.2|0.2
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005|~|~|~
20+|0.2|0.3|0.2|Benign/Borderline|536|216055494|Male and Female|Hemangioma|2006|0.2|0.3|0.2
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006|~|~|~
20+|0.3|0.3|0.3|Benign/Borderline|625|218481776|Male and Female|Hemangioma|2007|0.3|0.3|0.3
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007|~|~|~
20+|0.3|0.4|0.3|Benign/Borderline|773|220975702|Male and Female|Hemangioma|2008|0.3|0.4|0.3
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|924|223491138|Male and Female|Hemangioma|2009|0.4|0.4|0.4
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|1083|226162376|Male and Female|Hemangioma|2010|0.5|0.5|0.5
20+|~|~|~|Malignant|~|226162376|Male and Female|Hemangioma|2010|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1196|228824481|Male and Female|Hemangioma|2011|0.5|0.6|0.5
20+|~|~|~|Malignant|~|228824481|Male and Female|Hemangioma|2011|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|5600|1169527284|Male and Female|Hemangioma|2011-2015|0.5|0.5|0.5
20+|0.0|0.0|0.0|Malignant|16|1169527284|Male and Female|Hemangioma|2011-2015|0.0|0.0|0.0
20+|0.5|0.5|0.5|Benign/Borderline|1187|231502255|Male and Female|Hemangioma|2012|0.5|0.5|0.5
20+|~|~|~|Malignant|~|231502255|Male and Female|Hemangioma|2012|~|~|~
20+|0.5|0.5|0.5|Benign/Borderline|1196|233947093|Male and Female|Hemangioma|2013|0.5|0.5|0.5
20+|~|~|~|Malignant|~|233947093|Male and Female|Hemangioma|2013|~|~|~
20+|0.4|0.5|0.5|Benign/Borderline|1096|236440755|Male and Female|Hemangioma|2014|0.4|0.5|0.5
20+|~|~|~|Malignant|~|236440755|Male and Female|Hemangioma|2014|~|~|~
20+|0.4|0.4|0.4|Benign/Borderline|925|238812700|Male and Female|Hemangioma|2015|0.4|0.4|0.4
20+|~|~|~|Malignant|~|238812700|Male and Female|Hemangioma|2015|~|~|~
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|49|211050944|Male and Female|Local Extensions from Regional Tumors|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|46|213511339|Male and Female|Local Extensions from Regional Tumors|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|52|216055494|Male and Female|Local Extensions from Regional Tumors|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Local Extensions from Regional Tumors|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Local Extensions from Regional Tumors|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|53|223491138|Male and Female|Local Extensions from Regional Tumors|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Local Extensions from Regional Tumors|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226162376|Male and Female|Local Extensions from Regional Tumors|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Local Extensions from Regional Tumors|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|42|228824481|Male and Female|Local Extensions from Regional Tumors|2011|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Local Extensions from Regional Tumors|2011-2015|~|~|~
20+|0.0|0.0|0.0|Malignant|229|1169527284|Male and Female|Local Extensions from Regional Tumors|2011-2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Local Extensions from Regional Tumors|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|48|231502255|Male and Female|Local Extensions from Regional Tumors|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Local Extensions from Regional Tumors|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|45|233947093|Male and Female|Local Extensions from Regional Tumors|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Local Extensions from Regional Tumors|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|51|236440755|Male and Female|Local Extensions from Regional Tumors|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Local Extensions from Regional Tumors|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|43|238812700|Male and Female|Local Extensions from Regional Tumors|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|~|~|~
20+|0.6|0.7|0.6|Malignant|1343|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|~|~|~
20+|0.6|0.7|0.7|Malignant|1440|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|~|~|~
20+|0.6|0.7|0.7|Malignant|1434|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|~|~|~
20+|0.6|0.7|0.6|Malignant|1372|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|~|~|~
20+|0.6|0.7|0.7|Malignant|1475|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|~|~|~
20+|0.6|0.7|0.6|Malignant|1428|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|~|~|~
20+|0.6|0.7|0.6|Malignant|1508|226162376|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|~|~|~
20+|0.6|0.7|0.6|Malignant|1528|228824481|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011-2015|~|~|~
20+|0.6|0.6|0.6|Malignant|7646|1169527284|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011-2015|0.6|0.7|0.7
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|~|~|~
20+|0.6|0.6|0.6|Malignant|1456|231502255|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|~|~|~
20+|0.6|0.6|0.6|Malignant|1467|233947093|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013|0.6|0.7|0.6
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|~|~|~
20+|0.6|0.7|0.6|Malignant|1630|236440755|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014|0.7|0.7|0.7
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|~|~|~
20+|0.6|0.6|0.6|Malignant|1565|238812700|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015|0.6|0.7|0.7
20+|8.8|9.0|8.9|Benign/Borderline|18871|211050944|Male and Female|Meningioma|2004|8.8|9.1|8.9
20+|0.2|0.2|0.2|Malignant|441|211050944|Male and Female|Meningioma|2004|0.2|0.2|0.2
20+|9.8|10.1|9.9|Benign/Borderline|21486|213511339|Male and Female|Meningioma|2005|9.9|10.2|10.1
20+|0.2|0.2|0.2|Malignant|435|213511339|Male and Female|Meningioma|2005|0.2|0.2|0.2
20+|10.3|10.6|10.4|Benign/Borderline|22909|216055494|Male and Female|Meningioma|2006|10.5|10.7|10.6
20+|0.2|0.2|0.2|Malignant|404|216055494|Male and Female|Meningioma|2006|0.2|0.2|0.2
20+|10.6|10.8|10.7|Benign/Borderline|23938|218481776|Male and Female|Meningioma|2007|10.8|11.1|11.0
20+|0.2|0.2|0.2|Malignant|447|218481776|Male and Female|Meningioma|2007|0.2|0.2|0.2
20+|11.1|11.4|11.3|Benign/Borderline|25704|220975702|Male and Female|Meningioma|2008|11.5|11.8|11.6
20+|0.1|0.2|0.2|Malignant|361|220975702|Male and Female|Meningioma|2008|0.1|0.2|0.2
20+|11.8|12.1|12.0|Benign/Borderline|27772|223491138|Male and Female|Meningioma|2009|12.3|12.6|12.4
20+|0.1|0.2|0.1|Malignant|351|223491138|Male and Female|Meningioma|2009|0.1|0.2|0.2
20+|11.4|11.7|11.5|Benign/Borderline|27320|226162376|Male and Female|Meningioma|2010|11.9|12.2|12.1
20+|0.1|0.2|0.1|Malignant|325|226162376|Male and Female|Meningioma|2010|0.1|0.2|0.1
20+|11.4|11.7|11.6|Benign/Borderline|27839|228824481|Male and Female|Meningioma|2011|12.0|12.3|12.2
20+|0.1|0.2|0.1|Malignant|327|228824481|Male and Female|Meningioma|2011|0.1|0.2|0.1
20+|11.5|11.7|11.6|Benign/Borderline|145174|1169527284|Male and Female|Meningioma|2011-2015|12.3|12.5|12.4
20+|0.1|0.1|0.1|Malignant|1753|1169527284|Male and Female|Meningioma|2011-2015|0.1|0.2|0.1
20+|11.5|11.7|11.6|Benign/Borderline|28442|231502255|Male and Female|Meningioma|2012|12.1|12.4|12.3
20+|0.1|0.2|0.1|Malignant|348|231502255|Male and Female|Meningioma|2012|0.1|0.2|0.2
20+|11.6|11.8|11.7|Benign/Borderline|29198|233947093|Male and Female|Meningioma|2013|12.3|12.6|12.5
20+|0.1|0.2|0.2|Malignant|382|233947093|Male and Female|Meningioma|2013|0.1|0.2|0.2
20+|11.5|11.8|11.6|Benign/Borderline|29676|236440755|Male and Female|Meningioma|2014|12.4|12.7|12.6
20+|0.1|0.2|0.1|Malignant|376|236440755|Male and Female|Meningioma|2014|0.1|0.2|0.2
20+|11.4|11.7|11.5|Benign/Borderline|30019|238812700|Male and Female|Meningioma|2015|12.4|12.7|12.6
20+|0.1|0.1|0.1|Malignant|320|238812700|Male and Female|Meningioma|2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004|~|~|~
20+|0.2|0.3|0.2|Malignant|491|211050944|Male and Female|Mixed glioma|2004|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005|~|~|~
20+|0.2|0.3|0.3|Malignant|566|213511339|Male and Female|Mixed glioma|2005|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006|~|~|~
20+|0.3|0.3|0.3|Malignant|636|216055494|Male and Female|Mixed glioma|2006|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007|~|~|~
20+|0.3|0.3|0.3|Malignant|588|218481776|Male and Female|Mixed glioma|2007|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008|~|~|~
20+|0.3|0.3|0.3|Malignant|600|220975702|Male and Female|Mixed glioma|2008|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009|~|~|~
20+|0.3|0.3|0.3|Malignant|677|223491138|Male and Female|Mixed glioma|2009|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Mixed glioma|2010|~|~|~
20+|0.3|0.3|0.3|Malignant|611|226162376|Male and Female|Mixed glioma|2010|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Mixed glioma|2011|~|~|~
20+|0.3|0.3|0.3|Malignant|631|228824481|Male and Female|Mixed glioma|2011|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Mixed glioma|2011-2015|~|~|~
20+|0.2|0.2|0.2|Malignant|2555|1169527284|Male and Female|Mixed glioma|2011-2015|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Mixed glioma|2012|~|~|~
20+|0.2|0.3|0.3|Malignant|567|231502255|Male and Female|Mixed glioma|2012|0.2|0.3|0.2
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Mixed glioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|620|233947093|Male and Female|Mixed glioma|2013|0.2|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Mixed glioma|2014|~|~|~
20+|0.2|0.2|0.2|Malignant|463|236440755|Male and Female|Mixed glioma|2014|0.2|0.2|0.2
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Mixed glioma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|274|238812700|Male and Female|Mixed glioma|2015|0.1|0.1|0.1
20+|0.5|0.6|0.6|Benign/Borderline|1187|211050944|Male and Female|Neoplasm, unspecified|2004|0.5|0.6|0.6
20+|0.6|0.7|0.6|Malignant|1314|211050944|Male and Female|Neoplasm, unspecified|2004|0.6|0.7|0.6
20+|0.7|0.7|0.7|Benign/Borderline|1493|213511339|Male and Female|Neoplasm, unspecified|2005|0.7|0.7|0.7
20+|0.6|0.7|0.6|Malignant|1320|213511339|Male and Female|Neoplasm, unspecified|2005|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1406|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1283|216055494|Male and Female|Neoplasm, unspecified|2006|0.6|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1423|218481776|Male and Female|Neoplasm, unspecified|2007|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1216|218481776|Male and Female|Neoplasm, unspecified|2007|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1431|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.6|0.6|Malignant|1367|220975702|Male and Female|Neoplasm, unspecified|2008|0.6|0.7|0.6
20+|0.6|0.7|0.7|Benign/Borderline|1516|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.7
20+|0.6|0.6|0.6|Malignant|1422|223491138|Male and Female|Neoplasm, unspecified|2009|0.6|0.7|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1464|226162376|Male and Female|Neoplasm, unspecified|2010|0.6|0.7|0.6
20+|0.5|0.6|0.5|Malignant|1238|226162376|Male and Female|Neoplasm, unspecified|2010|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1448|228824481|Male and Female|Neoplasm, unspecified|2011|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1255|228824481|Male and Female|Neoplasm, unspecified|2011|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|7300|1169527284|Male and Female|Neoplasm, unspecified|2011-2015|0.6|0.6|0.6
20+|0.5|0.5|0.5|Malignant|6475|1169527284|Male and Female|Neoplasm, unspecified|2011-2015|0.5|0.6|0.6
20+|0.6|0.7|0.6|Benign/Borderline|1553|231502255|Male and Female|Neoplasm, unspecified|2012|0.6|0.7|0.7
20+|0.5|0.6|0.5|Malignant|1285|231502255|Male and Female|Neoplasm, unspecified|2012|0.5|0.6|0.6
20+|0.6|0.6|0.6|Benign/Borderline|1459|233947093|Male and Female|Neoplasm, unspecified|2013|0.6|0.7|0.6
20+|0.5|0.5|0.5|Malignant|1272|233947093|Male and Female|Neoplasm, unspecified|2013|0.5|0.6|0.5
20+|0.6|0.6|0.6|Benign/Borderline|1469|236440755|Male and Female|Neoplasm, unspecified|2014|0.6|0.7|0.6
20+|0.5|0.6|0.5|Malignant|1382|236440755|Male and Female|Neoplasm, unspecified|2014|0.6|0.6|0.6
20+|0.5|0.6|0.5|Benign/Borderline|1371|238812700|Male and Female|Neoplasm, unspecified|2015|0.5|0.6|0.6
20+|0.5|0.5|0.5|Malignant|1281|238812700|Male and Female|Neoplasm, unspecified|2015|0.5|0.6|0.5
20+|2.2|2.3|2.3|Benign/Borderline|4847|211050944|Male and Female|Nerve sheath, benign and malignant|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5460|213511339|Male and Female|Nerve sheath, benign and malignant|2005|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Nerve sheath, benign and malignant|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5544|216055494|Male and Female|Nerve sheath, benign and malignant|2006|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5620|218481776|Male and Female|Nerve sheath, benign and malignant|2007|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5701|220975702|Male and Female|Nerve sheath, benign and malignant|2008|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Nerve sheath, benign and malignant|2008|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|6014|223491138|Male and Female|Nerve sheath, benign and malignant|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|35|223491138|Male and Female|Nerve sheath, benign and malignant|2009|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5806|226162376|Male and Female|Nerve sheath, benign and malignant|2010|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|44|226162376|Male and Female|Nerve sheath, benign and malignant|2010|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|6143|228824481|Male and Female|Nerve sheath, benign and malignant|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|36|228824481|Male and Female|Nerve sheath, benign and malignant|2011|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|32670|1169527284|Male and Female|Nerve sheath, benign and malignant|2011-2015|2.8|2.8|2.8
20+|0.0|0.0|0.0|Malignant|203|1169527284|Male and Female|Nerve sheath, benign and malignant|2011-2015|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|6456|231502255|Male and Female|Nerve sheath, benign and malignant|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|50|231502255|Male and Female|Nerve sheath, benign and malignant|2012|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|6612|233947093|Male and Female|Nerve sheath, benign and malignant|2013|2.8|2.9|2.8
20+|0.0|0.0|0.0|Malignant|43|233947093|Male and Female|Nerve sheath, benign and malignant|2013|0.0|0.0|0.0
20+|2.7|2.8|2.7|Benign/Borderline|6884|236440755|Male and Female|Nerve sheath, benign and malignant|2014|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|37|236440755|Male and Female|Nerve sheath, benign and malignant|2014|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|6575|238812700|Male and Female|Nerve sheath, benign and malignant|2015|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|37|238812700|Male and Female|Nerve sheath, benign and malignant|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004|~|~|~
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005|~|~|~
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006|~|~|~
20+|0.0|0.0|0.0|Malignant|41|216055494|Male and Female|Neuroepithelial|2006|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007|~|~|~
20+|0.0|0.0|0.0|Malignant|52|218481776|Male and Female|Neuroepithelial|2007|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008|~|~|~
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009|~|~|~
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Neuroepithelial|2009|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Neuroepithelial|2010|~|~|~
20+|0.0|0.0|0.0|Malignant|52|226162376|Male and Female|Neuroepithelial|2010|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Neuroepithelial|2011|~|~|~
20+|0.0|0.0|0.0|Malignant|51|228824481|Male and Female|Neuroepithelial|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|29|1169527284|Male and Female|Neuroepithelial|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|274|1169527284|Male and Female|Neuroepithelial|2011-2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Neuroepithelial|2012|~|~|~
20+|0.0|0.0|0.0|Malignant|54|231502255|Male and Female|Neuroepithelial|2012|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Neuroepithelial|2013|~|~|~
20+|0.0|0.0|0.0|Malignant|49|233947093|Male and Female|Neuroepithelial|2013|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Neuroepithelial|2014|~|~|~
20+|0.0|0.0|0.0|Malignant|56|236440755|Male and Female|Neuroepithelial|2014|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Neuroepithelial|2015|~|~|~
20+|0.0|0.0|0.0|Malignant|64|238812700|Male and Female|Neuroepithelial|2015|0.0|0.0|0.0
20+|0.1|0.2|0.1|Benign/Borderline|314|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.1|0.2|0.1
20+|0.0|0.0|0.0|Malignant|37|211050944|Male and Female|Neuronal/glial, neuronal|2004|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|371|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|55|213511339|Male and Female|Neuronal/glial, neuronal|2005|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|386|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|43|216055494|Male and Female|Neuronal/glial, neuronal|2006|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|385|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|45|218481776|Male and Female|Neuronal/glial, neuronal|2007|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|419|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|47|220975702|Male and Female|Neuronal/glial, neuronal|2008|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|436|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|223491138|Male and Female|Neuronal/glial, neuronal|2009|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|482|226162376|Male and Female|Neuronal/glial, neuronal|2010|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|34|226162376|Male and Female|Neuronal/glial, neuronal|2010|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|424|228824481|Male and Female|Neuronal/glial, neuronal|2011|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|40|228824481|Male and Female|Neuronal/glial, neuronal|2011|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|2138|1169527284|Male and Female|Neuronal/glial, neuronal|2011-2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|174|1169527284|Male and Female|Neuronal/glial, neuronal|2011-2015|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|412|231502255|Male and Female|Neuronal/glial, neuronal|2012|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|41|231502255|Male and Female|Neuronal/glial, neuronal|2012|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|390|233947093|Male and Female|Neuronal/glial, neuronal|2013|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|233947093|Male and Female|Neuronal/glial, neuronal|2013|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|447|236440755|Male and Female|Neuronal/glial, neuronal|2014|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|33|236440755|Male and Female|Neuronal/glial, neuronal|2014|0.0|0.0|0.0
20+|0.2|0.2|0.2|Benign/Borderline|465|238812700|Male and Female|Neuronal/glial, neuronal|2015|0.2|0.2|0.2
20+|0.0|0.0|0.0|Malignant|30|238812700|Male and Female|Neuronal/glial, neuronal|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004|~|~|~
20+|0.4|0.4|0.4|Malignant|825|211050944|Male and Female|Oligodendroglioma|2004|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005|~|~|~
20+|0.4|0.4|0.4|Malignant|796|213511339|Male and Female|Oligodendroglioma|2005|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006|~|~|~
20+|0.4|0.4|0.4|Malignant|841|216055494|Male and Female|Oligodendroglioma|2006|0.4|0.4|0.4
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007|~|~|~
20+|0.4|0.4|0.4|Malignant|808|218481776|Male and Female|Oligodendroglioma|2007|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008|~|~|~
20+|0.3|0.4|0.4|Malignant|761|220975702|Male and Female|Oligodendroglioma|2008|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009|~|~|~
20+|0.4|0.4|0.4|Malignant|828|223491138|Male and Female|Oligodendroglioma|2009|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Oligodendroglioma|2010|~|~|~
20+|0.3|0.4|0.4|Malignant|794|226162376|Male and Female|Oligodendroglioma|2010|0.3|0.4|0.4
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Oligodendroglioma|2011|~|~|~
20+|0.3|0.4|0.3|Malignant|755|228824481|Male and Female|Oligodendroglioma|2011|0.3|0.4|0.3
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Oligodendroglioma|2011-2015|~|~|~
20+|0.3|0.3|0.3|Malignant|3499|1169527284|Male and Female|Oligodendroglioma|2011-2015|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Oligodendroglioma|2012|~|~|~
20+|0.3|0.3|0.3|Malignant|657|231502255|Male and Female|Oligodendroglioma|2012|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Oligodendroglioma|2013|~|~|~
20+|0.3|0.3|0.3|Malignant|697|233947093|Male and Female|Oligodendroglioma|2013|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Oligodendroglioma|2014|~|~|~
20+|0.3|0.3|0.3|Malignant|701|236440755|Male and Female|Oligodendroglioma|2014|0.3|0.3|0.3
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Oligodendroglioma|2015|~|~|~
20+|0.3|0.3|0.3|Malignant|689|238812700|Male and Female|Oligodendroglioma|2015|0.3|0.3|0.3
20+|0.1|0.1|0.1|Benign/Borderline|149|211050944|Male and Female|Other mesenchymal|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|55|211050944|Male and Female|Other mesenchymal|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|156|213511339|Male and Female|Other mesenchymal|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|63|213511339|Male and Female|Other mesenchymal|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|155|216055494|Male and Female|Other mesenchymal|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|216055494|Male and Female|Other mesenchymal|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|166|218481776|Male and Female|Other mesenchymal|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|75|218481776|Male and Female|Other mesenchymal|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|202|220975702|Male and Female|Other mesenchymal|2008|0.1|0.1|0.1
20+|0.0|0.1|0.0|Malignant|98|220975702|Male and Female|Other mesenchymal|2008|0.0|0.1|0.0
20+|0.1|0.1|0.1|Benign/Borderline|198|223491138|Male and Female|Other mesenchymal|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|72|223491138|Male and Female|Other mesenchymal|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|172|226162376|Male and Female|Other mesenchymal|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|67|226162376|Male and Female|Other mesenchymal|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|159|228824481|Male and Female|Other mesenchymal|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|74|228824481|Male and Female|Other mesenchymal|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|887|1169527284|Male and Female|Other mesenchymal|2011-2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|384|1169527284|Male and Female|Other mesenchymal|2011-2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|202|231502255|Male and Female|Other mesenchymal|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|67|231502255|Male and Female|Other mesenchymal|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|170|233947093|Male and Female|Other mesenchymal|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|83|233947093|Male and Female|Other mesenchymal|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|171|236440755|Male and Female|Other mesenchymal|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|79|236440755|Male and Female|Other mesenchymal|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|185|238812700|Male and Female|Other mesenchymal|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|81|238812700|Male and Female|Other mesenchymal|2015|0.0|0.0|0.0
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004|~|~|~
20+|0.1|0.1|0.1|Malignant|274|211050944|Male and Female|Pilocytic astrocytoma|2004|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005|~|~|~
20+|0.1|0.2|0.1|Malignant|305|213511339|Male and Female|Pilocytic astrocytoma|2005|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006|~|~|~
20+|0.1|0.2|0.1|Malignant|307|216055494|Male and Female|Pilocytic astrocytoma|2006|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007|~|~|~
20+|0.1|0.2|0.1|Malignant|304|218481776|Male and Female|Pilocytic astrocytoma|2007|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008|~|~|~
20+|0.1|0.1|0.1|Malignant|289|220975702|Male and Female|Pilocytic astrocytoma|2008|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009|~|~|~
20+|0.1|0.1|0.1|Malignant|272|223491138|Male and Female|Pilocytic astrocytoma|2009|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|226162376|Male and Female|Pilocytic astrocytoma|2010|~|~|~
20+|0.1|0.2|0.1|Malignant|328|226162376|Male and Female|Pilocytic astrocytoma|2010|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|228824481|Male and Female|Pilocytic astrocytoma|2011|~|~|~
20+|0.1|0.2|0.1|Malignant|331|228824481|Male and Female|Pilocytic astrocytoma|2011|0.1|0.2|0.1
20+|~|~|~|Benign/Borderline|~|1169527284|Male and Female|Pilocytic astrocytoma|2011-2015|~|~|~
20+|0.1|0.1|0.1|Malignant|1472|1169527284|Male and Female|Pilocytic astrocytoma|2011-2015|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|231502255|Male and Female|Pilocytic astrocytoma|2012|~|~|~
20+|0.1|0.1|0.1|Malignant|267|231502255|Male and Female|Pilocytic astrocytoma|2012|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|233947093|Male and Female|Pilocytic astrocytoma|2013|~|~|~
20+|0.1|0.1|0.1|Malignant|298|233947093|Male and Female|Pilocytic astrocytoma|2013|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|236440755|Male and Female|Pilocytic astrocytoma|2014|~|~|~
20+|0.1|0.1|0.1|Malignant|293|236440755|Male and Female|Pilocytic astrocytoma|2014|0.1|0.1|0.1
20+|~|~|~|Benign/Borderline|~|238812700|Male and Female|Pilocytic astrocytoma|2015|~|~|~
20+|0.1|0.1|0.1|Malignant|283|238812700|Male and Female|Pilocytic astrocytoma|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|45|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|48|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|218481776|Male and Female|Pineal parenchymal|2007|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|67|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|43|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Pineal parenchymal|2009|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|56|226162376|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|41|226162376|Male and Female|Pineal parenchymal|2010|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|60|228824481|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|43|228824481|Male and Female|Pineal parenchymal|2011|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|310|1169527284|Male and Female|Pineal parenchymal|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|249|1169527284|Male and Female|Pineal parenchymal|2011-2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|62|231502255|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|42|231502255|Male and Female|Pineal parenchymal|2012|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|66|233947093|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|70|233947093|Male and Female|Pineal parenchymal|2013|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|236440755|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|35|236440755|Male and Female|Pineal parenchymal|2014|0.0|0.0|0.0
20+|0.0|0.0|0.0|Benign/Borderline|61|238812700|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|0.0|0.0|0.0|Malignant|59|238812700|Male and Female|Pineal parenchymal|2015|0.0|0.0|0.0
20+|3.4|3.6|3.5|Benign/Borderline|7422|211050944|Male and Female|Pituitary|2004|3.4|3.6|3.5
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Pituitary|2004|0.0|0.0|0.0
20+|3.9|4.0|3.9|Benign/Borderline|8428|213511339|Male and Female|Pituitary|2005|3.9|4.0|3.9
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Pituitary|2005|0.0|0.0|0.0
20+|4.2|4.3|4.3|Benign/Borderline|9213|216055494|Male and Female|Pituitary|2006|4.2|4.4|4.3
20+|0.0|0.0|0.0|Malignant|31|216055494|Male and Female|Pituitary|2006|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|9728|218481776|Male and Female|Pituitary|2007|4.4|4.5|4.5
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Pituitary|2007|0.0|0.0|0.0
20+|4.7|4.8|4.7|Benign/Borderline|10520|220975702|Male and Female|Pituitary|2008|4.7|4.9|4.8
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008|~|~|~
20+|5.0|5.2|5.1|Benign/Borderline|11449|223491138|Male and Female|Pituitary|2009|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|23|223491138|Male and Female|Pituitary|2009|0.0|0.0|0.0
20+|5.0|5.2|5.1|Benign/Borderline|11553|226162376|Male and Female|Pituitary|2010|5.0|5.2|5.1
20+|0.0|0.0|0.0|Malignant|30|226162376|Male and Female|Pituitary|2010|0.0|0.0|0.0
20+|5.0|5.2|5.1|Benign/Borderline|11791|228824481|Male and Female|Pituitary|2011|5.1|5.2|5.2
20+|0.0|0.0|0.0|Malignant|36|228824481|Male and Female|Pituitary|2011|0.0|0.0|0.0
20+|5.2|5.3|5.2|Benign/Borderline|61626|1169527284|Male and Female|Pituitary|2011-2015|5.2|5.3|5.3
20+|0.0|0.0|0.0|Malignant|175|1169527284|Male and Female|Pituitary|2011-2015|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12585|231502255|Male and Female|Pituitary|2012|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|32|231502255|Male and Female|Pituitary|2012|0.0|0.0|0.0
20+|5.2|5.3|5.3|Benign/Borderline|12459|233947093|Male and Female|Pituitary|2013|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|41|233947093|Male and Female|Pituitary|2013|0.0|0.0|0.0
20+|5.1|5.3|5.2|Benign/Borderline|12424|236440755|Male and Female|Pituitary|2014|5.2|5.3|5.3
20+|0.0|0.0|0.0|Malignant|35|236440755|Male and Female|Pituitary|2014|0.0|0.0|0.0
20+|5.0|5.2|5.1|Benign/Borderline|12367|238812700|Male and Female|Pituitary|2015|5.1|5.3|5.2
20+|0.0|0.0|0.0|Malignant|31|238812700|Male and Female|Pituitary|2015|0.0|0.0|0.0
20+|16.1|16.4|16.3|Benign/Borderline|34558|211050944|Male and Female|Total|2004|16.2|16.5|16.4
20+|9.0|9.2|9.1|Malignant|19360|211050944|Male and Female|Total|2004|9.0|9.3|9.2
20+|18.1|18.5|18.3|Benign/Borderline|39463|213511339|Male and Female|Total|2005|18.3|18.7|18.5
20+|9.0|9.3|9.1|Malignant|19701|213511339|Male and Female|Total|2005|9.1|9.4|9.2
20+|18.9|19.3|19.1|Benign/Borderline|41764|216055494|Male and Female|Total|2006|19.1|19.5|19.3
20+|8.9|9.1|9.0|Malignant|19785|216055494|Male and Female|Total|2006|9.0|9.3|9.2
20+|19.3|19.7|19.5|Benign/Borderline|43457|218481776|Male and Female|Total|2007|19.7|20.1|19.9
20+|8.9|9.1|9.0|Malignant|20110|218481776|Male and Female|Total|2007|9.1|9.3|9.2
20+|20.3|20.7|20.5|Benign/Borderline|46426|220975702|Male and Female|Total|2008|20.8|21.2|21.0
20+|8.9|9.2|9.0|Malignant|20552|220975702|Male and Female|Total|2008|9.2|9.4|9.3
20+|21.6|21.9|21.7|Benign/Borderline|49987|223491138|Male and Female|Total|2009|22.2|22.6|22.4
20+|8.8|9.1|9.0|Malignant|20762|223491138|Male and Female|Total|2009|9.2|9.4|9.3
20+|21.0|21.4|21.2|Benign/Borderline|49618|226162376|Male and Female|Total|2010|21.7|22.1|21.9
20+|8.6|8.9|8.8|Malignant|20653|226162376|Male and Female|Total|2010|9.0|9.3|9.1
20+|21.2|21.6|21.4|Benign/Borderline|50716|228824481|Male and Female|Total|2011|22.0|22.4|22.2
20+|8.5|8.8|8.7|Malignant|20793|228824481|Male and Female|Total|2011|9.0|9.2|9.1
20+|21.5|21.6|21.5|Benign/Borderline|264178|1169527284|Male and Female|Total|2011-2015|22.5|22.7|22.6
20+|8.5|8.6|8.5|Malignant|106212|1169527284|Male and Female|Total|2011-2015|9.0|9.1|9.1
20+|21.6|22.0|21.8|Benign/Borderline|52601|231502255|Male and Female|Total|2012|22.5|22.9|22.7
20+|8.5|8.7|8.6|Malignant|21079|231502255|Male and Female|Total|2012|9.0|9.2|9.1
20+|21.5|21.9|21.7|Benign/Borderline|53235|233947093|Male and Female|Total|2013|22.6|22.9|22.8
20+|8.5|8.7|8.6|Malignant|21381|233947093|Male and Female|Total|2013|9.0|9.3|9.1
20+|21.5|21.8|21.6|Benign/Borderline|53923|236440755|Male and Female|Total|2014|22.6|23.0|22.8
20+|8.4|8.6|8.5|Malignant|21498|236440755|Male and Female|Total|2014|9.0|9.2|9.1
20+|21.0|21.3|21.2|Benign/Borderline|53703|238812700|Male and Female|Total|2015|22.3|22.7|22.5
20+|8.2|8.4|8.3|Malignant|21461|238812700|Male and Female|Total|2015|8.9|9.1|9.0
20+|2.2|2.3|2.3|Benign/Borderline|4847|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|2.2|2.4|2.3
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5463|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5546|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5622|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007|0.0|0.0|0.0
20+|2.4|2.6|2.5|Benign/Borderline|5705|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008|0.0|0.0|0.0
20+|2.5|2.7|2.6|Benign/Borderline|6021|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|35|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009|0.0|0.0|0.0
20+|2.4|2.5|2.5|Benign/Borderline|5810|226162376|Male and Female|Tumors of Cranial and Spinal Nerves|2010|2.5|2.6|2.6
20+|0.0|0.0|0.0|Malignant|44|226162376|Male and Female|Tumors of Cranial and Spinal Nerves|2010|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|6148|228824481|Male and Female|Tumors of Cranial and Spinal Nerves|2011|2.6|2.8|2.7
20+|0.0|0.0|0.0|Malignant|36|228824481|Male and Female|Tumors of Cranial and Spinal Nerves|2011|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|32700|1169527284|Male and Female|Tumors of Cranial and Spinal Nerves|2011-2015|2.8|2.8|2.8
20+|0.0|0.0|0.0|Malignant|203|1169527284|Male and Female|Tumors of Cranial and Spinal Nerves|2011-2015|0.0|0.0|0.0
20+|2.6|2.7|2.6|Benign/Borderline|6458|231502255|Male and Female|Tumors of Cranial and Spinal Nerves|2012|2.7|2.9|2.8
20+|0.0|0.0|0.0|Malignant|50|231502255|Male and Female|Tumors of Cranial and Spinal Nerves|2012|0.0|0.0|0.0
20+|2.6|2.7|2.7|Benign/Borderline|6617|233947093|Male and Female|Tumors of Cranial and Spinal Nerves|2013|2.8|2.9|2.8
20+|0.0|0.0|0.0|Malignant|43|233947093|Male and Female|Tumors of Cranial and Spinal Nerves|2013|0.0|0.0|0.0
20+|2.7|2.8|2.8|Benign/Borderline|6892|236440755|Male and Female|Tumors of Cranial and Spinal Nerves|2014|2.8|3.0|2.9
20+|0.0|0.0|0.0|Malignant|37|236440755|Male and Female|Tumors of Cranial and Spinal Nerves|2014|0.0|0.0|0.0
20+|2.5|2.6|2.6|Benign/Borderline|6585|238812700|Male and Female|Tumors of Cranial and Spinal Nerves|2015|2.7|2.8|2.8
20+|0.0|0.0|0.0|Malignant|37|238812700|Male and Female|Tumors of Cranial and Spinal Nerves|2015|0.0|0.0|0.0
20+|0.4|0.4|0.4|Benign/Borderline|825|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|0.4|0.4|0.4
20+|7.4|7.6|7.5|Malignant|15999|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004|7.5|7.7|7.6
20+|0.4|0.5|0.4|Benign/Borderline|961|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16225|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1035|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16400|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006|7.5|7.7|7.6
20+|0.4|0.5|0.5|Benign/Borderline|991|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|0.4|0.5|0.5
20+|7.4|7.6|7.5|Malignant|16761|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1067|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17041|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008|7.6|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1093|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|0.5|0.5|0.5
20+|7.4|7.6|7.5|Malignant|17312|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009|7.6|7.9|7.7
20+|0.5|0.6|0.5|Benign/Borderline|1189|226162376|Male and Female|Tumors of Neuroepthelial Tissue|2010|0.5|0.6|0.5
20+|7.2|7.4|7.3|Malignant|17302|226162376|Male and Female|Tumors of Neuroepthelial Tissue|2010|7.5|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1148|228824481|Male and Female|Tumors of Neuroepthelial Tissue|2011|0.5|0.5|0.5
20+|7.1|7.4|7.2|Malignant|17402|228824481|Male and Female|Tumors of Neuroepthelial Tissue|2011|7.5|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|5890|1169527284|Male and Female|Tumors of Neuroepthelial Tissue|2011-2015|0.5|0.5|0.5
20+|7.1|7.2|7.1|Malignant|88939|1169527284|Male and Female|Tumors of Neuroepthelial Tissue|2011-2015|7.6|7.7|7.6
20+|0.5|0.5|0.5|Benign/Borderline|1148|231502255|Male and Female|Tumors of Neuroepthelial Tissue|2012|0.5|0.5|0.5
20+|7.1|7.3|7.2|Malignant|17724|231502255|Male and Female|Tumors of Neuroepthelial Tissue|2012|7.5|7.8|7.7
20+|0.5|0.5|0.5|Benign/Borderline|1117|233947093|Male and Female|Tumors of Neuroepthelial Tissue|2013|0.4|0.5|0.5
20+|7.1|7.3|7.2|Malignant|17978|233947093|Male and Female|Tumors of Neuroepthelial Tissue|2013|7.6|7.8|7.7
20+|0.5|0.6|0.5|Benign/Borderline|1234|236440755|Male and Female|Tumors of Neuroepthelial Tissue|2014|0.5|0.6|0.5
20+|6.9|7.1|7.0|Malignant|17813|236440755|Male and Female|Tumors of Neuroepthelial Tissue|2014|7.4|7.6|7.5
20+|0.5|0.6|0.5|Benign/Borderline|1243|238812700|Male and Female|Tumors of Neuroepthelial Tissue|2015|0.5|0.6|0.5
20+|6.9|7.1|7.0|Malignant|18022|238812700|Male and Female|Tumors of Neuroepthelial Tissue|2015|7.4|7.7|7.5
20+|3.6|3.8|3.7|Benign/Borderline|7810|211050944|Male and Female|Tumors of Sellar Region|2004|3.6|3.8|3.7
20+|0.0|0.0|0.0|Malignant|43|211050944|Male and Female|Tumors of Sellar Region|2004|0.0|0.0|0.0
20+|4.0|4.2|4.1|Benign/Borderline|8842|213511339|Male and Female|Tumors of Sellar Region|2005|4.1|4.2|4.1
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Tumors of Sellar Region|2005|0.0|0.0|0.0
20+|4.3|4.5|4.4|Benign/Borderline|9603|216055494|Male and Female|Tumors of Sellar Region|2006|4.4|4.5|4.4
20+|0.0|0.0|0.0|Malignant|33|216055494|Male and Female|Tumors of Sellar Region|2006|0.0|0.0|0.0
20+|4.5|4.7|4.6|Benign/Borderline|10143|218481776|Male and Female|Tumors of Sellar Region|2007|4.6|4.7|4.6
20+|0.0|0.0|0.0|Malignant|33|218481776|Male and Female|Tumors of Sellar Region|2007|0.0|0.0|0.0
20+|4.8|5.0|4.9|Benign/Borderline|10940|220975702|Male and Female|Tumors of Sellar Region|2008|4.9|5.0|5.0
20+|0.0|0.0|0.0|Malignant|16|220975702|Male and Female|Tumors of Sellar Region|2008|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|11877|223491138|Male and Female|Tumors of Sellar Region|2009|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|24|223491138|Male and Female|Tumors of Sellar Region|2009|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|11990|226162376|Male and Female|Tumors of Sellar Region|2010|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|30|226162376|Male and Female|Tumors of Sellar Region|2010|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|12201|228824481|Male and Female|Tumors of Sellar Region|2011|5.2|5.4|5.3
20+|0.0|0.0|0.0|Malignant|38|228824481|Male and Female|Tumors of Sellar Region|2011|0.0|0.0|0.0
20+|5.4|5.4|5.4|Benign/Borderline|63790|1169527284|Male and Female|Tumors of Sellar Region|2011-2015|5.4|5.5|5.5
20+|0.0|0.0|0.0|Malignant|184|1169527284|Male and Female|Tumors of Sellar Region|2011-2015|0.0|0.0|0.0
20+|5.5|5.7|5.6|Benign/Borderline|13019|231502255|Male and Female|Tumors of Sellar Region|2012|5.5|5.7|5.6
20+|0.0|0.0|0.0|Malignant|32|231502255|Male and Female|Tumors of Sellar Region|2012|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12919|233947093|Male and Female|Tumors of Sellar Region|2013|5.4|5.6|5.5
20+|0.0|0.0|0.0|Malignant|42|233947093|Male and Female|Tumors of Sellar Region|2013|0.0|0.0|0.0
20+|5.3|5.5|5.4|Benign/Borderline|12844|236440755|Male and Female|Tumors of Sellar Region|2014|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|40|236440755|Male and Female|Tumors of Sellar Region|2014|0.0|0.0|0.0
20+|5.2|5.4|5.3|Benign/Borderline|12807|238812700|Male and Female|Tumors of Sellar Region|2015|5.3|5.5|5.4
20+|0.0|0.0|0.0|Malignant|32|238812700|Male and Female|Tumors of Sellar Region|2015|0.0|0.0|0.0
20+|9.0|9.3|9.2|Benign/Borderline|19475|211050944|Male and Female|Tumors of the Meninges|2004|9.1|9.4|9.2
20+|0.2|0.3|0.2|Malignant|497|211050944|Male and Female|Tumors of the Meninges|2004|0.2|0.3|0.2
20+|10.1|10.4|10.3|Benign/Borderline|22153|213511339|Male and Female|Tumors of the Meninges|2005|10.2|10.5|10.4
20+|0.2|0.3|0.2|Malignant|501|213511339|Male and Female|Tumors of the Meninges|2005|0.2|0.3|0.2
20+|10.6|10.9|10.7|Benign/Borderline|23562|216055494|Male and Female|Tumors of the Meninges|2006|10.8|11.0|10.9
20+|0.2|0.2|0.2|Malignant|467|216055494|Male and Female|Tumors of the Meninges|2006|0.2|0.2|0.2
20+|10.9|11.1|11.0|Benign/Borderline|24575|218481776|Male and Female|Tumors of the Meninges|2007|11.1|11.4|11.2
20+|0.2|0.3|0.2|Malignant|529|218481776|Male and Female|Tumors of the Meninges|2007|0.2|0.3|0.2
20+|11.4|11.7|11.6|Benign/Borderline|26434|220975702|Male and Female|Tumors of the Meninges|2008|11.8|12.1|12.0
20+|0.2|0.2|0.2|Malignant|463|220975702|Male and Female|Tumors of the Meninges|2008|0.2|0.2|0.2
20+|12.1|12.4|12.3|Benign/Borderline|28475|223491138|Male and Female|Tumors of the Meninges|2009|12.6|12.9|12.7
20+|0.2|0.2|0.2|Malignant|426|223491138|Male and Female|Tumors of the Meninges|2009|0.2|0.2|0.2
20+|11.7|12.0|11.9|Benign/Borderline|28017|226162376|Male and Female|Tumors of the Meninges|2010|12.2|12.5|12.4
20+|0.1|0.2|0.2|Malignant|394|226162376|Male and Female|Tumors of the Meninges|2010|0.2|0.2|0.2
20+|11.7|12.0|11.9|Benign/Borderline|28508|228824481|Male and Female|Tumors of the Meninges|2011|12.3|12.6|12.5
20+|0.2|0.2|0.2|Malignant|402|228824481|Male and Female|Tumors of the Meninges|2011|0.2|0.2|0.2
20+|11.8|12.0|11.9|Benign/Borderline|148591|1169527284|Male and Female|Tumors of the Meninges|2011-2015|12.6|12.8|12.7
20+|0.2|0.2|0.2|Malignant|2154|1169527284|Male and Female|Tumors of the Meninges|2011-2015|0.2|0.2|0.2
20+|11.8|12.0|11.9|Benign/Borderline|29171|231502255|Male and Female|Tumors of the Meninges|2012|12.5|12.7|12.6
20+|0.2|0.2|0.2|Malignant|415|231502255|Male and Female|Tumors of the Meninges|2012|0.2|0.2|0.2
20+|11.8|12.1|12.0|Benign/Borderline|29870|233947093|Male and Female|Tumors of the Meninges|2013|12.6|12.9|12.8
20+|0.2|0.2|0.2|Malignant|469|233947093|Male and Female|Tumors of the Meninges|2013|0.2|0.2|0.2
20+|11.8|12.1|11.9|Benign/Borderline|30326|236440755|Male and Female|Tumors of the Meninges|2014|12.7|13.0|12.8
20+|0.2|0.2|0.2|Malignant|462|236440755|Male and Female|Tumors of the Meninges|2014|0.2|0.2|0.2
20+|11.7|12.0|11.8|Benign/Borderline|30716|238812700|Male and Female|Tumors of the Meninges|2015|12.7|13.0|12.9
20+|0.1|0.2|0.2|Malignant|406|238812700|Male and Female|Tumors of the Meninges|2015|0.2|0.2|0.2
20+|0.7|0.8|0.7|Benign/Borderline|1560|211050944|Male and Female|Unclassified Tumors|2004|0.7|0.8|0.7
20+|0.6|0.7|0.6|Malignant|1327|211050944|Male and Female|Unclassified Tumors|2004|0.6|0.7|0.6
20+|0.9|1.0|0.9|Benign/Borderline|1975|213511339|Male and Female|Unclassified Tumors|2005|0.9|1.0|0.9
20+|0.6|0.7|0.6|Malignant|1333|213511339|Male and Female|Unclassified Tumors|2005|0.6|0.7|0.6
20+|0.9|0.9|0.9|Benign/Borderline|1952|216055494|Male and Female|Unclassified Tumors|2006|0.9|0.9|0.9
20+|0.6|0.6|0.6|Malignant|1299|216055494|Male and Female|Unclassified Tumors|2006|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2054|218481776|Male and Female|Unclassified Tumors|2007|0.9|1.0|0.9
20+|0.5|0.6|0.6|Malignant|1227|218481776|Male and Female|Unclassified Tumors|2007|0.5|0.6|0.6
20+|0.9|1.0|1.0|Benign/Borderline|2214|220975702|Male and Female|Unclassified Tumors|2008|1.0|1.0|1.0
20+|0.6|0.6|0.6|Malignant|1391|220975702|Male and Female|Unclassified Tumors|2008|0.6|0.7|0.6
20+|1.0|1.1|1.1|Benign/Borderline|2443|223491138|Male and Female|Unclassified Tumors|2009|1.1|1.1|1.1
20+|0.6|0.7|0.6|Malignant|1440|223491138|Male and Female|Unclassified Tumors|2009|0.6|0.7|0.6
20+|1.1|1.1|1.1|Benign/Borderline|2552|226162376|Male and Female|Unclassified Tumors|2010|1.1|1.2|1.1
20+|0.5|0.6|0.5|Malignant|1259|226162376|Male and Female|Unclassified Tumors|2010|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2650|228824481|Male and Female|Unclassified Tumors|2011|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1277|228824481|Male and Female|Unclassified Tumors|2011|0.5|0.6|0.6
20+|1.0|1.1|1.1|Benign/Borderline|12920|1169527284|Male and Female|Unclassified Tumors|2011-2015|1.1|1.1|1.1
20+|0.5|0.5|0.5|Malignant|6561|1169527284|Male and Female|Unclassified Tumors|2011-2015|0.5|0.6|0.6
20+|1.1|1.2|1.1|Benign/Borderline|2741|231502255|Male and Female|Unclassified Tumors|2012|1.1|1.2|1.2
20+|0.5|0.6|0.5|Malignant|1302|231502255|Male and Female|Unclassified Tumors|2012|0.5|0.6|0.6
20+|1.1|1.1|1.1|Benign/Borderline|2662|233947093|Male and Female|Unclassified Tumors|2013|1.1|1.2|1.1
20+|0.5|0.5|0.5|Malignant|1286|233947093|Male and Female|Unclassified Tumors|2013|0.5|0.6|0.5
20+|1.0|1.1|1.0|Benign/Borderline|2568|236440755|Male and Female|Unclassified Tumors|2014|1.0|1.1|1.1
20+|0.5|0.6|0.5|Malignant|1399|236440755|Male and Female|Unclassified Tumors|2014|0.6|0.6|0.6
20+|0.9|1.0|0.9|Benign/Borderline|2299|238812700|Male and Female|Unclassified Tumors|2015|0.9|1.0|1.0
20+|0.5|0.5|0.5|Malignant|1297|238812700|Male and Female|Unclassified Tumors|2015|0.5|0.6|0.5
20+|0.1|0.1|0.1|Benign/Borderline|151|211050944|Male and Female|Unique astrocytoma variants|2004|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|35|211050944|Male and Female|Unique astrocytoma variants|2004|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|155|213511339|Male and Female|Unique astrocytoma variants|2005|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Unique astrocytoma variants|2005|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|185|216055494|Male and Female|Unique astrocytoma variants|2006|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|216055494|Male and Female|Unique astrocytoma variants|2006|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|183|218481776|Male and Female|Unique astrocytoma variants|2007|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|48|218481776|Male and Female|Unique astrocytoma variants|2007|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|206|220975702|Male and Female|Unique astrocytoma variants|2008|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|220975702|Male and Female|Unique astrocytoma variants|2008|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|234|223491138|Male and Female|Unique astrocytoma variants|2009|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|65|223491138|Male and Female|Unique astrocytoma variants|2009|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|253|226162376|Male and Female|Unique astrocytoma variants|2010|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|46|226162376|Male and Female|Unique astrocytoma variants|2010|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|262|228824481|Male and Female|Unique astrocytoma variants|2011|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|60|228824481|Male and Female|Unique astrocytoma variants|2011|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|1318|1169527284|Male and Female|Unique astrocytoma variants|2011-2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|312|1169527284|Male and Female|Unique astrocytoma variants|2011-2015|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|270|231502255|Male and Female|Unique astrocytoma variants|2012|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|57|231502255|Male and Female|Unique astrocytoma variants|2012|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|259|233947093|Male and Female|Unique astrocytoma variants|2013|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|69|233947093|Male and Female|Unique astrocytoma variants|2013|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|262|236440755|Male and Female|Unique astrocytoma variants|2014|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|77|236440755|Male and Female|Unique astrocytoma variants|2014|0.0|0.0|0.0
20+|0.1|0.1|0.1|Benign/Borderline|265|238812700|Male and Female|Unique astrocytoma variants|2015|0.1|0.1|0.1
20+|0.0|0.0|0.0|Malignant|49|238812700|Male and Female|Unique astrocytoma variants|2015|0.0|0.0|0.0
